林欣霓的个人主页 - 老虎社区

林欣霓

林欣霓

暂无个人介绍

IP属地：未知

97关注

19粉丝

0主题

0勋章

2021-11-11

Wood saids The next big 'Aha moment' for the market is when we see some success on [Tesla's] full self-driving autonomous front[微笑]

抱歉，原内容已删除

2021-11-09

With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.

U.S. government to buy $1 billion more worth of Merck's COVID-19 pill<blockquote>美国政府将再购买价值10亿美元的默克COVID-19药物</blockquote>

2021-11-03

$KEPPEL DC REIT(AJBU.SI)$will increase position to average down to 2.40

2021-11-03

This 2day sudden shoot up? Any good news?

2021-08-27

Chip shortage will be a concern

Can Tesla Shares Hit $900 Again This Year?<blockquote>特斯拉股价今年能否再次触及900美元？</blockquote>

2021-08-26

Michael Burry vs Cathie Wood for win?

抱歉，原内容已删除

2021-08-25

X//@林欣霓: Agree penny stock is high risk...

Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>

2021-08-22

Agree penny stock is high risk...

Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>

2021-08-17

The vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose

Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster<blockquote>辉瑞和BioNTech寻求FDA批准Covid-19加强剂</blockquote>

2021-08-13

Take 3rd dose for those weak immune system

抱歉，原内容已删除

2021-08-05

Can still support Chinese EV company

抱歉，原内容已删除

2021-08-04

Google..

抱歉，原内容已删除

2021-07-21

AMC Is time fly to the moon again?

抱歉，原内容已删除

2021-07-14

Yes always take a rest and climb higher

抱歉，原内容已删除

2021-07-09

Keep for long term, aim for high dividend

5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge<blockquote>随着利率暴跌，值得买入并获得巨额股息的5只蓝筹股</blockquote>

2021-07-08

Sell and buying back after

抱歉，原内容已删除

2021-07-06

$KEPPEL DC REIT(AJBU.SI)$ shoot up so fast.. Not even have a chance to buy more at lower price..

2021-07-05

Illegally collected users' personal data

抱歉，原内容已删除

2021-07-01

The downward trend of unemployment ratesis a good sign that the labour market is steadily improving

抱歉，原内容已删除

2021-06-30

Japan.. Lost Decade

The Lost Decade: Lessons From Japan's Real Estate Crisis<blockquote>失去的十年：日本房地产危机的教训</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3580168616843436","uuid":"3580168616843436","gmtCreate":1617085654174,"gmtModify":1622127892219,"name":"林欣霓","pinyin":"lxnlinxinni","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":19,"headSize":97,"tweetSize":44,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.08","exceedPercentage":"60.84%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":870828808,"gmtCreate":1636602784935,"gmtModify":1636602785083,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Wood saids The next big 'Aha moment' for the market is when we see some success on [Tesla's] full self-driving autonomous front[微笑]&nbsp;","listText":"Wood saids The next big 'Aha moment' for the market is when we see some success on [Tesla's] full self-driving autonomous front[微笑]&nbsp;","text":"Wood saids The next big 'Aha moment' for the market is when we see some success on [Tesla's] full self-driving autonomous front[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870828808","repostId":"2182005821","repostType":4,"isVote":1,"tweetType":1,"viewCount":2226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844774304,"gmtCreate":1636465227237,"gmtModify":1636467782146,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.","listText":"With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.","text":"With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844774304","repostId":"1133150195","repostType":4,"repost":{"id":"1133150195","kind":"news","pubTimestamp":1636463600,"share":"https://www.laohu8.com/m/news/1133150195?lang=zh_CN&edition=full","pubTime":"2021-11-09 21:13","market":"us","language":"en","title":"U.S. government to buy $1 billion more worth of Merck's COVID-19 pill<blockquote>美国政府将再购买价值10亿美元的默克COVID-19药物</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133150195","media":"Reuters","summary":"Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by","content":"<p>Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck &amp; Co Inc(MRK.N)and partner Ridgeback Biotherapeutics, the companies said on Tuesday.</p><p><blockquote>路透11月9日-美国政府将再购买价值10亿美元的默克公司(MRK.N)及其合作伙伴Ridgeback Biotherapeutics周二表示。</blockquote></p><p> The government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.</p><p><blockquote>政府在6月份同意以12亿美元购买170万个疗程的莫努匹拉韦，现在正在行使选择权再购买140万个疗程。</blockquote></p><p> That brings the total secured courses to 3.1 million and worth $2.2 billion. Merck said the government has the right to buy 2 million more courses as part of the contract.</p><p><blockquote>这使得安全课程总数达到310万门，价值22亿美元。默克表示，作为合同的一部分，政府有权再购买200万门课程。</blockquote></p><p> The drug has been closely watched since data last month showed that when given early in the illness it could halve the chances of dying or being hospitalized for those most at risk of developing severe COVID-19.</p><p><blockquote>自上个月的数据显示，如果在疾病早期服用，该药物可以将最有可能患严重COVID-19的人的死亡或住院几率减半以来，该药物一直受到密切关注。</blockquote></p><p> \"Molnupiravir, if authorized, will be among the vaccines and medicines available to fight COVID-19 as part of our collective efforts to bring this pandemic to an end,\" said Frank Clyburn, president of Merck's human health business.</p><p><blockquote>默克人类健康业务总裁弗兰克·克莱伯恩(Frank Clyburn)表示：“如果获得授权，莫努匹拉韦将成为可用于对抗COVID-19的疫苗和药物之一，作为我们结束这一流行病的集体努力的一部分。”</blockquote></p><p> With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.</p><p><blockquote>由于治疗COVID-19患者的选择有限，美国政府还获得了数百万剂辉瑞公司(PFE)的抗病毒药物。上周显示，该药物可将有严重疾病风险的成年人住院或死亡几率降低89%。</blockquote></p><p> Merck's application with the U.S. Food and Drug Administration will be taken up by a panel of independent experts on Nov. 30, following which the regulator is expected to make a decision.</p><p><blockquote>默克公司向美国提出的申请。美国食品和药物管理局将于11月30日由一个独立专家小组接管，随后监管机构预计将做出决定。</blockquote></p><p> Britain last week became the first country in the world to clear the use of molnupiravir.</p><p><blockquote>英国上周成为世界上第一个批准使用莫努匹拉韦的国家。</blockquote></p><p> Merck expects to produce 10 million courses of the treatment by the end of this year, with at least 20 million set to be manufactured in 2022.</p><p><blockquote>默克预计到今年年底将生产1000万个疗程的治疗，其中至少2000万个疗程将在2022年生产。</blockquote></p><p> The drugmaker's shares rose nearly 1% to $83.41 in premarket trading.</p><p><blockquote>该制药商股价在盘前交易中上涨近1%至83.41美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. government to buy $1 billion more worth of Merck's COVID-19 pill<blockquote>美国政府将再购买价值10亿美元的默克COVID-19药物</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. government to buy $1 billion more worth of Merck's COVID-19 pill<blockquote>美国政府将再购买价值10亿美元的默克COVID-19药物</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-09 21:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck &amp; Co Inc(MRK.N)and partner Ridgeback Biotherapeutics, the companies said on Tuesday.</p><p><blockquote>路透11月9日-美国政府将再购买价值10亿美元的默克公司(MRK.N)及其合作伙伴Ridgeback Biotherapeutics周二表示。</blockquote></p><p> The government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.</p><p><blockquote>政府在6月份同意以12亿美元购买170万个疗程的莫努匹拉韦，现在正在行使选择权再购买140万个疗程。</blockquote></p><p> That brings the total secured courses to 3.1 million and worth $2.2 billion. Merck said the government has the right to buy 2 million more courses as part of the contract.</p><p><blockquote>这使得安全课程总数达到310万门，价值22亿美元。默克表示，作为合同的一部分，政府有权再购买200万门课程。</blockquote></p><p> The drug has been closely watched since data last month showed that when given early in the illness it could halve the chances of dying or being hospitalized for those most at risk of developing severe COVID-19.</p><p><blockquote>自上个月的数据显示，如果在疾病早期服用，该药物可以将最有可能患严重COVID-19的人的死亡或住院几率减半以来，该药物一直受到密切关注。</blockquote></p><p> \"Molnupiravir, if authorized, will be among the vaccines and medicines available to fight COVID-19 as part of our collective efforts to bring this pandemic to an end,\" said Frank Clyburn, president of Merck's human health business.</p><p><blockquote>默克人类健康业务总裁弗兰克·克莱伯恩(Frank Clyburn)表示：“如果获得授权，莫努匹拉韦将成为可用于对抗COVID-19的疫苗和药物之一，作为我们结束这一流行病的集体努力的一部分。”</blockquote></p><p> With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.</p><p><blockquote>由于治疗COVID-19患者的选择有限，美国政府还获得了数百万剂辉瑞公司(PFE)的抗病毒药物。上周显示，该药物可将有严重疾病风险的成年人住院或死亡几率降低89%。</blockquote></p><p> Merck's application with the U.S. Food and Drug Administration will be taken up by a panel of independent experts on Nov. 30, following which the regulator is expected to make a decision.</p><p><blockquote>默克公司向美国提出的申请。美国食品和药物管理局将于11月30日由一个独立专家小组接管，随后监管机构预计将做出决定。</blockquote></p><p> Britain last week became the first country in the world to clear the use of molnupiravir.</p><p><blockquote>英国上周成为世界上第一个批准使用莫努匹拉韦的国家。</blockquote></p><p> Merck expects to produce 10 million courses of the treatment by the end of this year, with at least 20 million set to be manufactured in 2022.</p><p><blockquote>默克预计到今年年底将生产1000万个疗程的治疗，其中至少2000万个疗程将在2022年生产。</blockquote></p><p> The drugmaker's shares rose nearly 1% to $83.41 in premarket trading.</p><p><blockquote>该制药商股价在盘前交易中上涨近1%至83.41美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/world/us/us-government-buy-14-mln-more-courses-mercks-covid-19-pill-2021-11-09/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.reuters.com/world/us/us-government-buy-14-mln-more-courses-mercks-covid-19-pill-2021-11-09/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133150195","content_text":"Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck & Co Inc(MRK.N)and partner Ridgeback Biotherapeutics, the companies said on Tuesday.\nThe government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.\nThat brings the total secured courses to 3.1 million and worth $2.2 billion. Merck said the government has the right to buy 2 million more courses as part of the contract.\nThe drug has been closely watched since data last month showed that when given early in the illness it could halve the chances of dying or being hospitalized for those most at risk of developing severe COVID-19.\n\"Molnupiravir, if authorized, will be among the vaccines and medicines available to fight COVID-19 as part of our collective efforts to bring this pandemic to an end,\" said Frank Clyburn, president of Merck's human health business.\nWith limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.\nMerck's application with the U.S. Food and Drug Administration will be taken up by a panel of independent experts on Nov. 30, following which the regulator is expected to make a decision.\nBritain last week became the first country in the world to clear the use of molnupiravir.\nMerck expects to produce 10 million courses of the treatment by the end of this year, with at least 20 million set to be manufactured in 2022.\nThe drugmaker's shares rose nearly 1% to $83.41 in premarket trading.","news_type":1,"symbols_score_info":{"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":1795,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841212454,"gmtCreate":1635914353891,"gmtModify":1635914354043,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>will increase position to average down to 2.40","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>will increase position to average down to 2.40","text":"$KEPPEL DC REIT(AJBU.SI)$will increase position to average down to 2.40","images":[{"img":"https://static.tigerbbs.com/1f56f9ef2bf442a89a6b1c99a97554db","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/841212454","isVote":1,"tweetType":1,"viewCount":3526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":841218712,"gmtCreate":1635914168365,"gmtModify":1635914168473,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"This 2day sudden shoot up? Any good news?&nbsp;","listText":"This 2day sudden shoot up? Any good news?&nbsp;","text":"This 2day sudden shoot up? Any good news?","images":[{"img":"https://static.tigerbbs.com/8636f4ef436550a97b1bd44349d18c4f","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841218712","isVote":1,"tweetType":1,"viewCount":2245,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":810788474,"gmtCreate":1630016254298,"gmtModify":1704954503604,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Chip shortage will be a concern","listText":"Chip shortage will be a concern","text":"Chip shortage will be a concern","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810788474","repostId":"1161561973","repostType":4,"repost":{"id":"1161561973","kind":"news","pubTimestamp":1629991651,"share":"https://www.laohu8.com/m/news/1161561973?lang=zh_CN&edition=full","pubTime":"2021-08-26 23:27","market":"us","language":"en","title":"Can Tesla Shares Hit $900 Again This Year?<blockquote>特斯拉股价今年能否再次触及900美元？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1161561973","media":"investing.com","summary":"Electric vehicle maker Tesla Motors' (NASDAQ:TSLA) stock is picking up momentum again. After falling","content":"<p>Electric vehicle maker <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a>' (NASDAQ:TSLA) stock is picking up momentum again. After falling from a record high $900.40, hit intraday on Jan. 25, TSLA shares have gained 17% during the past three months, outperforming the benchmark&nbsp;NASDAQ 100&nbsp;Index.</p><p><blockquote>电动汽车制造商<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>（纳斯达克：TSLA）股价再次上涨。在从1月25日盘中触及的900.40美元的历史新高下跌后，特斯拉股价在过去三个月内上涨了17%，跑赢了基准纳斯达克100指数。</blockquote></p><p> The biggest question Tesla bulls now have is, whether, on top of the current gains, can the EV manufacturer's stock push through back to the all-time high of $900 this year?</p><p><blockquote>特斯拉多头现在面临的最大问题是，除了当前的涨幅之外，这家电动汽车制造商的股价今年能否回升至900美元的历史高点？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b4b9078f00190f208dd63b32c4f617c6\" tg-width=\"651\" tg-height=\"708\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Tesla Weekly Chart.</p><p><blockquote>特斯拉周线图。</blockquote></p><p> Given the highly volatile nature of the stock, it’s tough to predict whether the current Tesla rally has legs. But it’s important to note that the outlook for its car sales is becoming more uncertain than it was a year ago.</p><p><blockquote>鉴于该股的高度波动性，很难预测当前的特斯拉反弹是否持续。但值得注意的是，其汽车销售前景比一年前变得更加不确定。</blockquote></p><p> First, the global chip shortage continues to cast doubt on Tesla’s ambitious sales targets for 2021. Chief Executive Officer Elon Musk highlighted challenges that come from the unpredictability of chip supplies and the hurdles he expects in ramping production at two new factories in Austin, Texas, and Berlin, later this year.</p><p><blockquote>首先，全球芯片短缺继续让人们对特斯拉2021年雄心勃勃的销售目标产生怀疑。首席执行官埃隆·马斯克强调了芯片供应的不可预测性带来的挑战，以及他预计今年晚些时候在德克萨斯州奥斯汀和柏林的两家新工厂提高产量的障碍。</blockquote></p><p> Tesla again delayed delivery of its semi-trailer truck—already two years late. The first trucks of this type are now slated for 2022. The company attributed the delay to supply-chain issues and limited battery-cell supply, as well as management trying to focus on getting new factories online. The company’s plans for its first pickup truck, once expected to go to customers as early as this year, are also being affected by parts issues.</p><p><blockquote>特斯拉再次推迟了半挂卡车的交付——已经晚了两年。第一批这种类型的卡车预计于2022年上市。该公司将延迟归因于供应链问题和电池供应有限，以及管理层试图专注于让新工厂上线。该公司首款皮卡的计划一度预计最早将于今年交付给客户，但也受到零部件问题的影响。</blockquote></p><p> This is what Musk told analysts last month:</p><p><blockquote>这是马斯克上个月对分析师说的话：</blockquote></p><p>   “While we’re making cars at full speed, the global chip-shortage situation remains quite serious. For the rest of this year, our growth rate will be determined by the slowest part in our supply chain.”  Regulatory Probe</p><p><blockquote>“在我们全速造车的同时，全球芯片短缺的情况仍然相当严重。在今年剩下的时间里，我们的增长率将由供应链中最慢的部分决定。”监管探针</blockquote></p><p> Besides the risks to the market’s earnings consensus for this fiscal year, Tesla is facing a regulatory probe that could result in a massive recall.</p><p><blockquote>除了本财年市场盈利共识面临风险外，特斯拉还面临监管调查，可能导致大规模召回。</blockquote></p><p> The U.S.opened a formal investigation&nbsp;into Tesla’s Autopilot system last week after almost a dozen collisions involving first-responder vehicles. In the last seven years, Tesla has charged clients thousands of dollars for this feature.</p><p><blockquote>在发生了近十几起涉及急救车辆的碰撞事件后，美国上周对特斯拉的自动驾驶系统展开了正式调查。在过去的七年里，特斯拉为此向客户收取了数千美元的费用。</blockquote></p><p> The probe by the National Highway Traffic Safety Administration (NHTSA) covers an estimated 765,000 Tesla Model Y, X, S and 3 vehicles from the 2014 model year onward. The regulator—which has the power to deem cars defective and order recalls—said&nbsp;it launched the investigation after 11 crashes that resulted in 17 injuries and one fatality.</p><p><blockquote>美国国家公路交通安全管理局(NHTSA)的调查涵盖了2014车型年起约765,000辆特斯拉Model Y、X、S和3辆汽车。该监管机构有权认定汽车有缺陷并下令召回，该监管机构表示，在发生11起导致17人受伤、1人死亡的事故后，它启动了调查。</blockquote></p><p> Bloomberg reported&nbsp;that Tesla has been criticized for years for labeling the system in a potentially misleading way. Since late 2016, it has marketed this higher-level functionality feature as Full Self-Driving Capability. In reality, Autopilot is a driver-assistance system that maintains vehicles’ speed and keeps them centered in lanes when engaged, though the driver is supposed to supervise at all times.</p><p><blockquote>彭博社报道称，特斯拉多年来一直因以可能误导的方式给该系统贴上标签而受到批评。自2016年底以来，它一直将这一更高级别的功能特性作为全自动驾驶功能进行营销。事实上，自动驾驶仪是一种驾驶员辅助系统，可以保持车辆的速度并在启动时使其保持在车道中央，尽管驾驶员应该始终进行监督。</blockquote></p><p> Tesla now sells that package of features—often referred to as FSD—for $10,000 or $199 a month.</p><p><blockquote>特斯拉现在以每月10,000美元或199美元的价格出售该功能包（通常称为FSD）。</blockquote></p><p> After the NHTSA launched of the probe, two Democratic senators asked the Federal Trade Commission to also investigate Tesla over the company’s advertising of its Autopilot and FSD technology.</p><p><blockquote>NHTSA发起调查后，两名民主党参议员要求联邦贸易委员会也调查特斯拉公司宣传其Autopilot和FSD技术的行为。</blockquote></p><p> In a&nbsp;letter&nbsp;last Wednesday, Sen. Richard Blumenthal of Connecticut and Sen. Ed Markey of Massachusetts asked FTC Chair Lina Khan to examine whether Tesla used “potentially deceptive and unfair practices” in its marketing of those technologies.</p><p><blockquote>在上周三的一封信中，康涅狄格参议员Richard Blumenthal和麻萨诸塞州参议员Ed Markey要求FTC主席Lina Khan调查特斯拉在营销这些技术时是否使用了“潜在的欺骗性和不公平的做法”。</blockquote></p><p> “We fear that Tesla’s Autopilot and FSD features are not as mature and reliable as the company pitches to the public,” they wrote, pointing to comments from Musk, as well as a 2019 YouTube video entitled “Full Self-Driving” and has a link to Tesla’s site.</p><p><blockquote>“我们担心特斯拉的Autopilot和FSD功能并不像该公司向公众宣传的那样成熟和可靠，”他们写道，并指出了马斯克的评论，以及2019年YouTube上一段题为“全自动驾驶”的视频，并有一个指向特斯拉网站的链接。</blockquote></p><p> Highlighting these risks and how they could affect Tesla’s current stock price, however, shouldn’t hide the fact that there are many analysts who continue to remain bullish on TSLA. Piper Sandler reiterated its overweight rating on the stock and its price target of $1,200 this month.</p><p><blockquote>然而，强调这些风险以及它们如何影响特斯拉当前的股价不应掩盖这样一个事实：许多分析师继续看好特斯拉。Piper Sandler重申了跑赢大盘对该股的评级以及本月1200美元的目标价。</blockquote></p><p> In a note, analysts Alexander Potter and Winnie Dong said:</p><p><blockquote>分析师Alexander Potter和Winnie Dong在一份报告中表示：</blockquote></p><p>   “Bottom line: We still really like this stock. Tesla is still the driving force behind higher [battery electric vehicle] penetration globally.”  <b>Bottom Line</b></p><p><blockquote>“底线：我们仍然非常喜欢这只股票。特斯拉仍然是全球[纯电动汽车]渗透率更高的驱动力。”<b>底线</b></blockquote></p><p> It’s difficult to predict the future course for Tesla stock given the huge amount of speculative interest in this name. But recent developments show that it will be quite hard for the EV automaker to exceed expectations in this tough manufacturing environment.</p><p><blockquote>鉴于人们对特斯拉股票的巨大投机兴趣，很难预测该股票的未来走势。但最近的事态发展表明，在这种严峻的制造环境下，这家电动汽车制造商很难超出预期。</blockquote></p><p> Investors should trade this name with caution.</p><p><blockquote>投资者应谨慎交易该名称。</blockquote></p><p></p>","source":"lsy1594375853987","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Tesla Shares Hit $900 Again This Year?<blockquote>特斯拉股价今年能否再次触及900美元？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Tesla Shares Hit $900 Again This Year?<blockquote>特斯拉股价今年能否再次触及900美元？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">investing.com</strong><span class=\"h-time small\">2021-08-26 23:27</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Electric vehicle maker <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a>' (NASDAQ:TSLA) stock is picking up momentum again. After falling from a record high $900.40, hit intraday on Jan. 25, TSLA shares have gained 17% during the past three months, outperforming the benchmark&nbsp;NASDAQ 100&nbsp;Index.</p><p><blockquote>电动汽车制造商<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>（纳斯达克：TSLA）股价再次上涨。在从1月25日盘中触及的900.40美元的历史新高下跌后，特斯拉股价在过去三个月内上涨了17%，跑赢了基准纳斯达克100指数。</blockquote></p><p> The biggest question Tesla bulls now have is, whether, on top of the current gains, can the EV manufacturer's stock push through back to the all-time high of $900 this year?</p><p><blockquote>特斯拉多头现在面临的最大问题是，除了当前的涨幅之外，这家电动汽车制造商的股价今年能否回升至900美元的历史高点？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b4b9078f00190f208dd63b32c4f617c6\" tg-width=\"651\" tg-height=\"708\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Tesla Weekly Chart.</p><p><blockquote>特斯拉周线图。</blockquote></p><p> Given the highly volatile nature of the stock, it’s tough to predict whether the current Tesla rally has legs. But it’s important to note that the outlook for its car sales is becoming more uncertain than it was a year ago.</p><p><blockquote>鉴于该股的高度波动性，很难预测当前的特斯拉反弹是否持续。但值得注意的是，其汽车销售前景比一年前变得更加不确定。</blockquote></p><p> First, the global chip shortage continues to cast doubt on Tesla’s ambitious sales targets for 2021. Chief Executive Officer Elon Musk highlighted challenges that come from the unpredictability of chip supplies and the hurdles he expects in ramping production at two new factories in Austin, Texas, and Berlin, later this year.</p><p><blockquote>首先，全球芯片短缺继续让人们对特斯拉2021年雄心勃勃的销售目标产生怀疑。首席执行官埃隆·马斯克强调了芯片供应的不可预测性带来的挑战，以及他预计今年晚些时候在德克萨斯州奥斯汀和柏林的两家新工厂提高产量的障碍。</blockquote></p><p> Tesla again delayed delivery of its semi-trailer truck—already two years late. The first trucks of this type are now slated for 2022. The company attributed the delay to supply-chain issues and limited battery-cell supply, as well as management trying to focus on getting new factories online. The company’s plans for its first pickup truck, once expected to go to customers as early as this year, are also being affected by parts issues.</p><p><blockquote>特斯拉再次推迟了半挂卡车的交付——已经晚了两年。第一批这种类型的卡车预计于2022年上市。该公司将延迟归因于供应链问题和电池供应有限，以及管理层试图专注于让新工厂上线。该公司首款皮卡的计划一度预计最早将于今年交付给客户，但也受到零部件问题的影响。</blockquote></p><p> This is what Musk told analysts last month:</p><p><blockquote>这是马斯克上个月对分析师说的话：</blockquote></p><p>   “While we’re making cars at full speed, the global chip-shortage situation remains quite serious. For the rest of this year, our growth rate will be determined by the slowest part in our supply chain.”  Regulatory Probe</p><p><blockquote>“在我们全速造车的同时，全球芯片短缺的情况仍然相当严重。在今年剩下的时间里，我们的增长率将由供应链中最慢的部分决定。”监管探针</blockquote></p><p> Besides the risks to the market’s earnings consensus for this fiscal year, Tesla is facing a regulatory probe that could result in a massive recall.</p><p><blockquote>除了本财年市场盈利共识面临风险外，特斯拉还面临监管调查，可能导致大规模召回。</blockquote></p><p> The U.S.opened a formal investigation&nbsp;into Tesla’s Autopilot system last week after almost a dozen collisions involving first-responder vehicles. In the last seven years, Tesla has charged clients thousands of dollars for this feature.</p><p><blockquote>在发生了近十几起涉及急救车辆的碰撞事件后，美国上周对特斯拉的自动驾驶系统展开了正式调查。在过去的七年里，特斯拉为此向客户收取了数千美元的费用。</blockquote></p><p> The probe by the National Highway Traffic Safety Administration (NHTSA) covers an estimated 765,000 Tesla Model Y, X, S and 3 vehicles from the 2014 model year onward. The regulator—which has the power to deem cars defective and order recalls—said&nbsp;it launched the investigation after 11 crashes that resulted in 17 injuries and one fatality.</p><p><blockquote>美国国家公路交通安全管理局(NHTSA)的调查涵盖了2014车型年起约765,000辆特斯拉Model Y、X、S和3辆汽车。该监管机构有权认定汽车有缺陷并下令召回，该监管机构表示，在发生11起导致17人受伤、1人死亡的事故后，它启动了调查。</blockquote></p><p> Bloomberg reported&nbsp;that Tesla has been criticized for years for labeling the system in a potentially misleading way. Since late 2016, it has marketed this higher-level functionality feature as Full Self-Driving Capability. In reality, Autopilot is a driver-assistance system that maintains vehicles’ speed and keeps them centered in lanes when engaged, though the driver is supposed to supervise at all times.</p><p><blockquote>彭博社报道称，特斯拉多年来一直因以可能误导的方式给该系统贴上标签而受到批评。自2016年底以来，它一直将这一更高级别的功能特性作为全自动驾驶功能进行营销。事实上，自动驾驶仪是一种驾驶员辅助系统，可以保持车辆的速度并在启动时使其保持在车道中央，尽管驾驶员应该始终进行监督。</blockquote></p><p> Tesla now sells that package of features—often referred to as FSD—for $10,000 or $199 a month.</p><p><blockquote>特斯拉现在以每月10,000美元或199美元的价格出售该功能包（通常称为FSD）。</blockquote></p><p> After the NHTSA launched of the probe, two Democratic senators asked the Federal Trade Commission to also investigate Tesla over the company’s advertising of its Autopilot and FSD technology.</p><p><blockquote>NHTSA发起调查后，两名民主党参议员要求联邦贸易委员会也调查特斯拉公司宣传其Autopilot和FSD技术的行为。</blockquote></p><p> In a&nbsp;letter&nbsp;last Wednesday, Sen. Richard Blumenthal of Connecticut and Sen. Ed Markey of Massachusetts asked FTC Chair Lina Khan to examine whether Tesla used “potentially deceptive and unfair practices” in its marketing of those technologies.</p><p><blockquote>在上周三的一封信中，康涅狄格参议员Richard Blumenthal和麻萨诸塞州参议员Ed Markey要求FTC主席Lina Khan调查特斯拉在营销这些技术时是否使用了“潜在的欺骗性和不公平的做法”。</blockquote></p><p> “We fear that Tesla’s Autopilot and FSD features are not as mature and reliable as the company pitches to the public,” they wrote, pointing to comments from Musk, as well as a 2019 YouTube video entitled “Full Self-Driving” and has a link to Tesla’s site.</p><p><blockquote>“我们担心特斯拉的Autopilot和FSD功能并不像该公司向公众宣传的那样成熟和可靠，”他们写道，并指出了马斯克的评论，以及2019年YouTube上一段题为“全自动驾驶”的视频，并有一个指向特斯拉网站的链接。</blockquote></p><p> Highlighting these risks and how they could affect Tesla’s current stock price, however, shouldn’t hide the fact that there are many analysts who continue to remain bullish on TSLA. Piper Sandler reiterated its overweight rating on the stock and its price target of $1,200 this month.</p><p><blockquote>然而，强调这些风险以及它们如何影响特斯拉当前的股价不应掩盖这样一个事实：许多分析师继续看好特斯拉。Piper Sandler重申了跑赢大盘对该股的评级以及本月1200美元的目标价。</blockquote></p><p> In a note, analysts Alexander Potter and Winnie Dong said:</p><p><blockquote>分析师Alexander Potter和Winnie Dong在一份报告中表示：</blockquote></p><p>   “Bottom line: We still really like this stock. Tesla is still the driving force behind higher [battery electric vehicle] penetration globally.”  <b>Bottom Line</b></p><p><blockquote>“底线：我们仍然非常喜欢这只股票。特斯拉仍然是全球[纯电动汽车]渗透率更高的驱动力。”<b>底线</b></blockquote></p><p> It’s difficult to predict the future course for Tesla stock given the huge amount of speculative interest in this name. But recent developments show that it will be quite hard for the EV automaker to exceed expectations in this tough manufacturing environment.</p><p><blockquote>鉴于人们对特斯拉股票的巨大投机兴趣，很难预测该股票的未来走势。但最近的事态发展表明，在这种严峻的制造环境下，这家电动汽车制造商很难超出预期。</blockquote></p><p> Investors should trade this name with caution.</p><p><blockquote>投资者应谨慎交易该名称。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investing.com/analysis/can-tesla-shares-hit-900-again-this-year-200599999\">investing.com</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.investing.com/analysis/can-tesla-shares-hit-900-again-this-year-200599999","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161561973","content_text":"Electric vehicle maker Tesla Motors' (NASDAQ:TSLA) stock is picking up momentum again. After falling from a record high $900.40, hit intraday on Jan. 25, TSLA shares have gained 17% during the past three months, outperforming the benchmark NASDAQ 100 Index.\nThe biggest question Tesla bulls now have is, whether, on top of the current gains, can the EV manufacturer's stock push through back to the all-time high of $900 this year?\nTesla Weekly Chart.\nGiven the highly volatile nature of the stock, it’s tough to predict whether the current Tesla rally has legs. But it’s important to note that the outlook for its car sales is becoming more uncertain than it was a year ago.\nFirst, the global chip shortage continues to cast doubt on Tesla’s ambitious sales targets for 2021. Chief Executive Officer Elon Musk highlighted challenges that come from the unpredictability of chip supplies and the hurdles he expects in ramping production at two new factories in Austin, Texas, and Berlin, later this year.\nTesla again delayed delivery of its semi-trailer truck—already two years late. The first trucks of this type are now slated for 2022. The company attributed the delay to supply-chain issues and limited battery-cell supply, as well as management trying to focus on getting new factories online. The company’s plans for its first pickup truck, once expected to go to customers as early as this year, are also being affected by parts issues.\nThis is what Musk told analysts last month:\n\n “While we’re making cars at full speed, the global chip-shortage situation remains quite serious. For the rest of this year, our growth rate will be determined by the slowest part in our supply chain.”\n\nRegulatory Probe\nBesides the risks to the market’s earnings consensus for this fiscal year, Tesla is facing a regulatory probe that could result in a massive recall.\nThe U.S.opened a formal investigation into Tesla’s Autopilot system last week after almost a dozen collisions involving first-responder vehicles. In the last seven years, Tesla has charged clients thousands of dollars for this feature.\nThe probe by the National Highway Traffic Safety Administration (NHTSA) covers an estimated 765,000 Tesla Model Y, X, S and 3 vehicles from the 2014 model year onward. The regulator—which has the power to deem cars defective and order recalls—said it launched the investigation after 11 crashes that resulted in 17 injuries and one fatality.\nBloomberg reported that Tesla has been criticized for years for labeling the system in a potentially misleading way. Since late 2016, it has marketed this higher-level functionality feature as Full Self-Driving Capability. In reality, Autopilot is a driver-assistance system that maintains vehicles’ speed and keeps them centered in lanes when engaged, though the driver is supposed to supervise at all times.\nTesla now sells that package of features—often referred to as FSD—for $10,000 or $199 a month.\nAfter the NHTSA launched of the probe, two Democratic senators asked the Federal Trade Commission to also investigate Tesla over the company’s advertising of its Autopilot and FSD technology.\nIn a letter last Wednesday, Sen. Richard Blumenthal of Connecticut and Sen. Ed Markey of Massachusetts asked FTC Chair Lina Khan to examine whether Tesla used “potentially deceptive and unfair practices” in its marketing of those technologies.\n“We fear that Tesla’s Autopilot and FSD features are not as mature and reliable as the company pitches to the public,” they wrote, pointing to comments from Musk, as well as a 2019 YouTube video entitled “Full Self-Driving” and has a link to Tesla’s site.\nHighlighting these risks and how they could affect Tesla’s current stock price, however, shouldn’t hide the fact that there are many analysts who continue to remain bullish on TSLA. Piper Sandler reiterated its overweight rating on the stock and its price target of $1,200 this month.\nIn a note, analysts Alexander Potter and Winnie Dong said:\n\n “Bottom line: We still really like this stock. Tesla is still the driving force behind higher [battery electric vehicle] penetration globally.”\n\nBottom Line\nIt’s difficult to predict the future course for Tesla stock given the huge amount of speculative interest in this name. But recent developments show that it will be quite hard for the EV automaker to exceed expectations in this tough manufacturing environment.\nInvestors should trade this name with caution.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810192870,"gmtCreate":1629950009190,"gmtModify":1631883959055,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Michael Burry vs Cathie Wood for win?&nbsp;","listText":"Michael Burry vs Cathie Wood for win?&nbsp;","text":"Michael Burry vs Cathie Wood for win?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810192870","repostId":"1101434650","repostType":4,"isVote":1,"tweetType":1,"viewCount":2010,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837072249,"gmtCreate":1629850527381,"gmtModify":1631888076526,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"X//<a href=\"https://laohu8.com/U/3580168616843436\">@林欣霓</a>: Agree penny stock is high risk...&nbsp;","listText":"X//<a href=\"https://laohu8.com/U/3580168616843436\">@林欣霓</a>: Agree penny stock is high risk...&nbsp;","text":"X//@林欣霓: Agree penny stock is high risk...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/837072249","repostId":"1172699620","repostType":4,"repost":{"id":"1172699620","kind":"news","pubTimestamp":1629450202,"share":"https://www.laohu8.com/m/news/1172699620?lang=zh_CN&edition=full","pubTime":"2021-08-20 17:03","market":"us","language":"en","title":"Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172699620","media":"Kiplinger","summary":"Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar","content":"<p>Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.</p><p><blockquote>细价股——那些低价交易的股票，通常每股股价不到一美元——是危险的。周期。事实上，除了少数例外，投资者应该避开这些超便宜的股票，这些股票通常在场外交易，而不是在主要交易所交易。</blockquote></p><p> Call them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"</p><p><blockquote>看涨期权他们细价股、微型股或场外交易股票；不管叫什么名字，都是坏消息。当前期投入如此之少的资金就可以进行投资时，快速轻松致富的承诺更容易上当。投资者可能会想，“风险有多大？”</blockquote></p><p> Plenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”</p><p><blockquote>大量。根据美国证券交易委员会的说法：“学术研究发现，场外交易股票往往流动性极差；经常成为涉嫌市场操纵的目标；平均产生负面且不稳定的投资回报；并且很少成长为大公司或过渡到在证券交易所上市。”</blockquote></p><p> We’ll break down what all that means below, but suffice to say, the SEC is not a fan.</p><p><blockquote>我们将在下面详细说明这一切的含义，但我只想说，SEC并不热衷于此。</blockquote></p><p> <h3><b>Why Penny Stocks Are So Dangerous</b></h3> To be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.</p><p><blockquote><h3><b>为什么细价股如此危险</b></h3>需要明确的是，这并不是说每个细价股或场外交易公司都是骗局。危险在于，场外市场是骗局股票的生存之地。把它想象成一个糟糕的社区。在那里会让你成为骗子的标志。</blockquote></p><p> For some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”</p><p><blockquote>在某些背景下，场外交易市场不同于纽约证券交易所或纳斯达克等交易集中的交易所。没有一个OTC交易所。相反，场外交易通过基于计算机和电话的系统将买家和卖家联系起来。任何不在纽约证券交易所、纳斯达克或其他美国成熟交易所交易的股票都可以进行场外交易。这些证券也被称为“非上市股票”。</blockquote></p><p> Typically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).</p><p><blockquote>通常，场外交易股票往往是高风险的微型股（市值低于3亿美元的小公司股票），其中包括纳米股（市值低于5000万美元的股票）。</blockquote></p><p> The SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.</p><p><blockquote>美国证券交易委员会长期以来一直警告投资者此类股票的高风险。该行业的自律机构金融业监管局（FINRA）同样对场外证券的购买和交易发出了危险信号。</blockquote></p><p> That’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.</p><p><blockquote>这是因为在场外交易市场上市的公司不需要像在纽约证券交易所或纳斯达克等主要交易所上市的公司那样提交定期或经审计的财务报告。换句话说，当他们声称有销售额和利润时，没有办法知道他们是否在说实话。各大交易所也有上市要求；场外交易股票则不然。例如，一家公司必须拥有至少400名股东且市值至少4000万美元才能在纽约证券交易所上市。OTC没有这样的要求。</blockquote></p><p> Put it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.</p><p><blockquote>综上所述，这使得无良的管理者更容易谎报业务前景或实施证券欺诈。</blockquote></p><p> But that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.</p><p><blockquote>但这还不是全部。在场外交易的股票往往“缺乏流动性”，这意味着它们的交易量通常很低，买家和卖家数量有限。这可能会使投资者很难或不可能以他们想要的价格买卖股票。</blockquote></p><p> That lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see&nbsp;<i>The Wolf of Wall Street</i>?</p><p><blockquote>流动性的缺乏也使许多场外交易股票成为“拉高抛售”计划的完美工具，即股票发起人引诱投资者购买股票，从而提高股价。然后，当价格足够高时，抽水者出售他的股票，导致股票下跌，给投资者留下糟糕的回报，甚至亏损。这里有人看到了吗<i>华尔街之狼</i>？</blockquote></p><p> To protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.</p><p><blockquote>为了保护投资者不上当受骗，SEC在2012年至2015年间暂停了800多只微型股（占场外交易市场的8%以上）的交易。股票一旦暂停交易，就不能重新上市，除非公司提供最新的财务信息来证明其实际运营。由于这种情况很少发生，交易暂停基本上使股票对诈骗艺术家毫无用处。</blockquote></p><p> <h3><b>Legitimate OTCs</b></h3> Be that as it may, there is one segment of the OTC market that investors need not fear.</p><p><blockquote><h3><b>合法OTC</b></h3>尽管如此，场外交易市场的一部分投资者不必担心。</blockquote></p><p> Amidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of&nbsp;<b>The <a href=\"https://laohu8.com/S/IDCBY\">Industrial and Commercial Bank of China Ltd.</a></b>&nbsp;(IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’s<b>Nestlé</b>(NSRGY), the largest food company in the world; China’s&nbsp;<b><a href=\"https://laohu8.com/S/TCEHY\">Tencent Holding Ltd.</a></b>&nbsp;(TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant&nbsp;<b><a href=\"https://laohu8.com/S/NTDOY\">Nintendo Co., Ltd.</a> </b>(NTDOY).</p><p><blockquote>在混混中，一些世界上最大、最受尊敬的外国公司将其美国股票在场外交易而不是在美国主要交易所上市。在这里，您可以找到<b>The<a href=\"https://laohu8.com/S/IDCBY\">中国工商银行。</a></b>（IDCBY），恰好是世界上最大的银行。您还可以购买瑞士的股票<b>雀巢</b>（NSRGY），全球最大的食品公司；中国的<b><a href=\"https://laohu8.com/S/TCEHY\">腾讯控股控股有限公司。</a></b>(TCEHY)，该国最大的互联网服务提供商之一；和日本游戏巨头<b><a href=\"https://laohu8.com/S/NTDOY\">任天堂有限公司。</a></b>（NTDOY）。</blockquote></p><p> Why would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?</p><p><blockquote>为什么大型国际上市公司会与发行高度投机性细价股的公司合作？</blockquote></p><p></p><p> The reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.</p><p><blockquote>原因与成本和便利性有关。例如，在纽约证券交易所或纳斯达克上市的外国公司必须为其所做的一切准备两套经审计的财务报表——一套符合国际会计准则，另一套符合公认会计原则(GAAP)在美国，这不是非处方药的要求。</blockquote></p><p> With an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.</p><p><blockquote>通过场外交易上市，外国公司可以以很低的成本和精力接触到庞大的美国股票投资者。</blockquote></p><p> The bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.</p><p><blockquote>最重要的是，除了大型老牌外国公司，场外交易股票风险太大。普通投资者不可能知道公司是否在上升。即使是合法的小公司也可能在一夜之间倒闭。场外交易股票的陷阱根本不值得。</blockquote></p><p> It’s easy enough to lose money investing in stocks. Why make it easier?</p><p><blockquote>投资股票很容易赔钱。为什么要让它更容易？</blockquote></p><p></p>","source":"lsy1629449927514","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPenny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Kiplinger</strong><span class=\"h-time small\">2021-08-20 17:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.</p><p><blockquote>细价股——那些低价交易的股票，通常每股股价不到一美元——是危险的。周期。事实上，除了少数例外，投资者应该避开这些超便宜的股票，这些股票通常在场外交易，而不是在主要交易所交易。</blockquote></p><p> Call them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"</p><p><blockquote>看涨期权他们细价股、微型股或场外交易股票；不管叫什么名字，都是坏消息。当前期投入如此之少的资金就可以进行投资时，快速轻松致富的承诺更容易上当。投资者可能会想，“风险有多大？”</blockquote></p><p> Plenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”</p><p><blockquote>大量。根据美国证券交易委员会的说法：“学术研究发现，场外交易股票往往流动性极差；经常成为涉嫌市场操纵的目标；平均产生负面且不稳定的投资回报；并且很少成长为大公司或过渡到在证券交易所上市。”</blockquote></p><p> We’ll break down what all that means below, but suffice to say, the SEC is not a fan.</p><p><blockquote>我们将在下面详细说明这一切的含义，但我只想说，SEC并不热衷于此。</blockquote></p><p> <h3><b>Why Penny Stocks Are So Dangerous</b></h3> To be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.</p><p><blockquote><h3><b>为什么细价股如此危险</b></h3>需要明确的是，这并不是说每个细价股或场外交易公司都是骗局。危险在于，场外市场是骗局股票的生存之地。把它想象成一个糟糕的社区。在那里会让你成为骗子的标志。</blockquote></p><p> For some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”</p><p><blockquote>在某些背景下，场外交易市场不同于纽约证券交易所或纳斯达克等交易集中的交易所。没有一个OTC交易所。相反，场外交易通过基于计算机和电话的系统将买家和卖家联系起来。任何不在纽约证券交易所、纳斯达克或其他美国成熟交易所交易的股票都可以进行场外交易。这些证券也被称为“非上市股票”。</blockquote></p><p> Typically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).</p><p><blockquote>通常，场外交易股票往往是高风险的微型股（市值低于3亿美元的小公司股票），其中包括纳米股（市值低于5000万美元的股票）。</blockquote></p><p> The SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.</p><p><blockquote>美国证券交易委员会长期以来一直警告投资者此类股票的高风险。该行业的自律机构金融业监管局（FINRA）同样对场外证券的购买和交易发出了危险信号。</blockquote></p><p> That’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.</p><p><blockquote>这是因为在场外交易市场上市的公司不需要像在纽约证券交易所或纳斯达克等主要交易所上市的公司那样提交定期或经审计的财务报告。换句话说，当他们声称有销售额和利润时，没有办法知道他们是否在说实话。各大交易所也有上市要求；场外交易股票则不然。例如，一家公司必须拥有至少400名股东且市值至少4000万美元才能在纽约证券交易所上市。OTC没有这样的要求。</blockquote></p><p> Put it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.</p><p><blockquote>综上所述，这使得无良的管理者更容易谎报业务前景或实施证券欺诈。</blockquote></p><p> But that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.</p><p><blockquote>但这还不是全部。在场外交易的股票往往“缺乏流动性”，这意味着它们的交易量通常很低，买家和卖家数量有限。这可能会使投资者很难或不可能以他们想要的价格买卖股票。</blockquote></p><p> That lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see&nbsp;<i>The Wolf of Wall Street</i>?</p><p><blockquote>流动性的缺乏也使许多场外交易股票成为“拉高抛售”计划的完美工具，即股票发起人引诱投资者购买股票，从而提高股价。然后，当价格足够高时，抽水者出售他的股票，导致股票下跌，给投资者留下糟糕的回报，甚至亏损。这里有人看到了吗<i>华尔街之狼</i>？</blockquote></p><p> To protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.</p><p><blockquote>为了保护投资者不上当受骗，SEC在2012年至2015年间暂停了800多只微型股（占场外交易市场的8%以上）的交易。股票一旦暂停交易，就不能重新上市，除非公司提供最新的财务信息来证明其实际运营。由于这种情况很少发生，交易暂停基本上使股票对诈骗艺术家毫无用处。</blockquote></p><p> <h3><b>Legitimate OTCs</b></h3> Be that as it may, there is one segment of the OTC market that investors need not fear.</p><p><blockquote><h3><b>合法OTC</b></h3>尽管如此，场外交易市场的一部分投资者不必担心。</blockquote></p><p> Amidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of&nbsp;<b>The <a href=\"https://laohu8.com/S/IDCBY\">Industrial and Commercial Bank of China Ltd.</a></b>&nbsp;(IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’s<b>Nestlé</b>(NSRGY), the largest food company in the world; China’s&nbsp;<b><a href=\"https://laohu8.com/S/TCEHY\">Tencent Holding Ltd.</a></b>&nbsp;(TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant&nbsp;<b><a href=\"https://laohu8.com/S/NTDOY\">Nintendo Co., Ltd.</a> </b>(NTDOY).</p><p><blockquote>在混混中，一些世界上最大、最受尊敬的外国公司将其美国股票在场外交易而不是在美国主要交易所上市。在这里，您可以找到<b>The<a href=\"https://laohu8.com/S/IDCBY\">中国工商银行。</a></b>（IDCBY），恰好是世界上最大的银行。您还可以购买瑞士的股票<b>雀巢</b>（NSRGY），全球最大的食品公司；中国的<b><a href=\"https://laohu8.com/S/TCEHY\">腾讯控股控股有限公司。</a></b>(TCEHY)，该国最大的互联网服务提供商之一；和日本游戏巨头<b><a href=\"https://laohu8.com/S/NTDOY\">任天堂有限公司。</a></b>（NTDOY）。</blockquote></p><p> Why would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?</p><p><blockquote>为什么大型国际上市公司会与发行高度投机性细价股的公司合作？</blockquote></p><p></p><p> The reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.</p><p><blockquote>原因与成本和便利性有关。例如，在纽约证券交易所或纳斯达克上市的外国公司必须为其所做的一切准备两套经审计的财务报表——一套符合国际会计准则，另一套符合公认会计原则(GAAP)在美国，这不是非处方药的要求。</blockquote></p><p> With an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.</p><p><blockquote>通过场外交易上市，外国公司可以以很低的成本和精力接触到庞大的美国股票投资者。</blockquote></p><p> The bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.</p><p><blockquote>最重要的是，除了大型老牌外国公司，场外交易股票风险太大。普通投资者不可能知道公司是否在上升。即使是合法的小公司也可能在一夜之间倒闭。场外交易股票的陷阱根本不值得。</blockquote></p><p> It’s easy enough to lose money investing in stocks. Why make it easier?</p><p><blockquote>投资股票很容易赔钱。为什么要让它更容易？</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.kiplinger.com/investing/603303/penny-stocks-always-stay-away\">Kiplinger</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TCEHY":"腾讯控股ADR","NTDOY":"任天堂","IDCBY":"工商银行ADR"},"source_url":"https://www.kiplinger.com/investing/603303/penny-stocks-always-stay-away","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172699620","content_text":"Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.\nCall them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"\nPlenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”\nWe’ll break down what all that means below, but suffice to say, the SEC is not a fan.\nWhy Penny Stocks Are So Dangerous\nTo be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.\nFor some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”\nTypically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).\nThe SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.\nThat’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.\nPut it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.\nBut that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.\nThat lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see The Wolf of Wall Street?\nTo protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.\nLegitimate OTCs\nBe that as it may, there is one segment of the OTC market that investors need not fear.\nAmidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of The Industrial and Commercial Bank of China Ltd. (IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’sNestlé(NSRGY), the largest food company in the world; China’s Tencent Holding Ltd. (TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant Nintendo Co., Ltd. (NTDOY).\nWhy would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?\nThe reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.\nWith an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.\nThe bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.\nIt’s easy enough to lose money investing in stocks. Why make it easier?","news_type":1,"symbols_score_info":{"IDCBY":0.9,"TCEHY":0.9,"NTDOY":0.9}},"isVote":1,"tweetType":1,"viewCount":1905,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":832181826,"gmtCreate":1629598305065,"gmtModify":1631888076539,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Agree penny stock is high risk...&nbsp;","listText":"Agree penny stock is high risk...&nbsp;","text":"Agree penny stock is high risk...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/832181826","repostId":"1172699620","repostType":4,"repost":{"id":"1172699620","kind":"news","pubTimestamp":1629450202,"share":"https://www.laohu8.com/m/news/1172699620?lang=zh_CN&edition=full","pubTime":"2021-08-20 17:03","market":"us","language":"en","title":"Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172699620","media":"Kiplinger","summary":"Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar","content":"<p>Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.</p><p><blockquote>细价股——那些低价交易的股票，通常每股股价不到一美元——是危险的。周期。事实上，除了少数例外，投资者应该避开这些超便宜的股票，这些股票通常在场外交易，而不是在主要交易所交易。</blockquote></p><p> Call them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"</p><p><blockquote>看涨期权他们细价股、微型股或场外交易股票；不管叫什么名字，都是坏消息。当前期投入如此之少的资金就可以进行投资时，快速轻松致富的承诺更容易上当。投资者可能会想，“风险有多大？”</blockquote></p><p> Plenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”</p><p><blockquote>大量。根据美国证券交易委员会的说法：“学术研究发现，场外交易股票往往流动性极差；经常成为涉嫌市场操纵的目标；平均产生负面且不稳定的投资回报；并且很少成长为大公司或过渡到在证券交易所上市。”</blockquote></p><p> We’ll break down what all that means below, but suffice to say, the SEC is not a fan.</p><p><blockquote>我们将在下面详细说明这一切的含义，但我只想说，SEC并不热衷于此。</blockquote></p><p> <h3><b>Why Penny Stocks Are So Dangerous</b></h3> To be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.</p><p><blockquote><h3><b>为什么细价股如此危险</b></h3>需要明确的是，这并不是说每个细价股或场外交易公司都是骗局。危险在于，场外市场是骗局股票的生存之地。把它想象成一个糟糕的社区。在那里会让你成为骗子的标志。</blockquote></p><p> For some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”</p><p><blockquote>在某些背景下，场外交易市场不同于纽约证券交易所或纳斯达克等交易集中的交易所。没有一个OTC交易所。相反，场外交易通过基于计算机和电话的系统将买家和卖家联系起来。任何不在纽约证券交易所、纳斯达克或其他美国成熟交易所交易的股票都可以进行场外交易。这些证券也被称为“非上市股票”。</blockquote></p><p> Typically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).</p><p><blockquote>通常，场外交易股票往往是高风险的微型股（市值低于3亿美元的小公司股票），其中包括纳米股（市值低于5000万美元的股票）。</blockquote></p><p> The SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.</p><p><blockquote>美国证券交易委员会长期以来一直警告投资者此类股票的高风险。该行业的自律机构金融业监管局（FINRA）同样对场外证券的购买和交易发出了危险信号。</blockquote></p><p> That’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.</p><p><blockquote>这是因为在场外交易市场上市的公司不需要像在纽约证券交易所或纳斯达克等主要交易所上市的公司那样提交定期或经审计的财务报告。换句话说，当他们声称有销售额和利润时，没有办法知道他们是否在说实话。各大交易所也有上市要求；场外交易股票则不然。例如，一家公司必须拥有至少400名股东且市值至少4000万美元才能在纽约证券交易所上市。OTC没有这样的要求。</blockquote></p><p> Put it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.</p><p><blockquote>综上所述，这使得无良的管理者更容易谎报业务前景或实施证券欺诈。</blockquote></p><p> But that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.</p><p><blockquote>但这还不是全部。在场外交易的股票往往“缺乏流动性”，这意味着它们的交易量通常很低，买家和卖家数量有限。这可能会使投资者很难或不可能以他们想要的价格买卖股票。</blockquote></p><p> That lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see&nbsp;<i>The Wolf of Wall Street</i>?</p><p><blockquote>流动性的缺乏也使许多场外交易股票成为“拉高抛售”计划的完美工具，即股票发起人引诱投资者购买股票，从而提高股价。然后，当价格足够高时，抽水者出售他的股票，导致股票下跌，给投资者留下糟糕的回报，甚至亏损。这里有人看到了吗<i>华尔街之狼</i>？</blockquote></p><p> To protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.</p><p><blockquote>为了保护投资者不上当受骗，SEC在2012年至2015年间暂停了800多只微型股（占场外交易市场的8%以上）的交易。股票一旦暂停交易，就不能重新上市，除非公司提供最新的财务信息来证明其实际运营。由于这种情况很少发生，交易暂停基本上使股票对诈骗艺术家毫无用处。</blockquote></p><p> <h3><b>Legitimate OTCs</b></h3> Be that as it may, there is one segment of the OTC market that investors need not fear.</p><p><blockquote><h3><b>合法OTC</b></h3>尽管如此，场外交易市场的一部分投资者不必担心。</blockquote></p><p> Amidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of&nbsp;<b>The <a href=\"https://laohu8.com/S/IDCBY\">Industrial and Commercial Bank of China Ltd.</a></b>&nbsp;(IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’s<b>Nestlé</b>(NSRGY), the largest food company in the world; China’s&nbsp;<b><a href=\"https://laohu8.com/S/TCEHY\">Tencent Holding Ltd.</a></b>&nbsp;(TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant&nbsp;<b><a href=\"https://laohu8.com/S/NTDOY\">Nintendo Co., Ltd.</a> </b>(NTDOY).</p><p><blockquote>在混混中，一些世界上最大、最受尊敬的外国公司将其美国股票在场外交易而不是在美国主要交易所上市。在这里，您可以找到<b>The<a href=\"https://laohu8.com/S/IDCBY\">中国工商银行。</a></b>（IDCBY），恰好是世界上最大的银行。您还可以购买瑞士的股票<b>雀巢</b>（NSRGY），全球最大的食品公司；中国的<b><a href=\"https://laohu8.com/S/TCEHY\">腾讯控股控股有限公司。</a></b>(TCEHY)，该国最大的互联网服务提供商之一；和日本游戏巨头<b><a href=\"https://laohu8.com/S/NTDOY\">任天堂有限公司。</a></b>（NTDOY）。</blockquote></p><p> Why would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?</p><p><blockquote>为什么大型国际上市公司会与发行高度投机性细价股的公司合作？</blockquote></p><p></p><p> The reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.</p><p><blockquote>原因与成本和便利性有关。例如，在纽约证券交易所或纳斯达克上市的外国公司必须为其所做的一切准备两套经审计的财务报表——一套符合国际会计准则，另一套符合公认会计原则(GAAP)在美国，这不是非处方药的要求。</blockquote></p><p> With an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.</p><p><blockquote>通过场外交易上市，外国公司可以以很低的成本和精力接触到庞大的美国股票投资者。</blockquote></p><p> The bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.</p><p><blockquote>最重要的是，除了大型老牌外国公司，场外交易股票风险太大。普通投资者不可能知道公司是否在上升。即使是合法的小公司也可能在一夜之间倒闭。场外交易股票的陷阱根本不值得。</blockquote></p><p> It’s easy enough to lose money investing in stocks. Why make it easier?</p><p><blockquote>投资股票很容易赔钱。为什么要让它更容易？</blockquote></p><p></p>","source":"lsy1629449927514","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPenny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Kiplinger</strong><span class=\"h-time small\">2021-08-20 17:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.</p><p><blockquote>细价股——那些低价交易的股票，通常每股股价不到一美元——是危险的。周期。事实上，除了少数例外，投资者应该避开这些超便宜的股票，这些股票通常在场外交易，而不是在主要交易所交易。</blockquote></p><p> Call them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"</p><p><blockquote>看涨期权他们细价股、微型股或场外交易股票；不管叫什么名字，都是坏消息。当前期投入如此之少的资金就可以进行投资时，快速轻松致富的承诺更容易上当。投资者可能会想，“风险有多大？”</blockquote></p><p> Plenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”</p><p><blockquote>大量。根据美国证券交易委员会的说法：“学术研究发现，场外交易股票往往流动性极差；经常成为涉嫌市场操纵的目标；平均产生负面且不稳定的投资回报；并且很少成长为大公司或过渡到在证券交易所上市。”</blockquote></p><p> We’ll break down what all that means below, but suffice to say, the SEC is not a fan.</p><p><blockquote>我们将在下面详细说明这一切的含义，但我只想说，SEC并不热衷于此。</blockquote></p><p> <h3><b>Why Penny Stocks Are So Dangerous</b></h3> To be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.</p><p><blockquote><h3><b>为什么细价股如此危险</b></h3>需要明确的是，这并不是说每个细价股或场外交易公司都是骗局。危险在于，场外市场是骗局股票的生存之地。把它想象成一个糟糕的社区。在那里会让你成为骗子的标志。</blockquote></p><p> For some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”</p><p><blockquote>在某些背景下，场外交易市场不同于纽约证券交易所或纳斯达克等交易集中的交易所。没有一个OTC交易所。相反，场外交易通过基于计算机和电话的系统将买家和卖家联系起来。任何不在纽约证券交易所、纳斯达克或其他美国成熟交易所交易的股票都可以进行场外交易。这些证券也被称为“非上市股票”。</blockquote></p><p> Typically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).</p><p><blockquote>通常，场外交易股票往往是高风险的微型股（市值低于3亿美元的小公司股票），其中包括纳米股（市值低于5000万美元的股票）。</blockquote></p><p> The SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.</p><p><blockquote>美国证券交易委员会长期以来一直警告投资者此类股票的高风险。该行业的自律机构金融业监管局（FINRA）同样对场外证券的购买和交易发出了危险信号。</blockquote></p><p> That’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.</p><p><blockquote>这是因为在场外交易市场上市的公司不需要像在纽约证券交易所或纳斯达克等主要交易所上市的公司那样提交定期或经审计的财务报告。换句话说，当他们声称有销售额和利润时，没有办法知道他们是否在说实话。各大交易所也有上市要求；场外交易股票则不然。例如，一家公司必须拥有至少400名股东且市值至少4000万美元才能在纽约证券交易所上市。OTC没有这样的要求。</blockquote></p><p> Put it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.</p><p><blockquote>综上所述，这使得无良的管理者更容易谎报业务前景或实施证券欺诈。</blockquote></p><p> But that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.</p><p><blockquote>但这还不是全部。在场外交易的股票往往“缺乏流动性”，这意味着它们的交易量通常很低，买家和卖家数量有限。这可能会使投资者很难或不可能以他们想要的价格买卖股票。</blockquote></p><p> That lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see&nbsp;<i>The Wolf of Wall Street</i>?</p><p><blockquote>流动性的缺乏也使许多场外交易股票成为“拉高抛售”计划的完美工具，即股票发起人引诱投资者购买股票，从而提高股价。然后，当价格足够高时，抽水者出售他的股票，导致股票下跌，给投资者留下糟糕的回报，甚至亏损。这里有人看到了吗<i>华尔街之狼</i>？</blockquote></p><p> To protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.</p><p><blockquote>为了保护投资者不上当受骗，SEC在2012年至2015年间暂停了800多只微型股（占场外交易市场的8%以上）的交易。股票一旦暂停交易，就不能重新上市，除非公司提供最新的财务信息来证明其实际运营。由于这种情况很少发生，交易暂停基本上使股票对诈骗艺术家毫无用处。</blockquote></p><p> <h3><b>Legitimate OTCs</b></h3> Be that as it may, there is one segment of the OTC market that investors need not fear.</p><p><blockquote><h3><b>合法OTC</b></h3>尽管如此，场外交易市场的一部分投资者不必担心。</blockquote></p><p> Amidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of&nbsp;<b>The <a href=\"https://laohu8.com/S/IDCBY\">Industrial and Commercial Bank of China Ltd.</a></b>&nbsp;(IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’s<b>Nestlé</b>(NSRGY), the largest food company in the world; China’s&nbsp;<b><a href=\"https://laohu8.com/S/TCEHY\">Tencent Holding Ltd.</a></b>&nbsp;(TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant&nbsp;<b><a href=\"https://laohu8.com/S/NTDOY\">Nintendo Co., Ltd.</a> </b>(NTDOY).</p><p><blockquote>在混混中，一些世界上最大、最受尊敬的外国公司将其美国股票在场外交易而不是在美国主要交易所上市。在这里，您可以找到<b>The<a href=\"https://laohu8.com/S/IDCBY\">中国工商银行。</a></b>（IDCBY），恰好是世界上最大的银行。您还可以购买瑞士的股票<b>雀巢</b>（NSRGY），全球最大的食品公司；中国的<b><a href=\"https://laohu8.com/S/TCEHY\">腾讯控股控股有限公司。</a></b>(TCEHY)，该国最大的互联网服务提供商之一；和日本游戏巨头<b><a href=\"https://laohu8.com/S/NTDOY\">任天堂有限公司。</a></b>（NTDOY）。</blockquote></p><p> Why would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?</p><p><blockquote>为什么大型国际上市公司会与发行高度投机性细价股的公司合作？</blockquote></p><p></p><p> The reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.</p><p><blockquote>原因与成本和便利性有关。例如，在纽约证券交易所或纳斯达克上市的外国公司必须为其所做的一切准备两套经审计的财务报表——一套符合国际会计准则，另一套符合公认会计原则(GAAP)在美国，这不是非处方药的要求。</blockquote></p><p> With an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.</p><p><blockquote>通过场外交易上市，外国公司可以以很低的成本和精力接触到庞大的美国股票投资者。</blockquote></p><p> The bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.</p><p><blockquote>最重要的是，除了大型老牌外国公司，场外交易股票风险太大。普通投资者不可能知道公司是否在上升。即使是合法的小公司也可能在一夜之间倒闭。场外交易股票的陷阱根本不值得。</blockquote></p><p> It’s easy enough to lose money investing in stocks. Why make it easier?</p><p><blockquote>投资股票很容易赔钱。为什么要让它更容易？</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.kiplinger.com/investing/603303/penny-stocks-always-stay-away\">Kiplinger</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TCEHY":"腾讯控股ADR","NTDOY":"任天堂","IDCBY":"工商银行ADR"},"source_url":"https://www.kiplinger.com/investing/603303/penny-stocks-always-stay-away","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172699620","content_text":"Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.\nCall them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"\nPlenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”\nWe’ll break down what all that means below, but suffice to say, the SEC is not a fan.\nWhy Penny Stocks Are So Dangerous\nTo be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.\nFor some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”\nTypically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).\nThe SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.\nThat’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.\nPut it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.\nBut that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.\nThat lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see The Wolf of Wall Street?\nTo protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.\nLegitimate OTCs\nBe that as it may, there is one segment of the OTC market that investors need not fear.\nAmidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of The Industrial and Commercial Bank of China Ltd. (IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’sNestlé(NSRGY), the largest food company in the world; China’s Tencent Holding Ltd. (TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant Nintendo Co., Ltd. (NTDOY).\nWhy would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?\nThe reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.\nWith an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.\nThe bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.\nIt’s easy enough to lose money investing in stocks. Why make it easier?","news_type":1,"symbols_score_info":{"IDCBY":0.9,"TCEHY":0.9,"NTDOY":0.9}},"isVote":1,"tweetType":1,"viewCount":2651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839643303,"gmtCreate":1629158484302,"gmtModify":1631888076553,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"The vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose","listText":"The vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose","text":"The vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/839643303","repostId":"1166738043","repostType":4,"repost":{"id":"1166738043","kind":"news","pubTimestamp":1629158127,"share":"https://www.laohu8.com/m/news/1166738043?lang=zh_CN&edition=full","pubTime":"2021-08-17 07:55","market":"us","language":"en","title":"Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster<blockquote>辉瑞和BioNTech寻求FDA批准Covid-19加强剂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166738043","media":"The Wall Street Journal","summary":"Early-stage study shows third dose of vaccine offers a higher level of protection, companies say\nThe","content":"<p>Early-stage study shows third dose of vaccine offers a higher level of protection, companies say</p><p><blockquote>公司表示，早期研究表明第三剂疫苗可提供更高水平的保护</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14a5e62531f6fe58f57ee8f19db73a40\" tg-width=\"860\" tg-height=\"573\" width=\"100%\" height=\"auto\"><span>The addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.</span></p><p><blockquote><p class=\"t-img-caption\"><span>辉瑞和BioNTech表示，添加第三剂似乎是安全的。宾夕法尼亚州施文克斯维尔的新冠肺炎疫苗接种。，药房。</span></p></blockquote></p><p> Pfizer&nbsp;Inc.&nbsp;and partner&nbsp;BioNTech SE&nbsp;have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.</p><p><blockquote>辉瑞公司和合作伙伴BioNTech SE已向美国卫生监管机构提交了在公众中清除Covid-19加强注射所需的数据。</blockquote></p><p> The companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.</p><p><blockquote>这些公司周一表示，他们向美国发送了。美国食品和药物管理局的一项小型早期研究结果显示，与标准的两剂方案相比，第三剂疫苗产生了更高水平的针对原始病毒以及针对β和δ变异体的中和抗体。</blockquote></p><p> The addition of the third dose also appeared safe in the trial, the companies said.</p><p><blockquote>两家公司表示，在试验中添加第三剂似乎也是安全的。</blockquote></p><p> Given the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against&nbsp;symptomatic Covid-19.</p><p><blockquote>两家公司表示，鉴于第三剂疫苗的免疫反应增强，在第二剂疫苗接种后六个月至一年内进行加强注射可能有助于保持对有症状的Covid-19的保护。</blockquote></p><p> Pfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.</p><p><blockquote>辉瑞和BioNTech也在进行一项更大规模的后期研究，评估第三剂疫苗是否能安全地提供更多保护。两家公司表示，他们预计这些结果将很快公布，然后将向FDA提交数据。</blockquote></p><p> The FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.</p><p><blockquote>FDA正在考虑一个更广泛的加强策略，该机构可能会在未来几周内发布。</blockquote></p><p> Two doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.</p><p><blockquote>两剂辉瑞-BioNTech疫苗被授权用于12岁及以上的人群，间隔三周注射。</blockquote></p><p> Some physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.</p><p><blockquote>美国的一些医生和科学家表示，对于普通人群是否需要加强剂，目前还没有明确的答案，部分原因是有证据表明疫苗在预防严重疾病方面仍然非常有效。</blockquote></p><p> Studies indicate the vaccine is still highly effective in people&nbsp;six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt&nbsp;he Delta variant, prompting research into adding a third dose.</p><p><blockquote>研究表明，该疫苗在接种第二剂疫苗六个月后仍然非常有效。然而，有一些证据表明，随着时间的推移，它的功效可能会减弱，而且这种疫苗对德尔塔变异毒株病的疗效并不那么有效，这促使研究增加第三剂。</blockquote></p><p> Last week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot&nbsp;for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.</p><p><blockquote>上周，FDA批准为某些免疫系统较弱的人注射第三剂mRNA疫苗，例如辉瑞-BioNTech疫苗，以增强他们对Covid-19的免疫防御。</blockquote></p><p> In the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.</p><p><blockquote>辉瑞和BioNTech表示，在针对一般健康人群的早期研究中，受试者接受了第三剂30微克剂量。受试者在接受第二剂后8至9个月接受额外剂量。</blockquote></p><p> Then researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.</p><p><blockquote>两家公司表示，然后研究人员测量了受试者的中和抗体水平，中和抗体在预防病毒方面发挥着至关重要的作用。</blockquote></p><p> The levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.</p><p><blockquote>两家公司表示，针对病毒的初始毒株以及Beta和Delta变种，水平有所上升。两家公司表示，加强剂量后，针对变种的中和抗体与早期菌株相似。</blockquote></p><p> Pfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.</p><p><blockquote>辉瑞在上个月的第二季度财报中公布了一些科学数据，但尚未详细说明结果。辉瑞的数据显示，第三次注射后，与注射两剂相比，18至55岁人群的抗体水平上升了5倍以上，65至85岁人群的抗体水平上升了11倍以上。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster<blockquote>辉瑞和BioNTech寻求FDA批准Covid-19加强剂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech Seek FDA Clearance for Covid-19 Booster<blockquote>辉瑞和BioNTech寻求FDA批准Covid-19加强剂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-08-17 07:55</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Early-stage study shows third dose of vaccine offers a higher level of protection, companies say</p><p><blockquote>公司表示，早期研究表明第三剂疫苗可提供更高水平的保护</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14a5e62531f6fe58f57ee8f19db73a40\" tg-width=\"860\" tg-height=\"573\" width=\"100%\" height=\"auto\"><span>The addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.</span></p><p><blockquote><p class=\"t-img-caption\"><span>辉瑞和BioNTech表示，添加第三剂似乎是安全的。宾夕法尼亚州施文克斯维尔的新冠肺炎疫苗接种。，药房。</span></p></blockquote></p><p> Pfizer&nbsp;Inc.&nbsp;and partner&nbsp;BioNTech SE&nbsp;have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.</p><p><blockquote>辉瑞公司和合作伙伴BioNTech SE已向美国卫生监管机构提交了在公众中清除Covid-19加强注射所需的数据。</blockquote></p><p> The companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.</p><p><blockquote>这些公司周一表示，他们向美国发送了。美国食品和药物管理局的一项小型早期研究结果显示，与标准的两剂方案相比，第三剂疫苗产生了更高水平的针对原始病毒以及针对β和δ变异体的中和抗体。</blockquote></p><p> The addition of the third dose also appeared safe in the trial, the companies said.</p><p><blockquote>两家公司表示，在试验中添加第三剂似乎也是安全的。</blockquote></p><p> Given the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against&nbsp;symptomatic Covid-19.</p><p><blockquote>两家公司表示，鉴于第三剂疫苗的免疫反应增强，在第二剂疫苗接种后六个月至一年内进行加强注射可能有助于保持对有症状的Covid-19的保护。</blockquote></p><p> Pfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.</p><p><blockquote>辉瑞和BioNTech也在进行一项更大规模的后期研究，评估第三剂疫苗是否能安全地提供更多保护。两家公司表示，他们预计这些结果将很快公布，然后将向FDA提交数据。</blockquote></p><p> The FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.</p><p><blockquote>FDA正在考虑一个更广泛的加强策略，该机构可能会在未来几周内发布。</blockquote></p><p> Two doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.</p><p><blockquote>两剂辉瑞-BioNTech疫苗被授权用于12岁及以上的人群，间隔三周注射。</blockquote></p><p> Some physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.</p><p><blockquote>美国的一些医生和科学家表示，对于普通人群是否需要加强剂，目前还没有明确的答案，部分原因是有证据表明疫苗在预防严重疾病方面仍然非常有效。</blockquote></p><p> Studies indicate the vaccine is still highly effective in people&nbsp;six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt&nbsp;he Delta variant, prompting research into adding a third dose.</p><p><blockquote>研究表明，该疫苗在接种第二剂疫苗六个月后仍然非常有效。然而，有一些证据表明，随着时间的推移，它的功效可能会减弱，而且这种疫苗对德尔塔变异毒株病的疗效并不那么有效，这促使研究增加第三剂。</blockquote></p><p> Last week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot&nbsp;for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.</p><p><blockquote>上周，FDA批准为某些免疫系统较弱的人注射第三剂mRNA疫苗，例如辉瑞-BioNTech疫苗，以增强他们对Covid-19的免疫防御。</blockquote></p><p> In the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.</p><p><blockquote>辉瑞和BioNTech表示，在针对一般健康人群的早期研究中，受试者接受了第三剂30微克剂量。受试者在接受第二剂后8至9个月接受额外剂量。</blockquote></p><p> Then researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.</p><p><blockquote>两家公司表示，然后研究人员测量了受试者的中和抗体水平，中和抗体在预防病毒方面发挥着至关重要的作用。</blockquote></p><p> The levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.</p><p><blockquote>两家公司表示，针对病毒的初始毒株以及Beta和Delta变种，水平有所上升。两家公司表示，加强剂量后，针对变种的中和抗体与早期菌株相似。</blockquote></p><p> Pfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.</p><p><blockquote>辉瑞在上个月的第二季度财报中公布了一些科学数据，但尚未详细说明结果。辉瑞的数据显示，第三次注射后，与注射两剂相比，18至55岁人群的抗体水平上升了5倍以上，65至85岁人群的抗体水平上升了11倍以上。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/pfizer-biontech-seek-fda-clearance-for-covid-19-booster-11629136057?mod=hp_lead_pos6\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://www.wsj.com/articles/pfizer-biontech-seek-fda-clearance-for-covid-19-booster-11629136057?mod=hp_lead_pos6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166738043","content_text":"Early-stage study shows third dose of vaccine offers a higher level of protection, companies say\nThe addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.\nPfizer Inc. and partner BioNTech SE have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.\nThe companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.\nThe addition of the third dose also appeared safe in the trial, the companies said.\nGiven the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against symptomatic Covid-19.\nPfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.\nThe FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.\nTwo doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.\nSome physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.\nStudies indicate the vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose.\nLast week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.\nIn the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.\nThen researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.\nThe levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.\nPfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":3033,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894215151,"gmtCreate":1628828691073,"gmtModify":1631888076569,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Take 3rd dose for those&nbsp;weak immune system&nbsp;","listText":"Take 3rd dose for those&nbsp;weak immune system&nbsp;","text":"Take 3rd dose for those weak immune system","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894215151","repostId":"1127554137","repostType":4,"isVote":1,"tweetType":1,"viewCount":1816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890679016,"gmtCreate":1628117554035,"gmtModify":1631888076584,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Can still support Chinese EV company","listText":"Can still support Chinese EV company","text":"Can still support Chinese EV company","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890679016","repostId":"1187165636","repostType":4,"isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807486722,"gmtCreate":1628050372766,"gmtModify":1631888076593,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Google..&nbsp;","listText":"Google..&nbsp;","text":"Google..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807486722","repostId":"2156412186","repostType":4,"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178620662,"gmtCreate":1626818904156,"gmtModify":1631888076605,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"AMC&nbsp;Is time fly to the moon again?&nbsp;","listText":"AMC&nbsp;Is time fly to the moon again?&nbsp;","text":"AMC Is time fly to the moon again?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/178620662","repostId":"2152657163","repostType":4,"isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":145702474,"gmtCreate":1626242949798,"gmtModify":1631888076625,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Yes always take a rest and climb higher","listText":"Yes always take a rest and climb higher","text":"Yes always take a rest and climb higher","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/145702474","repostId":"2151560584","repostType":2,"isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143570117,"gmtCreate":1625805135339,"gmtModify":1631888076640,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Keep for long term, aim for high dividend","listText":"Keep for long term, aim for high dividend","text":"Keep for long term, aim for high dividend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/143570117","repostId":"1119741032","repostType":4,"repost":{"id":"1119741032","kind":"news","pubTimestamp":1625803532,"share":"https://www.laohu8.com/m/news/1119741032?lang=zh_CN&edition=full","pubTime":"2021-07-09 12:05","market":"us","language":"en","title":"5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge<blockquote>随着利率暴跌，值得买入并获得巨额股息的5只蓝筹股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119741032","media":"24/7 wall street","summary":"Just last month, we were being warned that interest rates were ready to move meaningfully higher as ","content":"<p><a href=\"https://laohu8.com/S/JE\">Just</a> last month, we were being warned that interest rates were ready to move meaningfully higher as inflation and the Federal Reserve were teaming up to end the massive low interest rate paradigm we have been stuck in for years. Then, seemingly out of nowhere, rates have dived lower, with the 10-year Treasury trading at a 1.32% yield, down from near 1.70% at the end of May. The benchmark 30-year Treasury bond is back at the 1.94% level. These are the lowest interest rate levels since last winter.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>上个月，我们被警告说，随着通胀和美联储联手结束我们多年来陷入的大规模低利率模式，利率已准备好大幅走高。然后，利率似乎突然大幅走低，10年期国债收益率从5月底的近1.70%降至1.32%。基准30年期国债回到1.94%的水平。这是自去年冬天以来的最低利率水平。</blockquote></p><p> For income investors, this is another setback in what has become over a ten-year problem. While rates certainly could rise again, <a href=\"https://laohu8.com/S/AONE\">one</a> thing seems certain: the Federal Reserve will not raise rates until it is positive the economy is back at full strength. The only move the Fed looks poised to make in the near term is the beginning of the tapering of the $120 billion per month purchase of Treasury and mortgage debt.</p><p><blockquote>对于收益投资者来说，这是十多年来问题的又一次挫折。虽然利率肯定会再次上升，<a href=\"https://laohu8.com/S/AONE\">一</a>事情似乎是肯定的：在经济恢复全面强劲之前，美联储不会加息。美联储近期唯一准备采取的举措是开始缩减每月1200亿美元的国债和抵押贷款债务购买规模。</blockquote></p><p> We screened the BofA Securities research universe looking for blue chip stocks rated Buy that paid at least a 4% dividend. We found five that are very appealing now to growth and income investors. While all are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.</p><p><blockquote>我们筛选了美国银行证券研究领域，寻找支付至少4%股息的买入评级蓝筹股。我们发现了五种现在对成长型和收益型投资者非常有吸引力的股票。虽然所有报告都被评为买入，但重要的是要记住，任何分析师报告都不应用作任何买入或卖出决策的唯一依据。</blockquote></p><p> <a href=\"https://laohu8.com/S/MO\">Altria</a></p><p><blockquote><a href=\"https://laohu8.com/S/MO\">奥驰亚</a></blockquote></p><p> This maker of tobacco products offers value investors a great entry point now and was hit recently as cigarette sales have slowed. Altria Group Inc. (NYSE: MO) is the parent company of <a href=\"https://laohu8.com/S/PM\">Philip Morris</a> USA (cigarettes), UST (smokeless), John Middleton (cigars), Ste. Michelle Wine Estates and Philip Morris Capital. PMUSA enjoys a 51% share of the U.S. cigarette market, led by its top cigarette brand Marlboro.</p><p><blockquote>这家烟草产品制造商现在为价值投资者提供了一个很好的切入点，但最近由于卷烟销售放缓而受到打击。奥驰亚集团公司（纽约证券交易所股票代码：MO）是<a href=\"https://laohu8.com/S/PM\">菲利普·莫里斯</a>美国（香烟），UST（无烟），约翰米德尔顿（雪茄），Ste。米歇尔葡萄酒庄园和菲利普莫里斯资本。PMUSA在美国卷烟市场占据51%的份额，由其顶级卷烟品牌万宝路引领。</blockquote></p><p> Altria also owns over 10% of Anheuser-Busch InBev, the world’s largest brewer. In March 2008, it spun off its international cigarette business to shareholders. In December 2018, the company acquired 35% of Juul Labs, and it has purchased a 45% stake in cannabis company Cronus for $1.8 billion.</p><p><blockquote>奥驰亚还拥有全球最大啤酒制造商百威英博10%以上的股份。2008年3月，它将国际卷烟业务分拆给股东。2018年12月，该公司收购了Juul Labs 35%的股份，并以18亿美元收购了大麻公司Cronus 45%的股份。</blockquote></p><p> BofA Securities is very favorable toward the company’s plans for the future:</p><p><blockquote>美银证券非常看好该公司的未来计划：</blockquote></p><p>   Management presented at CAGNY (Consumer Analyst Group of <a href=\"https://laohu8.com/S/NWY\">New York</a>) where it discussed a new corporate focus on ESG, additional details on its IQOS plans and its “Moving beyond smoking” 10-yr plan. Smokeables (cigarettes/cigars) will remain an important part of its strategy, providing funding behind its long-term growth and shareholder returns. Over the last 5-yrs, smokeable and other comprehensive income grew at a 5.5% compounded annual growth rate despite volume declines.  Shareholders receive a 7.35% dividend. The analyst has a $58 target price on the shares, while the consensus target is lower at $53.89. Altria stock closed on Wednesday at $46.79 per share.</p><p><blockquote>管理层在CAGNY（消费者分析师小组<a href=\"https://laohu8.com/S/NWY\">纽约</a>）讨论了企业对ESG的新关注、IQOS计划及其“超越吸烟”10年计划的更多细节。Smokeables（香烟/雪茄）仍将是其战略的重要组成部分，为其长期增长和股东回报提供资金。在过去的5年里，尽管数量下降，吸烟和其他综合收入仍以5.5%的复合年增长率增长。股东获得7.35%的股息。分析师对该股的目标价为58美元，而共识目标价较低，为53.89美元。奥驰亚股价周三收于每股46.79美元。</blockquote></p><p> <a href=\"https://laohu8.com/S/CVX\">Chevron</a></p><p><blockquote><a href=\"https://laohu8.com/S/CVX\">雪佛龙</a></blockquote></p><p> This energy giant is a solid way for investors who are more conservative to be positioned in the sector. Chevron Corp. (NYSE: CVX) is a U.S.-based integrated oil and gas company, with worldwide operations in exploration and production, refining and marketing, transportation and petrochemicals. The company sports a sizable dividend and has a solid place in the sector when it comes to natural gas and liquefied natural gas.</p><p><blockquote>对于较为保守的投资者来说，这家能源巨头是在该行业定位的可靠途径。雪佛龙公司（纽约证券交易所股票代码：CVX）是一家总部位于美国的综合性石油和天然气公司，在勘探和生产、炼油和营销、运输和石化领域开展全球业务。该公司拥有可观的股息，并在天然气和液化天然气领域拥有稳固的地位。</blockquote></p><p> With the strongest financial base of the majors, coupled with an attractive relative asset base, many on Wall Street feel that Chevron offers the most straightforwardly positive risk/reward. Although current conditions do not warrant a large focus on production growth, Chevron possesses numerous medium-term drivers (<a href=\"https://laohu8.com/S/NBL\">Noble</a> integration, Permian, TCO/WPMP expansion, Gulf of Mexico exploration, Vaca Muerta, and so on) that should support production levels in the coming years.</p><p><blockquote>凭借各大巨头中最强大的财务基础，加上有吸引力的相对资产基础，华尔街的许多人认为雪佛龙提供了最直接的正风险/回报。尽管目前的情况不值得大力关注产量增长，但雪佛龙拥有众多中期驱动因素（<a href=\"https://laohu8.com/S/NBL\">高尚的</a>一体化、二叠纪、TCO/WPMP扩张、墨西哥湾勘探、Vaca Muerta等）应该会支持未来几年的生产水平。</blockquote></p><p> <a href=\"https://laohu8.com/S/IBM\">IBM</a></p><p><blockquote><a href=\"https://laohu8.com/S/IBM\">IBM</a></blockquote></p><p> This old-school tech giant still offers investors a very solid entry point. International Business Machines Corp. (NYSE: IBM) is a leading provider of enterprise solutions, offering a broad portfolio of information technology (IT) hardware, business and IT services, and a full suite of software solutions.</p><p><blockquote>这家老派科技巨头仍然为投资者提供了一个非常坚实的切入点。国际商业机器公司（纽约证券交易所代码：IBM）是一家领先的企业解决方案提供商，提供广泛的信息技术（IT）硬件、商业和IT服务以及全套软件解决方案。</blockquote></p><p> The company integrates its hardware products with its software and services offerings in order to provide high-value solutions. Analysts have cited the company’s potential in the public cloud as a reason for their positive outlook going forward.</p><p><blockquote>该公司将其硬件产品与其软件和服务产品相集成，以提供高价值的解决方案。分析师将该公司在公共云领域的潜力作为他们对未来前景持积极态度的原因。</blockquote></p><p> CEO Ginni Rommety, who had been in the position since 2012, stepped down in January, and the stock market greeted the news in a very positive manner. Arvind Krishna, who has led the company’s cloud computing business, became the new chief executive. Rometty will remain as executive board chair until the end of the year.</p><p><blockquote>自2012年以来一直担任该职位的首席执行官吉尼·罗梅蒂(Ginni Rommety)于1月份辞职，股市以非常积极的方式迎接这一消息。领导该公司云计算业务的Arvind Krishna成为新任首席执行官。罗睿兰将继续担任执行董事会主席直至今年年底。</blockquote></p><p></p><p> Holders of IBM stock receive a 4.69% dividend. The $175 BofA Securities price target is well above the $144.14 consensus figure. The shares closed at $139.82 on Wednesday.</p><p><blockquote>IBM股票持有人获得4.69%的股息。美国银行证券175美元的目标价远高于144.14美元的共识价。该股周三收于139.82美元。</blockquote></p><p> Shareholders receive a 5.21% dividend, which analysts feel comfortable will remain at current levels. The BofA Securities price target is $125, which compares to a $122.48 consensus target and the last Chevron stock trade on Wednesday at $102.93 a share.</p><p><blockquote>股东获得5.21%的股息，分析师认为股息将保持在当前水平。美国银行证券的目标价为125美元，而共识目标价为122.48美元，周三雪佛龙股票最后一次交易价格为每股102.93美元。</blockquote></p><p> LyondellBasell</p><p><blockquote>利安德巴塞尔</blockquote></p><p> This top chemical company with a sterling balance sheet is another solid play for conservative investors. LyondellBasell Industries N.V. (NYSE: LYB) manufactures chemicals and polymers, refines crude oil, produces gasoline blending components and develops and licenses technologies for production of polymers.</p><p><blockquote>这家拥有良好资产负债表的顶级化工公司是保守投资者的另一个可靠选择。利安德巴塞尔工业公司（纽约证券交易所股票代码：LYB）生产化学品和聚合物、精炼原油、生产汽油混合成分以及开发和许可聚合物生产技术。</blockquote></p><p> Over half of earnings are generated in the company’s Olefins and Polyolefins Americas segment, where costs are linked to the price of cheap natural gas in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States, while selling prices are correlated with the price of oil. The company has pursued a strategy of low-cost, high return on invested capital debottlenecks coupled with cash returns to shareholders.</p><p><blockquote>超过一半的收入来自该公司的烯烃和聚烯烃美洲部门，该部门的成本与该地区廉价天然气的价格相关。<a href=\"https://laohu8.com/S/UBNK\">团结的</a>国家，而销售价格与石油价格相关。该公司奉行低成本、高投资资本回报率的战略，消除瓶颈，并向股东提供现金回报。</blockquote></p><p> Note that debottlenecking is the process of identifying specific areas or equipment in oil and gas facilities that limit the flow of product (known as bottlenecks) and optimizing them so that overall capacity in the plant can be increased.</p><p><blockquote>请注意，去瓶颈是识别石油和天然气设施中限制产品流动的特定区域或设备（称为瓶颈）并对其进行优化的过程，以便提高工厂的整体产能。</blockquote></p><p> The company offers a 4.50% dividend. BofA Securities has set a $117 price target. The consensus target is $118.41, and LyondellBasell stock ended Wednesday at $100.40 a share.</p><p><blockquote>该公司提供4.50%的股息。美银证券将目标价定为117美元。共识目标为118.41美元，利安德巴塞尔股票周三收于每股100.40美元。</blockquote></p><p></p>","source":"lsy1620372341666","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge<blockquote>随着利率暴跌，值得买入并获得巨额股息的5只蓝筹股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge<blockquote>随着利率暴跌，值得买入并获得巨额股息的5只蓝筹股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">24/7 wall street</strong><span class=\"h-time small\">2021-07-09 12:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/JE\">Just</a> last month, we were being warned that interest rates were ready to move meaningfully higher as inflation and the Federal Reserve were teaming up to end the massive low interest rate paradigm we have been stuck in for years. Then, seemingly out of nowhere, rates have dived lower, with the 10-year Treasury trading at a 1.32% yield, down from near 1.70% at the end of May. The benchmark 30-year Treasury bond is back at the 1.94% level. These are the lowest interest rate levels since last winter.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>上个月，我们被警告说，随着通胀和美联储联手结束我们多年来陷入的大规模低利率模式，利率已准备好大幅走高。然后，利率似乎突然大幅走低，10年期国债收益率从5月底的近1.70%降至1.32%。基准30年期国债回到1.94%的水平。这是自去年冬天以来的最低利率水平。</blockquote></p><p> For income investors, this is another setback in what has become over a ten-year problem. While rates certainly could rise again, <a href=\"https://laohu8.com/S/AONE\">one</a> thing seems certain: the Federal Reserve will not raise rates until it is positive the economy is back at full strength. The only move the Fed looks poised to make in the near term is the beginning of the tapering of the $120 billion per month purchase of Treasury and mortgage debt.</p><p><blockquote>对于收益投资者来说，这是十多年来问题的又一次挫折。虽然利率肯定会再次上升，<a href=\"https://laohu8.com/S/AONE\">一</a>事情似乎是肯定的：在经济恢复全面强劲之前，美联储不会加息。美联储近期唯一准备采取的举措是开始缩减每月1200亿美元的国债和抵押贷款债务购买规模。</blockquote></p><p> We screened the BofA Securities research universe looking for blue chip stocks rated Buy that paid at least a 4% dividend. We found five that are very appealing now to growth and income investors. While all are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.</p><p><blockquote>我们筛选了美国银行证券研究领域，寻找支付至少4%股息的买入评级蓝筹股。我们发现了五种现在对成长型和收益型投资者非常有吸引力的股票。虽然所有报告都被评为买入，但重要的是要记住，任何分析师报告都不应用作任何买入或卖出决策的唯一依据。</blockquote></p><p> <a href=\"https://laohu8.com/S/MO\">Altria</a></p><p><blockquote><a href=\"https://laohu8.com/S/MO\">奥驰亚</a></blockquote></p><p> This maker of tobacco products offers value investors a great entry point now and was hit recently as cigarette sales have slowed. Altria Group Inc. (NYSE: MO) is the parent company of <a href=\"https://laohu8.com/S/PM\">Philip Morris</a> USA (cigarettes), UST (smokeless), John Middleton (cigars), Ste. Michelle Wine Estates and Philip Morris Capital. PMUSA enjoys a 51% share of the U.S. cigarette market, led by its top cigarette brand Marlboro.</p><p><blockquote>这家烟草产品制造商现在为价值投资者提供了一个很好的切入点，但最近由于卷烟销售放缓而受到打击。奥驰亚集团公司（纽约证券交易所股票代码：MO）是<a href=\"https://laohu8.com/S/PM\">菲利普·莫里斯</a>美国（香烟），UST（无烟），约翰米德尔顿（雪茄），Ste。米歇尔葡萄酒庄园和菲利普莫里斯资本。PMUSA在美国卷烟市场占据51%的份额，由其顶级卷烟品牌万宝路引领。</blockquote></p><p> Altria also owns over 10% of Anheuser-Busch InBev, the world’s largest brewer. In March 2008, it spun off its international cigarette business to shareholders. In December 2018, the company acquired 35% of Juul Labs, and it has purchased a 45% stake in cannabis company Cronus for $1.8 billion.</p><p><blockquote>奥驰亚还拥有全球最大啤酒制造商百威英博10%以上的股份。2008年3月，它将国际卷烟业务分拆给股东。2018年12月，该公司收购了Juul Labs 35%的股份，并以18亿美元收购了大麻公司Cronus 45%的股份。</blockquote></p><p> BofA Securities is very favorable toward the company’s plans for the future:</p><p><blockquote>美银证券非常看好该公司的未来计划：</blockquote></p><p>   Management presented at CAGNY (Consumer Analyst Group of <a href=\"https://laohu8.com/S/NWY\">New York</a>) where it discussed a new corporate focus on ESG, additional details on its IQOS plans and its “Moving beyond smoking” 10-yr plan. Smokeables (cigarettes/cigars) will remain an important part of its strategy, providing funding behind its long-term growth and shareholder returns. Over the last 5-yrs, smokeable and other comprehensive income grew at a 5.5% compounded annual growth rate despite volume declines.  Shareholders receive a 7.35% dividend. The analyst has a $58 target price on the shares, while the consensus target is lower at $53.89. Altria stock closed on Wednesday at $46.79 per share.</p><p><blockquote>管理层在CAGNY（消费者分析师小组<a href=\"https://laohu8.com/S/NWY\">纽约</a>）讨论了企业对ESG的新关注、IQOS计划及其“超越吸烟”10年计划的更多细节。Smokeables（香烟/雪茄）仍将是其战略的重要组成部分，为其长期增长和股东回报提供资金。在过去的5年里，尽管数量下降，吸烟和其他综合收入仍以5.5%的复合年增长率增长。股东获得7.35%的股息。分析师对该股的目标价为58美元，而共识目标价较低，为53.89美元。奥驰亚股价周三收于每股46.79美元。</blockquote></p><p> <a href=\"https://laohu8.com/S/CVX\">Chevron</a></p><p><blockquote><a href=\"https://laohu8.com/S/CVX\">雪佛龙</a></blockquote></p><p> This energy giant is a solid way for investors who are more conservative to be positioned in the sector. Chevron Corp. (NYSE: CVX) is a U.S.-based integrated oil and gas company, with worldwide operations in exploration and production, refining and marketing, transportation and petrochemicals. The company sports a sizable dividend and has a solid place in the sector when it comes to natural gas and liquefied natural gas.</p><p><blockquote>对于较为保守的投资者来说，这家能源巨头是在该行业定位的可靠途径。雪佛龙公司（纽约证券交易所股票代码：CVX）是一家总部位于美国的综合性石油和天然气公司，在勘探和生产、炼油和营销、运输和石化领域开展全球业务。该公司拥有可观的股息，并在天然气和液化天然气领域拥有稳固的地位。</blockquote></p><p> With the strongest financial base of the majors, coupled with an attractive relative asset base, many on Wall Street feel that Chevron offers the most straightforwardly positive risk/reward. Although current conditions do not warrant a large focus on production growth, Chevron possesses numerous medium-term drivers (<a href=\"https://laohu8.com/S/NBL\">Noble</a> integration, Permian, TCO/WPMP expansion, Gulf of Mexico exploration, Vaca Muerta, and so on) that should support production levels in the coming years.</p><p><blockquote>凭借各大巨头中最强大的财务基础，加上有吸引力的相对资产基础，华尔街的许多人认为雪佛龙提供了最直接的正风险/回报。尽管目前的情况不值得大力关注产量增长，但雪佛龙拥有众多中期驱动因素（<a href=\"https://laohu8.com/S/NBL\">高尚的</a>一体化、二叠纪、TCO/WPMP扩张、墨西哥湾勘探、Vaca Muerta等）应该会支持未来几年的生产水平。</blockquote></p><p> <a href=\"https://laohu8.com/S/IBM\">IBM</a></p><p><blockquote><a href=\"https://laohu8.com/S/IBM\">IBM</a></blockquote></p><p> This old-school tech giant still offers investors a very solid entry point. International Business Machines Corp. (NYSE: IBM) is a leading provider of enterprise solutions, offering a broad portfolio of information technology (IT) hardware, business and IT services, and a full suite of software solutions.</p><p><blockquote>这家老派科技巨头仍然为投资者提供了一个非常坚实的切入点。国际商业机器公司（纽约证券交易所代码：IBM）是一家领先的企业解决方案提供商，提供广泛的信息技术（IT）硬件、商业和IT服务以及全套软件解决方案。</blockquote></p><p> The company integrates its hardware products with its software and services offerings in order to provide high-value solutions. Analysts have cited the company’s potential in the public cloud as a reason for their positive outlook going forward.</p><p><blockquote>该公司将其硬件产品与其软件和服务产品相集成，以提供高价值的解决方案。分析师将该公司在公共云领域的潜力作为他们对未来前景持积极态度的原因。</blockquote></p><p> CEO Ginni Rommety, who had been in the position since 2012, stepped down in January, and the stock market greeted the news in a very positive manner. Arvind Krishna, who has led the company’s cloud computing business, became the new chief executive. Rometty will remain as executive board chair until the end of the year.</p><p><blockquote>自2012年以来一直担任该职位的首席执行官吉尼·罗梅蒂(Ginni Rommety)于1月份辞职，股市以非常积极的方式迎接这一消息。领导该公司云计算业务的Arvind Krishna成为新任首席执行官。罗睿兰将继续担任执行董事会主席直至今年年底。</blockquote></p><p></p><p> Holders of IBM stock receive a 4.69% dividend. The $175 BofA Securities price target is well above the $144.14 consensus figure. The shares closed at $139.82 on Wednesday.</p><p><blockquote>IBM股票持有人获得4.69%的股息。美国银行证券175美元的目标价远高于144.14美元的共识价。该股周三收于139.82美元。</blockquote></p><p> Shareholders receive a 5.21% dividend, which analysts feel comfortable will remain at current levels. The BofA Securities price target is $125, which compares to a $122.48 consensus target and the last Chevron stock trade on Wednesday at $102.93 a share.</p><p><blockquote>股东获得5.21%的股息，分析师认为股息将保持在当前水平。美国银行证券的目标价为125美元，而共识目标价为122.48美元，周三雪佛龙股票最后一次交易价格为每股102.93美元。</blockquote></p><p> LyondellBasell</p><p><blockquote>利安德巴塞尔</blockquote></p><p> This top chemical company with a sterling balance sheet is another solid play for conservative investors. LyondellBasell Industries N.V. (NYSE: LYB) manufactures chemicals and polymers, refines crude oil, produces gasoline blending components and develops and licenses technologies for production of polymers.</p><p><blockquote>这家拥有良好资产负债表的顶级化工公司是保守投资者的另一个可靠选择。利安德巴塞尔工业公司（纽约证券交易所股票代码：LYB）生产化学品和聚合物、精炼原油、生产汽油混合成分以及开发和许可聚合物生产技术。</blockquote></p><p> Over half of earnings are generated in the company’s Olefins and Polyolefins Americas segment, where costs are linked to the price of cheap natural gas in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States, while selling prices are correlated with the price of oil. The company has pursued a strategy of low-cost, high return on invested capital debottlenecks coupled with cash returns to shareholders.</p><p><blockquote>超过一半的收入来自该公司的烯烃和聚烯烃美洲部门，该部门的成本与该地区廉价天然气的价格相关。<a href=\"https://laohu8.com/S/UBNK\">团结的</a>国家，而销售价格与石油价格相关。该公司奉行低成本、高投资资本回报率的战略，消除瓶颈，并向股东提供现金回报。</blockquote></p><p> Note that debottlenecking is the process of identifying specific areas or equipment in oil and gas facilities that limit the flow of product (known as bottlenecks) and optimizing them so that overall capacity in the plant can be increased.</p><p><blockquote>请注意，去瓶颈是识别石油和天然气设施中限制产品流动的特定区域或设备（称为瓶颈）并对其进行优化的过程，以便提高工厂的整体产能。</blockquote></p><p> The company offers a 4.50% dividend. BofA Securities has set a $117 price target. The consensus target is $118.41, and LyondellBasell stock ended Wednesday at $100.40 a share.</p><p><blockquote>该公司提供4.50%的股息。美银证券将目标价定为117美元。共识目标为118.41美元，利安德巴塞尔股票周三收于每股100.40美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://247wallst.com/investing/2021/07/08/5-blue-chip-stocks-to-buy-with-huge-dividends-as-interest-rates-plunge/\">24/7 wall street</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://247wallst.com/investing/2021/07/08/5-blue-chip-stocks-to-buy-with-huge-dividends-as-interest-rates-plunge/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119741032","content_text":"Just last month, we were being warned that interest rates were ready to move meaningfully higher as inflation and the Federal Reserve were teaming up to end the massive low interest rate paradigm we have been stuck in for years. Then, seemingly out of nowhere, rates have dived lower, with the 10-year Treasury trading at a 1.32% yield, down from near 1.70% at the end of May. The benchmark 30-year Treasury bond is back at the 1.94% level. These are the lowest interest rate levels since last winter.\nFor income investors, this is another setback in what has become over a ten-year problem. While rates certainly could rise again, one thing seems certain: the Federal Reserve will not raise rates until it is positive the economy is back at full strength. The only move the Fed looks poised to make in the near term is the beginning of the tapering of the $120 billion per month purchase of Treasury and mortgage debt.\nWe screened the BofA Securities research universe looking for blue chip stocks rated Buy that paid at least a 4% dividend. We found five that are very appealing now to growth and income investors. While all are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.\nAltria\nThis maker of tobacco products offers value investors a great entry point now and was hit recently as cigarette sales have slowed. Altria Group Inc. (NYSE: MO) is the parent company of Philip Morris USA (cigarettes), UST (smokeless), John Middleton (cigars), Ste. Michelle Wine Estates and Philip Morris Capital. PMUSA enjoys a 51% share of the U.S. cigarette market, led by its top cigarette brand Marlboro.\nAltria also owns over 10% of Anheuser-Busch InBev, the world’s largest brewer. In March 2008, it spun off its international cigarette business to shareholders. In December 2018, the company acquired 35% of Juul Labs, and it has purchased a 45% stake in cannabis company Cronus for $1.8 billion.\nBofA Securities is very favorable toward the company’s plans for the future:\n\n Management presented at CAGNY (Consumer Analyst Group of New York) where it discussed a new corporate focus on ESG, additional details on its IQOS plans and its “Moving beyond smoking” 10-yr plan. Smokeables (cigarettes/cigars) will remain an important part of its strategy, providing funding behind its long-term growth and shareholder returns. Over the last 5-yrs, smokeable and other comprehensive income grew at a 5.5% compounded annual growth rate despite volume declines.\n\nShareholders receive a 7.35% dividend. The analyst has a $58 target price on the shares, while the consensus target is lower at $53.89. Altria stock closed on Wednesday at $46.79 per share.\nChevron\nThis energy giant is a solid way for investors who are more conservative to be positioned in the sector. Chevron Corp. (NYSE: CVX) is a U.S.-based integrated oil and gas company, with worldwide operations in exploration and production, refining and marketing, transportation and petrochemicals. The company sports a sizable dividend and has a solid place in the sector when it comes to natural gas and liquefied natural gas.\nWith the strongest financial base of the majors, coupled with an attractive relative asset base, many on Wall Street feel that Chevron offers the most straightforwardly positive risk/reward. Although current conditions do not warrant a large focus on production growth, Chevron possesses numerous medium-term drivers (Noble integration, Permian, TCO/WPMP expansion, Gulf of Mexico exploration, Vaca Muerta, and so on) that should support production levels in the coming years.\nIBM\nThis old-school tech giant still offers investors a very solid entry point. International Business Machines Corp. (NYSE: IBM) is a leading provider of enterprise solutions, offering a broad portfolio of information technology (IT) hardware, business and IT services, and a full suite of software solutions.\nThe company integrates its hardware products with its software and services offerings in order to provide high-value solutions. Analysts have cited the company’s potential in the public cloud as a reason for their positive outlook going forward.\nCEO Ginni Rommety, who had been in the position since 2012, stepped down in January, and the stock market greeted the news in a very positive manner. Arvind Krishna, who has led the company’s cloud computing business, became the new chief executive. Rometty will remain as executive board chair until the end of the year.\nHolders of IBM stock receive a 4.69% dividend. The $175 BofA Securities price target is well above the $144.14 consensus figure. The shares closed at $139.82 on Wednesday.\nShareholders receive a 5.21% dividend, which analysts feel comfortable will remain at current levels. The BofA Securities price target is $125, which compares to a $122.48 consensus target and the last Chevron stock trade on Wednesday at $102.93 a share.\nLyondellBasell\nThis top chemical company with a sterling balance sheet is another solid play for conservative investors. LyondellBasell Industries N.V. (NYSE: LYB) manufactures chemicals and polymers, refines crude oil, produces gasoline blending components and develops and licenses technologies for production of polymers.\nOver half of earnings are generated in the company’s Olefins and Polyolefins Americas segment, where costs are linked to the price of cheap natural gas in the United States, while selling prices are correlated with the price of oil. The company has pursued a strategy of low-cost, high return on invested capital debottlenecks coupled with cash returns to shareholders.\nNote that debottlenecking is the process of identifying specific areas or equipment in oil and gas facilities that limit the flow of product (known as bottlenecks) and optimizing them so that overall capacity in the plant can be increased.\nThe company offers a 4.50% dividend. BofA Securities has set a $117 price target. The consensus target is $118.41, and LyondellBasell stock ended Wednesday at $100.40 a share.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":149858428,"gmtCreate":1625716746964,"gmtModify":1633938045510,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Sell and buying back after","listText":"Sell and buying back after","text":"Sell and buying back after","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/149858428","repostId":"2149313255","repostType":4,"isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154495218,"gmtCreate":1625537592434,"gmtModify":1631888415100,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a> shoot up so fast.. Not even have a chance to buy more at lower price..&nbsp;","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a> shoot up so fast.. Not even have a chance to buy more at lower price..&nbsp;","text":"$KEPPEL DC REIT(AJBU.SI)$ shoot up so fast.. Not even have a chance to buy more at lower price..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/154495218","isVote":1,"tweetType":1,"viewCount":1029,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":155431842,"gmtCreate":1625448121186,"gmtModify":1633940625081,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Illegally collected users' personal data","listText":"Illegally collected users' personal data","text":"Illegally collected users' personal data","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155431842","repostId":"1169840279","repostType":4,"isVote":1,"tweetType":1,"viewCount":726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158093253,"gmtCreate":1625111637872,"gmtModify":1633944655601,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"The downward trend of unemployment ratesis a good sign that the labour market is steadily improving","listText":"The downward trend of unemployment ratesis a good sign that the labour market is steadily improving","text":"The downward trend of unemployment ratesis a good sign that the labour market is steadily improving","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/158093253","repostId":"2148189849","repostType":4,"isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153625682,"gmtCreate":1625022923246,"gmtModify":1633945717868,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580168616843436","authorIdStr":"3580168616843436"},"themes":[],"htmlText":"Japan.. Lost Decade","listText":"Japan.. Lost Decade","text":"Japan.. Lost Decade","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/153625682","repostId":"1160246970","repostType":4,"repost":{"id":"1160246970","kind":"news","pubTimestamp":1625016621,"share":"https://www.laohu8.com/m/news/1160246970?lang=zh_CN&edition=full","pubTime":"2021-06-30 09:30","market":"us","language":"en","title":"The Lost Decade: Lessons From Japan's Real Estate Crisis<blockquote>失去的十年：日本房地产危机的教训</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1160246970","media":"investopedia","summary":"What Was Japan's \"Lost Decade\" Real Estate Crisis?\nFree markets economies are subject tocycles.Econo","content":"<p><b>What Was Japan's \"Lost Decade\" Real Estate Crisis?</b></p><p><blockquote><b>日本“失去的十年”房地产危机是什么？</b></blockquote></p><p> Free markets economies are subject tocycles.Economic cyclesconsist of fluctuating periods of economic expansion andcontractionas measured by a nation'sgross domestic product(GDP).</p><p><blockquote>自由市场经济受到周期的影响。经济周期由以一个国家的国内生产总值（GDP）衡量的经济扩张和收缩的波动时期组成。</blockquote></p><p> The length of economic cycles (periods of expansion vs. contraction) can vary greatly. The traditional measure of an economicrecessionis two or more consecutive quarters of falling gross domestic product. There are also economic depressions, which are extended periods of economic contraction such as theGreat Depressionof the 1930s.</p><p><blockquote>经济周期的长度（扩张期与收缩期）可能会有很大差异。经济衰退的传统衡量标准是国内生产总值连续两个或两个以上季度下降。还有经济萧条，即长期的经济收缩，例如20世纪30年代的大萧条。</blockquote></p><p> From 1991 through 2001, Japan experienced a period of economicstagnationand price deflation known as \"Japan'sLost Decade.\" While the Japanese economy outgrew this period, it did so at a much slower pace than other industrialized nations. During this period, the Japanese economy suffered from both acredit crunchand aliquidity trap.</p><p><blockquote>从1991年到2001年，日本经历了一段被称为“日本失去的十年”的经济停滞和物价通缩时期。虽然日本经济增长超过了这一时期，但其增长速度比其他工业化国家慢得多。在此期间，日本经济遭受了信贷紧缩和流动性陷阱。</blockquote></p><p> Understanding Japan's \"Lost Decade\" Real Estate CrisisJapan's Lost Decade</p><p><blockquote>了解日本“失去的十年”房地产危机日本失去的十年</blockquote></p><p> Japan's economy was the envy of the world in the 1980s—it grew at an average annual rate (as measured by GDP) of 3.89% in the 1980s, compared to 3.07% in the United States.1But Japan's economy ran into troubles in the 1990s.</p><p><blockquote>日本经济在20世纪80年代令世界羡慕——20世纪80年代的年均增长率（以GDP衡量）为3.89%，而美国为3.07%。1但日本经济在20世纪90年代陷入了困境。</blockquote></p><p> From 1991 to 2003, the Japanese economy, as measured by GDP, grew only 1.14% annually, well below that of other industrialized nations.1</p><p><blockquote>从1991年到2003年，以GDP衡量的日本经济年增长率仅为1.14%，远低于其他工业化国家。</blockquote></p><p> <b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>Japan's \"Lost Decade\" was a period that lasted from about 1991 to 2001 that saw a great slowdown in Japan's previously bustling economy.</li>  <li>The main causes of this economic slowdown were raising interest rates that set a liquidity trap at the same time that a credit crunch was unfolding.</li>  <li>The major lessons economies can take from Japan's \"Lost Decade\" include using available public funds to restructure banks' balance sheets and that sometimes the fear of inflation can cause stagnation.</li> </ul> Japan's equity andreal estatebubbles burst starting in the fall of 1989. Equity values plunged 60% from late 1989 to August 1992,2whileland valuesdropped throughout the 1990s, falling an incredible 70% by 2001.3</p><p><blockquote><ul><li>日本“失去的十年”是从1991年左右持续到2001年的一段时间，日本以前繁荣的经济大幅放缓。</li><li>经济放缓的主要原因是加息，在信贷紧缩展开的同时，加息造成了流动性陷阱。</li><li>各经济体可以从日本“失去的十年”中吸取的主要教训包括利用可用的公共资金重组银行资产负债表，以及有时对通胀的担忧会导致经济停滞。</li></ul>日本的股票和房地产泡沫从1989年秋天开始破裂。从1989年末到1992年8月，股票价值暴跌了60%，2而土地价值在整个20世纪90年代都在下跌，到2001年更是惊人地下跌了70%。</blockquote></p><p> <b>The Bank of Japan's Interest Rate Mistakes</b></p><p><blockquote><b>日本央行的利率失误</b></blockquote></p><p> It is generally acknowledged that theBank of Japan(BoJ), Japan'scentral bank, made several mistakes that may have added to and prolonged the negative effects of the bursting of the equity and real estate bubbles.</p><p><blockquote>人们普遍认为，日本央行（BoJ）犯了几个错误，这些错误可能加剧并延长了股票和房地产泡沫破裂的负面影响。</blockquote></p><p> For example, monetary policy was stop-and-go; concerned aboutinflationand asset prices, the Bank of Japan put the brakes on themoney supplyin the late 1980s, which may have contributed to the bursting of the equity bubble. Then, as equity values fell, the BoJ continued to raise interest rates because it remained concerned with still-appreciating real estate values.4</p><p><blockquote>例如，货币政策走走停停；出于对通货膨胀和资产价格的担忧，日本央行在20世纪80年代末抑制了货币供应，这可能导致了股票泡沫的破裂。然后，随着股票价值的下跌，日本央行继续提高利率，因为它仍然担心仍在升值的房地产价值。</blockquote></p><p> Higher interest rates contributed to the end of rising land prices, but they also helped the overall economy slide into a downward spiral. In 1991, as equity and land prices fell, the Bank of Japan dramatically reversed course and began to cut interest rates.5But it was too late, aliquiditytrap had already been set, and a credit crunch was setting in.</p><p><blockquote>较高的利率有助于结束土地价格上涨，但也帮助整体经济陷入螺旋式下降。1991年，随着股票和土地价格下跌，日本银行戏剧性地改变了方针，开始降息。5但为时已晚，流动性陷阱已经设置，信贷紧缩正在发生。</blockquote></p><p> <b>A Liquidity Trap</b></p><p><blockquote><b>流动性陷阱</b></blockquote></p><p> A liquidity trap is an economic scenario in which households and investors sit on cash; either in short-term accounts or literally as cash on hand.</p><p><blockquote>流动性陷阱是指家庭和投资者坐拥现金的经济情景；要么是短期账户，要么是手头现金。</blockquote></p><p> They might do this for a few reasons: they have no confidence that they can earn a higherrate of returnby investing, they believedeflationis on the horizon (cash will increase in value relative to fixed assets), or deflation already exists. All three reasons are highly correlated, and under such circumstances, household and investor beliefs become reality.</p><p><blockquote>他们这样做可能有几个原因：他们没有信心通过投资获得更高的回报率，他们相信通货紧缩即将到来（现金相对于固定资产的价值会增加），或者通货紧缩已经存在。这三个原因都是高度相关的，在这种情况下，家庭和投资者的信念成为现实。</blockquote></p><p> In a liquidity trap, low interest rates, as a matter ofmonetary policy, become ineffective. People and investors simply don't spend or invest. They believe goods and services will be cheaper tomorrow, so they wait to consume, and they believe they can earn a better return by simply sitting on their money than by investing it. The Bank of Japan'sdiscount ratewas 0.5% for much of the 1990s, but it failed to stimulate the Japanese economy, and deflation persisted.6</p><p><blockquote>在流动性陷阱中，低利率作为货币政策变得无效。人们和投资者根本不消费或投资。他们相信明天商品和服务会更便宜，所以他们等待消费，他们相信简单地坐拥资金比投资更能获得更好的回报。在20世纪90年代的大部分时间里，日本央行的贴现率为0.5%，但这未能刺激日本经济，通货紧缩持续存在。</blockquote></p><p> <b>Breaking Out of a Liquidity Trap</b></p><p><blockquote><b>打破流动性陷阱</b></blockquote></p><p> To break out of a liquidity trap, households and businesses have to be willing to spend and invest. One way of getting them to do so is throughfiscal policy. Governments can give money directly to consumers through reductions intax rates, issuances of tax rebates, and public spending.</p><p><blockquote>为了摆脱流动性陷阱，家庭和企业必须愿意支出和投资。让他们这样做的一种方法是通过财政政策。政府可以通过降低税率、发放退税和公共支出直接向消费者提供资金。</blockquote></p><p></p><p> Japan tried several fiscal policy measures to break out of its liquidity trap, but it is generally believed that these measures were not executed well—money was wasted on inefficient public works projects and given to failing businesses. Most economists agree that for fiscal stimulus policy to be effective, money must be allocated efficiently. In other words, let the market decide where to spend and invest by placing money directly in the hands of consumers. (For related reading, check out<i>What Is Fiscal Policy?</i>)</p><p><blockquote>日本尝试了几项财政政策措施以突破其流动性陷阱，但人们普遍认为这些措施执行得并不好——钱被浪费在效率低下的公共工程项目上，并被给予了失败的企业。大多数经济学家都认为，为了使财政刺激政策有效，必须有效地分配资金。换句话说，通过将钱直接放在消费者手中，让市场决定在哪里消费和投资。（相关阅读，请查看<i>什么是财政政策？</i>)</blockquote></p><p> Another way to break out of the liquidity trap is to \"re-inflate\" the economy by increasing the actual supply of money as opposed to targetingnominal interest rates. A central bank can inject money into an economy without regard for an established target interest rate (such as thefed funds ratein the U.S.) through the purchase ofgovernment bondsinopen-market operations.</p><p><blockquote>打破流动性陷阱的另一种方法是通过增加实际货币供应量来“重新膨胀”经济，而不是以名义利率为目标。央行可以通过在公开市场操作中购买政府债券，向经济注入资金，而无需考虑既定的目标利率（例如美国的联邦基金利率）。</blockquote></p><p> This is when a central bank purchases a bond, in which case it effectively exchanges it for cash, which increases the money supply. This is known as themonetizationof debt. (It should be noted that open-market operations are also used to attain and maintain target interest rates, but when a central bank monetizes the debt, it does so without regard for a target interest rate.) (To learn more, read<i>How do central banks inject money into the economy?</i>)</p><p><blockquote>这是指中央银行购买债券，在这种情况下，它实际上将其兑换成现金，从而增加货币供应量。这就是所谓的债务货币化。（应该注意的是，公开市场操作也用于实现和维持目标利率，但当央行将债务货币化时，它是在不考虑目标利率的情况下这样做的。）（要了解更多信息，请阅读<i>央行如何向经济注入资金？</i>)</blockquote></p><p> In 2001, the Bank of Japan began to target the money supply instead of interest rates, which helped to moderate deflation and stimulateeconomic growth.5 However, when a central bank injects money into thefinancial system, banks are left with more money on hand, but also must be willing to lend that money out. This brings us to the next problem Japan faced: a credit crunch.</p><p><blockquote>2001年，日本央行开始以货币供应量而不是利率为目标，这有助于缓解通货紧缩并刺激经济增长。5然而，当央行向金融体系注入资金时，银行手头会有更多的资金，但也必须愿意将这些钱借出去。这给我们带来了日本面临的下一个问题：信贷紧缩。</blockquote></p><p> <b>Credit Crunch</b></p><p><blockquote><b>信贷紧缩</b></blockquote></p><p> A credit crunch is an economic scenario in which banks have tightened lending requirements and for the most part, do not lend.</p><p><blockquote>信贷紧缩是一种经济情况，在这种情况下，银行收紧了贷款要求，并且在大多数情况下不放贷。</blockquote></p><p> They may not lend for several reasons, including: 1) the need to hold onto reserves in order repair theirbalance sheetsafter suffering loses, which happened to Japanese banks that had invested heavily in real estate, and 2) there might be a generalpullbackin risk-taking, which happened in the United States in 2007 and 2008 asfinancial institutionsthat initially suffered losses related tosubprime mortgagelending pulled back in all types of lending, deleveraged their balance sheets, and generally sought to reduce their levels of risk in all areas.</p><p><blockquote>他们可能出于几个原因不放贷，包括：1）在遭受损失后需要持有准备金以修复资产负债表，这发生在大量投资房地产的日本银行身上；2）风险承担可能会普遍回落，2007年和2008年美国就发生了这种情况，最初遭受次级抵押贷款相关损失的金融机构减少了所有类型的贷款，去杠杆化了资产负债表，并普遍寻求降低所有领域的风险水平。</blockquote></p><p> Calculated risk-taking and lending is the life-blood of afree marketeconomy. When capital is put to work, jobs are created, spending increases, efficiencies are discovered (productivity increases), and the economy grows. On the other hand, when banks are reluctant to lend, it is difficult for the economy to grow.</p><p><blockquote>有计划的风险承担和借贷是自由市场经济的命脉。当资本投入工作时，就业机会被创造出来，支出增加，效率被发现（生产率提高），经济增长。另一方面，当银行惜贷时，经济就难以增长。</blockquote></p><p> In the same manner that a liquidity trap leads to deflation, a credit crunch is also conducive to deflation as banks are unwilling to lend, and therefore consumers and businesses are unable to spend, causing prices to fall.</p><p><blockquote>正如流动性陷阱导致通货紧缩一样，信贷紧缩也有利于通货紧缩，因为银行不愿意放贷，因此消费者和企业无法消费，导致价格下跌。</blockquote></p><p> <b>Solutions to a Credit Crunch</b></p><p><blockquote><b>信贷紧缩的解决方案</b></blockquote></p><p> Japan also suffered from a credit crunch in the 1990s and Japanese banks were slow to take losses. Even though public funds were made available to banks to restructure their balance sheets, they failed to do so because of the fear of stigma associated with revealing long-concealed losses and the fear of losing control to foreign investors.7 To break out of a credit crunch, bank losses must be recognized, the banking system must be transparent, and banks must gain confidence in their ability to assess and manage risk.</p><p><blockquote>日本在20世纪90年代也遭受了信贷紧缩，日本银行承担损失的速度很慢。尽管向银行提供了公共资金来重组其资产负债表，但它们未能这样做，因为担心披露长期隐瞒的损失会带来耻辱，担心失去对外国投资者的控制权。7为了摆脱信贷紧缩，必须承认银行损失，银行系统必须透明，银行必须对其评估和管理风险的能力充满信心。</blockquote></p><p> Clearly, deflation causes a lot of problems. When asset prices are falling, households and investors hoard cash because cash will be worth more tomorrow than it is today. This creates a liquidity trap. When asset prices fall, the value ofcollateralbacking loans falls, which in turn leads to bank losses. When banks suffer losses, they stop lending, creating a credit crunch.</p><p><blockquote>显然，通货紧缩会导致很多问题。当资产价格下跌时，家庭和投资者会囤积现金，因为现金明天会比今天更值钱。这就造成了流动性陷阱。当资产价格下跌时，抵押品支持贷款的价值就会下降，进而导致银行损失。当银行遭受损失时，它们会停止放贷，从而造成信贷紧缩。</blockquote></p><p> Most of the time, we think ofinflationas a very bad economic problem, which it can be, but re-inflating an economy might be precisely what is needed to avoid prolonged periods of slow growth such as what Japan experienced in the 1990s.</p><p><blockquote>大多数时候，我们认为通货膨胀是一个非常严重的经济问题，事实也确实如此，但经济重新通胀可能正是避免日本在20世纪90年代经历的长期缓慢增长所需要的。</blockquote></p><p> The problem is that re-inflating an economy isn't easy, especially when banks are unwilling to lend. Notable American economistMilton Friedmansuggested that the way to avoid a liquidity trap is by bypassingfinancial intermediariesand giving money directly to individuals to spend. This is known as \"helicopter money,\" because the theory is that a central bank could literally drop money from a helicopter.8 This also suggests that regardless of which country you live in, life is all about being in the right place at the right time.</p><p><blockquote>问题是让经济重新膨胀并不容易，尤其是在银行不愿意放贷的情况下。美国著名经济学家米尔顿·弗里德曼提出，避免流动性陷阱的方法是绕过金融中介，直接将钱交给个人消费。这被称为“直升机撒钱”，因为该理论认为中央银行可以从直升机上投放资金。8这也表明，无论你生活在哪个国家，生活就是在正确的时间出现在正确的地点。</blockquote></p><p></p>","source":"lsy1606203311635","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Lost Decade: Lessons From Japan's Real Estate Crisis<blockquote>失去的十年：日本房地产危机的教训</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Lost Decade: Lessons From Japan's Real Estate Crisis<blockquote>失去的十年：日本房地产危机的教训</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">investopedia</strong><span class=\"h-time small\">2021-06-30 09:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>What Was Japan's \"Lost Decade\" Real Estate Crisis?</b></p><p><blockquote><b>日本“失去的十年”房地产危机是什么？</b></blockquote></p><p> Free markets economies are subject tocycles.Economic cyclesconsist of fluctuating periods of economic expansion andcontractionas measured by a nation'sgross domestic product(GDP).</p><p><blockquote>自由市场经济受到周期的影响。经济周期由以一个国家的国内生产总值（GDP）衡量的经济扩张和收缩的波动时期组成。</blockquote></p><p> The length of economic cycles (periods of expansion vs. contraction) can vary greatly. The traditional measure of an economicrecessionis two or more consecutive quarters of falling gross domestic product. There are also economic depressions, which are extended periods of economic contraction such as theGreat Depressionof the 1930s.</p><p><blockquote>经济周期的长度（扩张期与收缩期）可能会有很大差异。经济衰退的传统衡量标准是国内生产总值连续两个或两个以上季度下降。还有经济萧条，即长期的经济收缩，例如20世纪30年代的大萧条。</blockquote></p><p> From 1991 through 2001, Japan experienced a period of economicstagnationand price deflation known as \"Japan'sLost Decade.\" While the Japanese economy outgrew this period, it did so at a much slower pace than other industrialized nations. During this period, the Japanese economy suffered from both acredit crunchand aliquidity trap.</p><p><blockquote>从1991年到2001年，日本经历了一段被称为“日本失去的十年”的经济停滞和物价通缩时期。虽然日本经济增长超过了这一时期，但其增长速度比其他工业化国家慢得多。在此期间，日本经济遭受了信贷紧缩和流动性陷阱。</blockquote></p><p> Understanding Japan's \"Lost Decade\" Real Estate CrisisJapan's Lost Decade</p><p><blockquote>了解日本“失去的十年”房地产危机日本失去的十年</blockquote></p><p> Japan's economy was the envy of the world in the 1980s—it grew at an average annual rate (as measured by GDP) of 3.89% in the 1980s, compared to 3.07% in the United States.1But Japan's economy ran into troubles in the 1990s.</p><p><blockquote>日本经济在20世纪80年代令世界羡慕——20世纪80年代的年均增长率（以GDP衡量）为3.89%，而美国为3.07%。1但日本经济在20世纪90年代陷入了困境。</blockquote></p><p> From 1991 to 2003, the Japanese economy, as measured by GDP, grew only 1.14% annually, well below that of other industrialized nations.1</p><p><blockquote>从1991年到2003年，以GDP衡量的日本经济年增长率仅为1.14%，远低于其他工业化国家。</blockquote></p><p> <b>KEY TAKEAWAYS</b></p><p><blockquote><b>关键要点</b></blockquote></p><p> <ul>  <li>Japan's \"Lost Decade\" was a period that lasted from about 1991 to 2001 that saw a great slowdown in Japan's previously bustling economy.</li>  <li>The main causes of this economic slowdown were raising interest rates that set a liquidity trap at the same time that a credit crunch was unfolding.</li>  <li>The major lessons economies can take from Japan's \"Lost Decade\" include using available public funds to restructure banks' balance sheets and that sometimes the fear of inflation can cause stagnation.</li> </ul> Japan's equity andreal estatebubbles burst starting in the fall of 1989. Equity values plunged 60% from late 1989 to August 1992,2whileland valuesdropped throughout the 1990s, falling an incredible 70% by 2001.3</p><p><blockquote><ul><li>日本“失去的十年”是从1991年左右持续到2001年的一段时间，日本以前繁荣的经济大幅放缓。</li><li>经济放缓的主要原因是加息，在信贷紧缩展开的同时，加息造成了流动性陷阱。</li><li>各经济体可以从日本“失去的十年”中吸取的主要教训包括利用可用的公共资金重组银行资产负债表，以及有时对通胀的担忧会导致经济停滞。</li></ul>日本的股票和房地产泡沫从1989年秋天开始破裂。从1989年末到1992年8月，股票价值暴跌了60%，2而土地价值在整个20世纪90年代都在下跌，到2001年更是惊人地下跌了70%。</blockquote></p><p> <b>The Bank of Japan's Interest Rate Mistakes</b></p><p><blockquote><b>日本央行的利率失误</b></blockquote></p><p> It is generally acknowledged that theBank of Japan(BoJ), Japan'scentral bank, made several mistakes that may have added to and prolonged the negative effects of the bursting of the equity and real estate bubbles.</p><p><blockquote>人们普遍认为，日本央行（BoJ）犯了几个错误，这些错误可能加剧并延长了股票和房地产泡沫破裂的负面影响。</blockquote></p><p> For example, monetary policy was stop-and-go; concerned aboutinflationand asset prices, the Bank of Japan put the brakes on themoney supplyin the late 1980s, which may have contributed to the bursting of the equity bubble. Then, as equity values fell, the BoJ continued to raise interest rates because it remained concerned with still-appreciating real estate values.4</p><p><blockquote>例如，货币政策走走停停；出于对通货膨胀和资产价格的担忧，日本央行在20世纪80年代末抑制了货币供应，这可能导致了股票泡沫的破裂。然后，随着股票价值的下跌，日本央行继续提高利率，因为它仍然担心仍在升值的房地产价值。</blockquote></p><p> Higher interest rates contributed to the end of rising land prices, but they also helped the overall economy slide into a downward spiral. In 1991, as equity and land prices fell, the Bank of Japan dramatically reversed course and began to cut interest rates.5But it was too late, aliquiditytrap had already been set, and a credit crunch was setting in.</p><p><blockquote>较高的利率有助于结束土地价格上涨，但也帮助整体经济陷入螺旋式下降。1991年，随着股票和土地价格下跌，日本银行戏剧性地改变了方针，开始降息。5但为时已晚，流动性陷阱已经设置，信贷紧缩正在发生。</blockquote></p><p> <b>A Liquidity Trap</b></p><p><blockquote><b>流动性陷阱</b></blockquote></p><p> A liquidity trap is an economic scenario in which households and investors sit on cash; either in short-term accounts or literally as cash on hand.</p><p><blockquote>流动性陷阱是指家庭和投资者坐拥现金的经济情景；要么是短期账户，要么是手头现金。</blockquote></p><p> They might do this for a few reasons: they have no confidence that they can earn a higherrate of returnby investing, they believedeflationis on the horizon (cash will increase in value relative to fixed assets), or deflation already exists. All three reasons are highly correlated, and under such circumstances, household and investor beliefs become reality.</p><p><blockquote>他们这样做可能有几个原因：他们没有信心通过投资获得更高的回报率，他们相信通货紧缩即将到来（现金相对于固定资产的价值会增加），或者通货紧缩已经存在。这三个原因都是高度相关的，在这种情况下，家庭和投资者的信念成为现实。</blockquote></p><p> In a liquidity trap, low interest rates, as a matter ofmonetary policy, become ineffective. People and investors simply don't spend or invest. They believe goods and services will be cheaper tomorrow, so they wait to consume, and they believe they can earn a better return by simply sitting on their money than by investing it. The Bank of Japan'sdiscount ratewas 0.5% for much of the 1990s, but it failed to stimulate the Japanese economy, and deflation persisted.6</p><p><blockquote>在流动性陷阱中，低利率作为货币政策变得无效。人们和投资者根本不消费或投资。他们相信明天商品和服务会更便宜，所以他们等待消费，他们相信简单地坐拥资金比投资更能获得更好的回报。在20世纪90年代的大部分时间里，日本央行的贴现率为0.5%，但这未能刺激日本经济，通货紧缩持续存在。</blockquote></p><p> <b>Breaking Out of a Liquidity Trap</b></p><p><blockquote><b>打破流动性陷阱</b></blockquote></p><p> To break out of a liquidity trap, households and businesses have to be willing to spend and invest. One way of getting them to do so is throughfiscal policy. Governments can give money directly to consumers through reductions intax rates, issuances of tax rebates, and public spending.</p><p><blockquote>为了摆脱流动性陷阱，家庭和企业必须愿意支出和投资。让他们这样做的一种方法是通过财政政策。政府可以通过降低税率、发放退税和公共支出直接向消费者提供资金。</blockquote></p><p></p><p> Japan tried several fiscal policy measures to break out of its liquidity trap, but it is generally believed that these measures were not executed well—money was wasted on inefficient public works projects and given to failing businesses. Most economists agree that for fiscal stimulus policy to be effective, money must be allocated efficiently. In other words, let the market decide where to spend and invest by placing money directly in the hands of consumers. (For related reading, check out<i>What Is Fiscal Policy?</i>)</p><p><blockquote>日本尝试了几项财政政策措施以突破其流动性陷阱，但人们普遍认为这些措施执行得并不好——钱被浪费在效率低下的公共工程项目上，并被给予了失败的企业。大多数经济学家都认为，为了使财政刺激政策有效，必须有效地分配资金。换句话说，通过将钱直接放在消费者手中，让市场决定在哪里消费和投资。（相关阅读，请查看<i>什么是财政政策？</i>)</blockquote></p><p> Another way to break out of the liquidity trap is to \"re-inflate\" the economy by increasing the actual supply of money as opposed to targetingnominal interest rates. A central bank can inject money into an economy without regard for an established target interest rate (such as thefed funds ratein the U.S.) through the purchase ofgovernment bondsinopen-market operations.</p><p><blockquote>打破流动性陷阱的另一种方法是通过增加实际货币供应量来“重新膨胀”经济，而不是以名义利率为目标。央行可以通过在公开市场操作中购买政府债券，向经济注入资金，而无需考虑既定的目标利率（例如美国的联邦基金利率）。</blockquote></p><p> This is when a central bank purchases a bond, in which case it effectively exchanges it for cash, which increases the money supply. This is known as themonetizationof debt. (It should be noted that open-market operations are also used to attain and maintain target interest rates, but when a central bank monetizes the debt, it does so without regard for a target interest rate.) (To learn more, read<i>How do central banks inject money into the economy?</i>)</p><p><blockquote>这是指中央银行购买债券，在这种情况下，它实际上将其兑换成现金，从而增加货币供应量。这就是所谓的债务货币化。（应该注意的是，公开市场操作也用于实现和维持目标利率，但当央行将债务货币化时，它是在不考虑目标利率的情况下这样做的。）（要了解更多信息，请阅读<i>央行如何向经济注入资金？</i>)</blockquote></p><p> In 2001, the Bank of Japan began to target the money supply instead of interest rates, which helped to moderate deflation and stimulateeconomic growth.5 However, when a central bank injects money into thefinancial system, banks are left with more money on hand, but also must be willing to lend that money out. This brings us to the next problem Japan faced: a credit crunch.</p><p><blockquote>2001年，日本央行开始以货币供应量而不是利率为目标，这有助于缓解通货紧缩并刺激经济增长。5然而，当央行向金融体系注入资金时，银行手头会有更多的资金，但也必须愿意将这些钱借出去。这给我们带来了日本面临的下一个问题：信贷紧缩。</blockquote></p><p> <b>Credit Crunch</b></p><p><blockquote><b>信贷紧缩</b></blockquote></p><p> A credit crunch is an economic scenario in which banks have tightened lending requirements and for the most part, do not lend.</p><p><blockquote>信贷紧缩是一种经济情况，在这种情况下，银行收紧了贷款要求，并且在大多数情况下不放贷。</blockquote></p><p> They may not lend for several reasons, including: 1) the need to hold onto reserves in order repair theirbalance sheetsafter suffering loses, which happened to Japanese banks that had invested heavily in real estate, and 2) there might be a generalpullbackin risk-taking, which happened in the United States in 2007 and 2008 asfinancial institutionsthat initially suffered losses related tosubprime mortgagelending pulled back in all types of lending, deleveraged their balance sheets, and generally sought to reduce their levels of risk in all areas.</p><p><blockquote>他们可能出于几个原因不放贷，包括：1）在遭受损失后需要持有准备金以修复资产负债表，这发生在大量投资房地产的日本银行身上；2）风险承担可能会普遍回落，2007年和2008年美国就发生了这种情况，最初遭受次级抵押贷款相关损失的金融机构减少了所有类型的贷款，去杠杆化了资产负债表，并普遍寻求降低所有领域的风险水平。</blockquote></p><p> Calculated risk-taking and lending is the life-blood of afree marketeconomy. When capital is put to work, jobs are created, spending increases, efficiencies are discovered (productivity increases), and the economy grows. On the other hand, when banks are reluctant to lend, it is difficult for the economy to grow.</p><p><blockquote>有计划的风险承担和借贷是自由市场经济的命脉。当资本投入工作时，就业机会被创造出来，支出增加，效率被发现（生产率提高），经济增长。另一方面，当银行惜贷时，经济就难以增长。</blockquote></p><p> In the same manner that a liquidity trap leads to deflation, a credit crunch is also conducive to deflation as banks are unwilling to lend, and therefore consumers and businesses are unable to spend, causing prices to fall.</p><p><blockquote>正如流动性陷阱导致通货紧缩一样，信贷紧缩也有利于通货紧缩，因为银行不愿意放贷，因此消费者和企业无法消费，导致价格下跌。</blockquote></p><p> <b>Solutions to a Credit Crunch</b></p><p><blockquote><b>信贷紧缩的解决方案</b></blockquote></p><p> Japan also suffered from a credit crunch in the 1990s and Japanese banks were slow to take losses. Even though public funds were made available to banks to restructure their balance sheets, they failed to do so because of the fear of stigma associated with revealing long-concealed losses and the fear of losing control to foreign investors.7 To break out of a credit crunch, bank losses must be recognized, the banking system must be transparent, and banks must gain confidence in their ability to assess and manage risk.</p><p><blockquote>日本在20世纪90年代也遭受了信贷紧缩，日本银行承担损失的速度很慢。尽管向银行提供了公共资金来重组其资产负债表，但它们未能这样做，因为担心披露长期隐瞒的损失会带来耻辱，担心失去对外国投资者的控制权。7为了摆脱信贷紧缩，必须承认银行损失，银行系统必须透明，银行必须对其评估和管理风险的能力充满信心。</blockquote></p><p> Clearly, deflation causes a lot of problems. When asset prices are falling, households and investors hoard cash because cash will be worth more tomorrow than it is today. This creates a liquidity trap. When asset prices fall, the value ofcollateralbacking loans falls, which in turn leads to bank losses. When banks suffer losses, they stop lending, creating a credit crunch.</p><p><blockquote>显然，通货紧缩会导致很多问题。当资产价格下跌时，家庭和投资者会囤积现金，因为现金明天会比今天更值钱。这就造成了流动性陷阱。当资产价格下跌时，抵押品支持贷款的价值就会下降，进而导致银行损失。当银行遭受损失时，它们会停止放贷，从而造成信贷紧缩。</blockquote></p><p> Most of the time, we think ofinflationas a very bad economic problem, which it can be, but re-inflating an economy might be precisely what is needed to avoid prolonged periods of slow growth such as what Japan experienced in the 1990s.</p><p><blockquote>大多数时候，我们认为通货膨胀是一个非常严重的经济问题，事实也确实如此，但经济重新通胀可能正是避免日本在20世纪90年代经历的长期缓慢增长所需要的。</blockquote></p><p> The problem is that re-inflating an economy isn't easy, especially when banks are unwilling to lend. Notable American economistMilton Friedmansuggested that the way to avoid a liquidity trap is by bypassingfinancial intermediariesand giving money directly to individuals to spend. This is known as \"helicopter money,\" because the theory is that a central bank could literally drop money from a helicopter.8 This also suggests that regardless of which country you live in, life is all about being in the right place at the right time.</p><p><blockquote>问题是让经济重新膨胀并不容易，尤其是在银行不愿意放贷的情况下。美国著名经济学家米尔顿·弗里德曼提出，避免流动性陷阱的方法是绕过金融中介，直接将钱交给个人消费。这被称为“直升机撒钱”，因为该理论认为中央银行可以从直升机上投放资金。8这也表明，无论你生活在哪个国家，生活就是在正确的时间出现在正确的地点。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investopedia.com/articles/economics/08/japan-1990s-credit-crunch-liquidity-trap.asp?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral\">investopedia</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.investopedia.com/articles/economics/08/japan-1990s-credit-crunch-liquidity-trap.asp?utm_campaign=quote-yahoo&utm_source=yahoo&utm_medium=referral","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160246970","content_text":"What Was Japan's \"Lost Decade\" Real Estate Crisis?\nFree markets economies are subject tocycles.Economic cyclesconsist of fluctuating periods of economic expansion andcontractionas measured by a nation'sgross domestic product(GDP).\nThe length of economic cycles (periods of expansion vs. contraction) can vary greatly. The traditional measure of an economicrecessionis two or more consecutive quarters of falling gross domestic product. There are also economic depressions, which are extended periods of economic contraction such as theGreat Depressionof the 1930s.\nFrom 1991 through 2001, Japan experienced a period of economicstagnationand price deflation known as \"Japan'sLost Decade.\" While the Japanese economy outgrew this period, it did so at a much slower pace than other industrialized nations. During this period, the Japanese economy suffered from both acredit crunchand aliquidity trap.\nUnderstanding Japan's \"Lost Decade\" Real Estate CrisisJapan's Lost Decade\nJapan's economy was the envy of the world in the 1980s—it grew at an average annual rate (as measured by GDP) of 3.89% in the 1980s, compared to 3.07% in the United States.1But Japan's economy ran into troubles in the 1990s.\nFrom 1991 to 2003, the Japanese economy, as measured by GDP, grew only 1.14% annually, well below that of other industrialized nations.1\nKEY TAKEAWAYS\n\nJapan's \"Lost Decade\" was a period that lasted from about 1991 to 2001 that saw a great slowdown in Japan's previously bustling economy.\nThe main causes of this economic slowdown were raising interest rates that set a liquidity trap at the same time that a credit crunch was unfolding.\nThe major lessons economies can take from Japan's \"Lost Decade\" include using available public funds to restructure banks' balance sheets and that sometimes the fear of inflation can cause stagnation.\n\nJapan's equity andreal estatebubbles burst starting in the fall of 1989. Equity values plunged 60% from late 1989 to August 1992,2whileland valuesdropped throughout the 1990s, falling an incredible 70% by 2001.3\nThe Bank of Japan's Interest Rate Mistakes\nIt is generally acknowledged that theBank of Japan(BoJ), Japan'scentral bank, made several mistakes that may have added to and prolonged the negative effects of the bursting of the equity and real estate bubbles.\nFor example, monetary policy was stop-and-go; concerned aboutinflationand asset prices, the Bank of Japan put the brakes on themoney supplyin the late 1980s, which may have contributed to the bursting of the equity bubble. Then, as equity values fell, the BoJ continued to raise interest rates because it remained concerned with still-appreciating real estate values.4\nHigher interest rates contributed to the end of rising land prices, but they also helped the overall economy slide into a downward spiral. In 1991, as equity and land prices fell, the Bank of Japan dramatically reversed course and began to cut interest rates.5But it was too late, aliquiditytrap had already been set, and a credit crunch was setting in.\nA Liquidity Trap\nA liquidity trap is an economic scenario in which households and investors sit on cash; either in short-term accounts or literally as cash on hand.\nThey might do this for a few reasons: they have no confidence that they can earn a higherrate of returnby investing, they believedeflationis on the horizon (cash will increase in value relative to fixed assets), or deflation already exists. All three reasons are highly correlated, and under such circumstances, household and investor beliefs become reality.\nIn a liquidity trap, low interest rates, as a matter ofmonetary policy, become ineffective. People and investors simply don't spend or invest. They believe goods and services will be cheaper tomorrow, so they wait to consume, and they believe they can earn a better return by simply sitting on their money than by investing it. The Bank of Japan'sdiscount ratewas 0.5% for much of the 1990s, but it failed to stimulate the Japanese economy, and deflation persisted.6\nBreaking Out of a Liquidity Trap\nTo break out of a liquidity trap, households and businesses have to be willing to spend and invest. One way of getting them to do so is throughfiscal policy. Governments can give money directly to consumers through reductions intax rates, issuances of tax rebates, and public spending.\nJapan tried several fiscal policy measures to break out of its liquidity trap, but it is generally believed that these measures were not executed well—money was wasted on inefficient public works projects and given to failing businesses. Most economists agree that for fiscal stimulus policy to be effective, money must be allocated efficiently. In other words, let the market decide where to spend and invest by placing money directly in the hands of consumers. (For related reading, check outWhat Is Fiscal Policy?)\nAnother way to break out of the liquidity trap is to \"re-inflate\" the economy by increasing the actual supply of money as opposed to targetingnominal interest rates. A central bank can inject money into an economy without regard for an established target interest rate (such as thefed funds ratein the U.S.) through the purchase ofgovernment bondsinopen-market operations.\nThis is when a central bank purchases a bond, in which case it effectively exchanges it for cash, which increases the money supply. This is known as themonetizationof debt. (It should be noted that open-market operations are also used to attain and maintain target interest rates, but when a central bank monetizes the debt, it does so without regard for a target interest rate.) (To learn more, readHow do central banks inject money into the economy?)\nIn 2001, the Bank of Japan began to target the money supply instead of interest rates, which helped to moderate deflation and stimulateeconomic growth.5 However, when a central bank injects money into thefinancial system, banks are left with more money on hand, but also must be willing to lend that money out. This brings us to the next problem Japan faced: a credit crunch.\nCredit Crunch\nA credit crunch is an economic scenario in which banks have tightened lending requirements and for the most part, do not lend.\nThey may not lend for several reasons, including: 1) the need to hold onto reserves in order repair theirbalance sheetsafter suffering loses, which happened to Japanese banks that had invested heavily in real estate, and 2) there might be a generalpullbackin risk-taking, which happened in the United States in 2007 and 2008 asfinancial institutionsthat initially suffered losses related tosubprime mortgagelending pulled back in all types of lending, deleveraged their balance sheets, and generally sought to reduce their levels of risk in all areas.\nCalculated risk-taking and lending is the life-blood of afree marketeconomy. When capital is put to work, jobs are created, spending increases, efficiencies are discovered (productivity increases), and the economy grows. On the other hand, when banks are reluctant to lend, it is difficult for the economy to grow.\nIn the same manner that a liquidity trap leads to deflation, a credit crunch is also conducive to deflation as banks are unwilling to lend, and therefore consumers and businesses are unable to spend, causing prices to fall.\nSolutions to a Credit Crunch\nJapan also suffered from a credit crunch in the 1990s and Japanese banks were slow to take losses. Even though public funds were made available to banks to restructure their balance sheets, they failed to do so because of the fear of stigma associated with revealing long-concealed losses and the fear of losing control to foreign investors.7 To break out of a credit crunch, bank losses must be recognized, the banking system must be transparent, and banks must gain confidence in their ability to assess and manage risk.\nClearly, deflation causes a lot of problems. When asset prices are falling, households and investors hoard cash because cash will be worth more tomorrow than it is today. This creates a liquidity trap. When asset prices fall, the value ofcollateralbacking loans falls, which in turn leads to bank losses. When banks suffer losses, they stop lending, creating a credit crunch.\nMost of the time, we think ofinflationas a very bad economic problem, which it can be, but re-inflating an economy might be precisely what is needed to avoid prolonged periods of slow growth such as what Japan experienced in the 1990s.\nThe problem is that re-inflating an economy isn't easy, especially when banks are unwilling to lend. Notable American economistMilton Friedmansuggested that the way to avoid a liquidity trap is by bypassingfinancial intermediariesand giving money directly to individuals to spend. This is known as \"helicopter money,\" because the theory is that a central bank could literally drop money from a helicopter.8 This also suggests that regardless of which country you live in, life is all about being in the right place at the right time.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":839643303,"gmtCreate":1629158484302,"gmtModify":1631888076553,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"The vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose","listText":"The vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose","text":"The vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/839643303","repostId":"1166738043","repostType":4,"repost":{"id":"1166738043","kind":"news","pubTimestamp":1629158127,"share":"https://www.laohu8.com/m/news/1166738043?lang=zh_CN&edition=full","pubTime":"2021-08-17 07:55","market":"us","language":"en","title":"Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster<blockquote>辉瑞和BioNTech寻求FDA批准Covid-19加强剂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166738043","media":"The Wall Street Journal","summary":"Early-stage study shows third dose of vaccine offers a higher level of protection, companies say\nThe","content":"<p>Early-stage study shows third dose of vaccine offers a higher level of protection, companies say</p><p><blockquote>公司表示，早期研究表明第三剂疫苗可提供更高水平的保护</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14a5e62531f6fe58f57ee8f19db73a40\" tg-width=\"860\" tg-height=\"573\" width=\"100%\" height=\"auto\"><span>The addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.</span></p><p><blockquote><p class=\"t-img-caption\"><span>辉瑞和BioNTech表示，添加第三剂似乎是安全的。宾夕法尼亚州施文克斯维尔的新冠肺炎疫苗接种。，药房。</span></p></blockquote></p><p> Pfizer&nbsp;Inc.&nbsp;and partner&nbsp;BioNTech SE&nbsp;have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.</p><p><blockquote>辉瑞公司和合作伙伴BioNTech SE已向美国卫生监管机构提交了在公众中清除Covid-19加强注射所需的数据。</blockquote></p><p> The companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.</p><p><blockquote>这些公司周一表示，他们向美国发送了。美国食品和药物管理局的一项小型早期研究结果显示，与标准的两剂方案相比，第三剂疫苗产生了更高水平的针对原始病毒以及针对β和δ变异体的中和抗体。</blockquote></p><p> The addition of the third dose also appeared safe in the trial, the companies said.</p><p><blockquote>两家公司表示，在试验中添加第三剂似乎也是安全的。</blockquote></p><p> Given the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against&nbsp;symptomatic Covid-19.</p><p><blockquote>两家公司表示，鉴于第三剂疫苗的免疫反应增强，在第二剂疫苗接种后六个月至一年内进行加强注射可能有助于保持对有症状的Covid-19的保护。</blockquote></p><p> Pfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.</p><p><blockquote>辉瑞和BioNTech也在进行一项更大规模的后期研究，评估第三剂疫苗是否能安全地提供更多保护。两家公司表示，他们预计这些结果将很快公布，然后将向FDA提交数据。</blockquote></p><p> The FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.</p><p><blockquote>FDA正在考虑一个更广泛的加强策略，该机构可能会在未来几周内发布。</blockquote></p><p> Two doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.</p><p><blockquote>两剂辉瑞-BioNTech疫苗被授权用于12岁及以上的人群，间隔三周注射。</blockquote></p><p> Some physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.</p><p><blockquote>美国的一些医生和科学家表示，对于普通人群是否需要加强剂，目前还没有明确的答案，部分原因是有证据表明疫苗在预防严重疾病方面仍然非常有效。</blockquote></p><p> Studies indicate the vaccine is still highly effective in people&nbsp;six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt&nbsp;he Delta variant, prompting research into adding a third dose.</p><p><blockquote>研究表明，该疫苗在接种第二剂疫苗六个月后仍然非常有效。然而，有一些证据表明，随着时间的推移，它的功效可能会减弱，而且这种疫苗对德尔塔变异毒株病的疗效并不那么有效，这促使研究增加第三剂。</blockquote></p><p> Last week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot&nbsp;for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.</p><p><blockquote>上周，FDA批准为某些免疫系统较弱的人注射第三剂mRNA疫苗，例如辉瑞-BioNTech疫苗，以增强他们对Covid-19的免疫防御。</blockquote></p><p> In the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.</p><p><blockquote>辉瑞和BioNTech表示，在针对一般健康人群的早期研究中，受试者接受了第三剂30微克剂量。受试者在接受第二剂后8至9个月接受额外剂量。</blockquote></p><p> Then researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.</p><p><blockquote>两家公司表示，然后研究人员测量了受试者的中和抗体水平，中和抗体在预防病毒方面发挥着至关重要的作用。</blockquote></p><p> The levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.</p><p><blockquote>两家公司表示，针对病毒的初始毒株以及Beta和Delta变种，水平有所上升。两家公司表示，加强剂量后，针对变种的中和抗体与早期菌株相似。</blockquote></p><p> Pfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.</p><p><blockquote>辉瑞在上个月的第二季度财报中公布了一些科学数据，但尚未详细说明结果。辉瑞的数据显示，第三次注射后，与注射两剂相比，18至55岁人群的抗体水平上升了5倍以上，65至85岁人群的抗体水平上升了11倍以上。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster<blockquote>辉瑞和BioNTech寻求FDA批准Covid-19加强剂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer, BioNTech Seek FDA Clearance for Covid-19 Booster<blockquote>辉瑞和BioNTech寻求FDA批准Covid-19加强剂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-08-17 07:55</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Early-stage study shows third dose of vaccine offers a higher level of protection, companies say</p><p><blockquote>公司表示，早期研究表明第三剂疫苗可提供更高水平的保护</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14a5e62531f6fe58f57ee8f19db73a40\" tg-width=\"860\" tg-height=\"573\" width=\"100%\" height=\"auto\"><span>The addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.</span></p><p><blockquote><p class=\"t-img-caption\"><span>辉瑞和BioNTech表示，添加第三剂似乎是安全的。宾夕法尼亚州施文克斯维尔的新冠肺炎疫苗接种。，药房。</span></p></blockquote></p><p> Pfizer&nbsp;Inc.&nbsp;and partner&nbsp;BioNTech SE&nbsp;have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.</p><p><blockquote>辉瑞公司和合作伙伴BioNTech SE已向美国卫生监管机构提交了在公众中清除Covid-19加强注射所需的数据。</blockquote></p><p> The companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.</p><p><blockquote>这些公司周一表示，他们向美国发送了。美国食品和药物管理局的一项小型早期研究结果显示，与标准的两剂方案相比，第三剂疫苗产生了更高水平的针对原始病毒以及针对β和δ变异体的中和抗体。</blockquote></p><p> The addition of the third dose also appeared safe in the trial, the companies said.</p><p><blockquote>两家公司表示，在试验中添加第三剂似乎也是安全的。</blockquote></p><p> Given the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against&nbsp;symptomatic Covid-19.</p><p><blockquote>两家公司表示，鉴于第三剂疫苗的免疫反应增强，在第二剂疫苗接种后六个月至一年内进行加强注射可能有助于保持对有症状的Covid-19的保护。</blockquote></p><p> Pfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.</p><p><blockquote>辉瑞和BioNTech也在进行一项更大规模的后期研究，评估第三剂疫苗是否能安全地提供更多保护。两家公司表示，他们预计这些结果将很快公布，然后将向FDA提交数据。</blockquote></p><p> The FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.</p><p><blockquote>FDA正在考虑一个更广泛的加强策略，该机构可能会在未来几周内发布。</blockquote></p><p> Two doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.</p><p><blockquote>两剂辉瑞-BioNTech疫苗被授权用于12岁及以上的人群，间隔三周注射。</blockquote></p><p> Some physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.</p><p><blockquote>美国的一些医生和科学家表示，对于普通人群是否需要加强剂，目前还没有明确的答案，部分原因是有证据表明疫苗在预防严重疾病方面仍然非常有效。</blockquote></p><p> Studies indicate the vaccine is still highly effective in people&nbsp;six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt&nbsp;he Delta variant, prompting research into adding a third dose.</p><p><blockquote>研究表明，该疫苗在接种第二剂疫苗六个月后仍然非常有效。然而，有一些证据表明，随着时间的推移，它的功效可能会减弱，而且这种疫苗对德尔塔变异毒株病的疗效并不那么有效，这促使研究增加第三剂。</blockquote></p><p> Last week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot&nbsp;for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.</p><p><blockquote>上周，FDA批准为某些免疫系统较弱的人注射第三剂mRNA疫苗，例如辉瑞-BioNTech疫苗，以增强他们对Covid-19的免疫防御。</blockquote></p><p> In the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.</p><p><blockquote>辉瑞和BioNTech表示，在针对一般健康人群的早期研究中，受试者接受了第三剂30微克剂量。受试者在接受第二剂后8至9个月接受额外剂量。</blockquote></p><p> Then researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.</p><p><blockquote>两家公司表示，然后研究人员测量了受试者的中和抗体水平，中和抗体在预防病毒方面发挥着至关重要的作用。</blockquote></p><p> The levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.</p><p><blockquote>两家公司表示，针对病毒的初始毒株以及Beta和Delta变种，水平有所上升。两家公司表示，加强剂量后，针对变种的中和抗体与早期菌株相似。</blockquote></p><p> Pfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.</p><p><blockquote>辉瑞在上个月的第二季度财报中公布了一些科学数据，但尚未详细说明结果。辉瑞的数据显示，第三次注射后，与注射两剂相比，18至55岁人群的抗体水平上升了5倍以上，65至85岁人群的抗体水平上升了11倍以上。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/pfizer-biontech-seek-fda-clearance-for-covid-19-booster-11629136057?mod=hp_lead_pos6\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://www.wsj.com/articles/pfizer-biontech-seek-fda-clearance-for-covid-19-booster-11629136057?mod=hp_lead_pos6","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166738043","content_text":"Early-stage study shows third dose of vaccine offers a higher level of protection, companies say\nThe addition of a third dose appeared safe, Pfizer and BioNTech said. A Covid-19 vaccination at a Schwenksville, Pa., pharmacy.\nPfizer Inc. and partner BioNTech SE have submitted data to U.S. health regulators needed to cleara Covid-19 booster shot among the general public.\nThe companies said Monday they sent to the U.S. Food and Drug Administration results from a small, early-stage study showing a third dose of their vaccine generated higher levels of neutralizing antibodies against the original virus and against the Beta and Delta variants than the standard two-dose regimen.\nThe addition of the third dose also appeared safe in the trial, the companies said.\nGiven the immune response boost from a third dose, the companies said, a booster shot within six months to a year after the second shot might help maintain protection against symptomatic Covid-19.\nPfizer and BioNTech are also conducting a larger late-stage study evaluating whether a third dose safely provides more protection. The companies said they expect those results shortly and will then submit the data to the FDA.\nThe FDA is considering a broader booster strategy, which the agency could issue in the next few weeks.\nTwo doses of the Pfizer-BioNTech shot, given three weeks apart, are authorized for people ages 12 years and older.\nSome physicians and scientists in the U.S. say there isn’t a clear answer yet on whether boosters are needed for the general population, partly because of evidence that shows vaccines continue to be highly effective at preventing severe disease.\nStudies indicate the vaccine is still highly effective in people six months after their second dose. Yet there is some evidence its efficacy might diminish over longer periods, and the shot isn’t as effective againstt he Delta variant, prompting research into adding a third dose.\nLast week, the FDA authorized a third dose of an mRNA vaccine like the Pfizer-BioNTech shot for certain people with weakened immune systems, in a bid to bolster their immune defenses against Covid-19.\nIn the early-stage study looking at a booster among generally healthy people, subjects got a third 30-microgram dose, Pfizer and BioNTech said. The subjects received the extra dose eight to nine months after receiving their second dose.\nThen researchers measured in subjects their levels of neutralizing antibodies, which play a crucial role in protection against the virus, the companies said.\nThe levels rose against the initial strain of the virus, as well as the Beta and Delta variants, the companies said. After the booster dose, neutralizing antibodies against the variants were similar to the earlier strain, the companies said.\nPfizer presented some of the scientific data during its second-quarter earnings presentation last month, but hasn’t detailed the results yet. After a third shot, antibody levels were up more than five times among people ages 18 to 55 and more than 11 times in people ages 65 to 85, compared with two doses, according to Pfizer’s data.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":3033,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115145238,"gmtCreate":1622963445624,"gmtModify":1631888362146,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Agree can buy and hold technology stocks","listText":"Agree can buy and hold technology stocks","text":"Agree can buy and hold technology stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/115145238","repostId":"2140540596","repostType":4,"isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810788474,"gmtCreate":1630016254298,"gmtModify":1704954503604,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Chip shortage will be a concern","listText":"Chip shortage will be a concern","text":"Chip shortage will be a concern","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810788474","repostId":"1161561973","repostType":4,"repost":{"id":"1161561973","kind":"news","pubTimestamp":1629991651,"share":"https://www.laohu8.com/m/news/1161561973?lang=zh_CN&edition=full","pubTime":"2021-08-26 23:27","market":"us","language":"en","title":"Can Tesla Shares Hit $900 Again This Year?<blockquote>特斯拉股价今年能否再次触及900美元？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1161561973","media":"investing.com","summary":"Electric vehicle maker Tesla Motors' (NASDAQ:TSLA) stock is picking up momentum again. After falling","content":"<p>Electric vehicle maker <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a>' (NASDAQ:TSLA) stock is picking up momentum again. After falling from a record high $900.40, hit intraday on Jan. 25, TSLA shares have gained 17% during the past three months, outperforming the benchmark&nbsp;NASDAQ 100&nbsp;Index.</p><p><blockquote>电动汽车制造商<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>（纳斯达克：TSLA）股价再次上涨。在从1月25日盘中触及的900.40美元的历史新高下跌后，特斯拉股价在过去三个月内上涨了17%，跑赢了基准纳斯达克100指数。</blockquote></p><p> The biggest question Tesla bulls now have is, whether, on top of the current gains, can the EV manufacturer's stock push through back to the all-time high of $900 this year?</p><p><blockquote>特斯拉多头现在面临的最大问题是，除了当前的涨幅之外，这家电动汽车制造商的股价今年能否回升至900美元的历史高点？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b4b9078f00190f208dd63b32c4f617c6\" tg-width=\"651\" tg-height=\"708\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Tesla Weekly Chart.</p><p><blockquote>特斯拉周线图。</blockquote></p><p> Given the highly volatile nature of the stock, it’s tough to predict whether the current Tesla rally has legs. But it’s important to note that the outlook for its car sales is becoming more uncertain than it was a year ago.</p><p><blockquote>鉴于该股的高度波动性，很难预测当前的特斯拉反弹是否持续。但值得注意的是，其汽车销售前景比一年前变得更加不确定。</blockquote></p><p> First, the global chip shortage continues to cast doubt on Tesla’s ambitious sales targets for 2021. Chief Executive Officer Elon Musk highlighted challenges that come from the unpredictability of chip supplies and the hurdles he expects in ramping production at two new factories in Austin, Texas, and Berlin, later this year.</p><p><blockquote>首先，全球芯片短缺继续让人们对特斯拉2021年雄心勃勃的销售目标产生怀疑。首席执行官埃隆·马斯克强调了芯片供应的不可预测性带来的挑战，以及他预计今年晚些时候在德克萨斯州奥斯汀和柏林的两家新工厂提高产量的障碍。</blockquote></p><p> Tesla again delayed delivery of its semi-trailer truck—already two years late. The first trucks of this type are now slated for 2022. The company attributed the delay to supply-chain issues and limited battery-cell supply, as well as management trying to focus on getting new factories online. The company’s plans for its first pickup truck, once expected to go to customers as early as this year, are also being affected by parts issues.</p><p><blockquote>特斯拉再次推迟了半挂卡车的交付——已经晚了两年。第一批这种类型的卡车预计于2022年上市。该公司将延迟归因于供应链问题和电池供应有限，以及管理层试图专注于让新工厂上线。该公司首款皮卡的计划一度预计最早将于今年交付给客户，但也受到零部件问题的影响。</blockquote></p><p> This is what Musk told analysts last month:</p><p><blockquote>这是马斯克上个月对分析师说的话：</blockquote></p><p>   “While we’re making cars at full speed, the global chip-shortage situation remains quite serious. For the rest of this year, our growth rate will be determined by the slowest part in our supply chain.”  Regulatory Probe</p><p><blockquote>“在我们全速造车的同时，全球芯片短缺的情况仍然相当严重。在今年剩下的时间里，我们的增长率将由供应链中最慢的部分决定。”监管探针</blockquote></p><p> Besides the risks to the market’s earnings consensus for this fiscal year, Tesla is facing a regulatory probe that could result in a massive recall.</p><p><blockquote>除了本财年市场盈利共识面临风险外，特斯拉还面临监管调查，可能导致大规模召回。</blockquote></p><p> The U.S.opened a formal investigation&nbsp;into Tesla’s Autopilot system last week after almost a dozen collisions involving first-responder vehicles. In the last seven years, Tesla has charged clients thousands of dollars for this feature.</p><p><blockquote>在发生了近十几起涉及急救车辆的碰撞事件后，美国上周对特斯拉的自动驾驶系统展开了正式调查。在过去的七年里，特斯拉为此向客户收取了数千美元的费用。</blockquote></p><p> The probe by the National Highway Traffic Safety Administration (NHTSA) covers an estimated 765,000 Tesla Model Y, X, S and 3 vehicles from the 2014 model year onward. The regulator—which has the power to deem cars defective and order recalls—said&nbsp;it launched the investigation after 11 crashes that resulted in 17 injuries and one fatality.</p><p><blockquote>美国国家公路交通安全管理局(NHTSA)的调查涵盖了2014车型年起约765,000辆特斯拉Model Y、X、S和3辆汽车。该监管机构有权认定汽车有缺陷并下令召回，该监管机构表示，在发生11起导致17人受伤、1人死亡的事故后，它启动了调查。</blockquote></p><p> Bloomberg reported&nbsp;that Tesla has been criticized for years for labeling the system in a potentially misleading way. Since late 2016, it has marketed this higher-level functionality feature as Full Self-Driving Capability. In reality, Autopilot is a driver-assistance system that maintains vehicles’ speed and keeps them centered in lanes when engaged, though the driver is supposed to supervise at all times.</p><p><blockquote>彭博社报道称，特斯拉多年来一直因以可能误导的方式给该系统贴上标签而受到批评。自2016年底以来，它一直将这一更高级别的功能特性作为全自动驾驶功能进行营销。事实上，自动驾驶仪是一种驾驶员辅助系统，可以保持车辆的速度并在启动时使其保持在车道中央，尽管驾驶员应该始终进行监督。</blockquote></p><p> Tesla now sells that package of features—often referred to as FSD—for $10,000 or $199 a month.</p><p><blockquote>特斯拉现在以每月10,000美元或199美元的价格出售该功能包（通常称为FSD）。</blockquote></p><p> After the NHTSA launched of the probe, two Democratic senators asked the Federal Trade Commission to also investigate Tesla over the company’s advertising of its Autopilot and FSD technology.</p><p><blockquote>NHTSA发起调查后，两名民主党参议员要求联邦贸易委员会也调查特斯拉公司宣传其Autopilot和FSD技术的行为。</blockquote></p><p> In a&nbsp;letter&nbsp;last Wednesday, Sen. Richard Blumenthal of Connecticut and Sen. Ed Markey of Massachusetts asked FTC Chair Lina Khan to examine whether Tesla used “potentially deceptive and unfair practices” in its marketing of those technologies.</p><p><blockquote>在上周三的一封信中，康涅狄格参议员Richard Blumenthal和麻萨诸塞州参议员Ed Markey要求FTC主席Lina Khan调查特斯拉在营销这些技术时是否使用了“潜在的欺骗性和不公平的做法”。</blockquote></p><p> “We fear that Tesla’s Autopilot and FSD features are not as mature and reliable as the company pitches to the public,” they wrote, pointing to comments from Musk, as well as a 2019 YouTube video entitled “Full Self-Driving” and has a link to Tesla’s site.</p><p><blockquote>“我们担心特斯拉的Autopilot和FSD功能并不像该公司向公众宣传的那样成熟和可靠，”他们写道，并指出了马斯克的评论，以及2019年YouTube上一段题为“全自动驾驶”的视频，并有一个指向特斯拉网站的链接。</blockquote></p><p> Highlighting these risks and how they could affect Tesla’s current stock price, however, shouldn’t hide the fact that there are many analysts who continue to remain bullish on TSLA. Piper Sandler reiterated its overweight rating on the stock and its price target of $1,200 this month.</p><p><blockquote>然而，强调这些风险以及它们如何影响特斯拉当前的股价不应掩盖这样一个事实：许多分析师继续看好特斯拉。Piper Sandler重申了跑赢大盘对该股的评级以及本月1200美元的目标价。</blockquote></p><p> In a note, analysts Alexander Potter and Winnie Dong said:</p><p><blockquote>分析师Alexander Potter和Winnie Dong在一份报告中表示：</blockquote></p><p>   “Bottom line: We still really like this stock. Tesla is still the driving force behind higher [battery electric vehicle] penetration globally.”  <b>Bottom Line</b></p><p><blockquote>“底线：我们仍然非常喜欢这只股票。特斯拉仍然是全球[纯电动汽车]渗透率更高的驱动力。”<b>底线</b></blockquote></p><p> It’s difficult to predict the future course for Tesla stock given the huge amount of speculative interest in this name. But recent developments show that it will be quite hard for the EV automaker to exceed expectations in this tough manufacturing environment.</p><p><blockquote>鉴于人们对特斯拉股票的巨大投机兴趣，很难预测该股票的未来走势。但最近的事态发展表明，在这种严峻的制造环境下，这家电动汽车制造商很难超出预期。</blockquote></p><p> Investors should trade this name with caution.</p><p><blockquote>投资者应谨慎交易该名称。</blockquote></p><p></p>","source":"lsy1594375853987","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Tesla Shares Hit $900 Again This Year?<blockquote>特斯拉股价今年能否再次触及900美元？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Tesla Shares Hit $900 Again This Year?<blockquote>特斯拉股价今年能否再次触及900美元？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">investing.com</strong><span class=\"h-time small\">2021-08-26 23:27</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Electric vehicle maker <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a>' (NASDAQ:TSLA) stock is picking up momentum again. After falling from a record high $900.40, hit intraday on Jan. 25, TSLA shares have gained 17% during the past three months, outperforming the benchmark&nbsp;NASDAQ 100&nbsp;Index.</p><p><blockquote>电动汽车制造商<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>（纳斯达克：TSLA）股价再次上涨。在从1月25日盘中触及的900.40美元的历史新高下跌后，特斯拉股价在过去三个月内上涨了17%，跑赢了基准纳斯达克100指数。</blockquote></p><p> The biggest question Tesla bulls now have is, whether, on top of the current gains, can the EV manufacturer's stock push through back to the all-time high of $900 this year?</p><p><blockquote>特斯拉多头现在面临的最大问题是，除了当前的涨幅之外，这家电动汽车制造商的股价今年能否回升至900美元的历史高点？</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b4b9078f00190f208dd63b32c4f617c6\" tg-width=\"651\" tg-height=\"708\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Tesla Weekly Chart.</p><p><blockquote>特斯拉周线图。</blockquote></p><p> Given the highly volatile nature of the stock, it’s tough to predict whether the current Tesla rally has legs. But it’s important to note that the outlook for its car sales is becoming more uncertain than it was a year ago.</p><p><blockquote>鉴于该股的高度波动性，很难预测当前的特斯拉反弹是否持续。但值得注意的是，其汽车销售前景比一年前变得更加不确定。</blockquote></p><p> First, the global chip shortage continues to cast doubt on Tesla’s ambitious sales targets for 2021. Chief Executive Officer Elon Musk highlighted challenges that come from the unpredictability of chip supplies and the hurdles he expects in ramping production at two new factories in Austin, Texas, and Berlin, later this year.</p><p><blockquote>首先，全球芯片短缺继续让人们对特斯拉2021年雄心勃勃的销售目标产生怀疑。首席执行官埃隆·马斯克强调了芯片供应的不可预测性带来的挑战，以及他预计今年晚些时候在德克萨斯州奥斯汀和柏林的两家新工厂提高产量的障碍。</blockquote></p><p> Tesla again delayed delivery of its semi-trailer truck—already two years late. The first trucks of this type are now slated for 2022. The company attributed the delay to supply-chain issues and limited battery-cell supply, as well as management trying to focus on getting new factories online. The company’s plans for its first pickup truck, once expected to go to customers as early as this year, are also being affected by parts issues.</p><p><blockquote>特斯拉再次推迟了半挂卡车的交付——已经晚了两年。第一批这种类型的卡车预计于2022年上市。该公司将延迟归因于供应链问题和电池供应有限，以及管理层试图专注于让新工厂上线。该公司首款皮卡的计划一度预计最早将于今年交付给客户，但也受到零部件问题的影响。</blockquote></p><p> This is what Musk told analysts last month:</p><p><blockquote>这是马斯克上个月对分析师说的话：</blockquote></p><p>   “While we’re making cars at full speed, the global chip-shortage situation remains quite serious. For the rest of this year, our growth rate will be determined by the slowest part in our supply chain.”  Regulatory Probe</p><p><blockquote>“在我们全速造车的同时，全球芯片短缺的情况仍然相当严重。在今年剩下的时间里，我们的增长率将由供应链中最慢的部分决定。”监管探针</blockquote></p><p> Besides the risks to the market’s earnings consensus for this fiscal year, Tesla is facing a regulatory probe that could result in a massive recall.</p><p><blockquote>除了本财年市场盈利共识面临风险外，特斯拉还面临监管调查，可能导致大规模召回。</blockquote></p><p> The U.S.opened a formal investigation&nbsp;into Tesla’s Autopilot system last week after almost a dozen collisions involving first-responder vehicles. In the last seven years, Tesla has charged clients thousands of dollars for this feature.</p><p><blockquote>在发生了近十几起涉及急救车辆的碰撞事件后，美国上周对特斯拉的自动驾驶系统展开了正式调查。在过去的七年里，特斯拉为此向客户收取了数千美元的费用。</blockquote></p><p> The probe by the National Highway Traffic Safety Administration (NHTSA) covers an estimated 765,000 Tesla Model Y, X, S and 3 vehicles from the 2014 model year onward. The regulator—which has the power to deem cars defective and order recalls—said&nbsp;it launched the investigation after 11 crashes that resulted in 17 injuries and one fatality.</p><p><blockquote>美国国家公路交通安全管理局(NHTSA)的调查涵盖了2014车型年起约765,000辆特斯拉Model Y、X、S和3辆汽车。该监管机构有权认定汽车有缺陷并下令召回，该监管机构表示，在发生11起导致17人受伤、1人死亡的事故后，它启动了调查。</blockquote></p><p> Bloomberg reported&nbsp;that Tesla has been criticized for years for labeling the system in a potentially misleading way. Since late 2016, it has marketed this higher-level functionality feature as Full Self-Driving Capability. In reality, Autopilot is a driver-assistance system that maintains vehicles’ speed and keeps them centered in lanes when engaged, though the driver is supposed to supervise at all times.</p><p><blockquote>彭博社报道称，特斯拉多年来一直因以可能误导的方式给该系统贴上标签而受到批评。自2016年底以来，它一直将这一更高级别的功能特性作为全自动驾驶功能进行营销。事实上，自动驾驶仪是一种驾驶员辅助系统，可以保持车辆的速度并在启动时使其保持在车道中央，尽管驾驶员应该始终进行监督。</blockquote></p><p> Tesla now sells that package of features—often referred to as FSD—for $10,000 or $199 a month.</p><p><blockquote>特斯拉现在以每月10,000美元或199美元的价格出售该功能包（通常称为FSD）。</blockquote></p><p> After the NHTSA launched of the probe, two Democratic senators asked the Federal Trade Commission to also investigate Tesla over the company’s advertising of its Autopilot and FSD technology.</p><p><blockquote>NHTSA发起调查后，两名民主党参议员要求联邦贸易委员会也调查特斯拉公司宣传其Autopilot和FSD技术的行为。</blockquote></p><p> In a&nbsp;letter&nbsp;last Wednesday, Sen. Richard Blumenthal of Connecticut and Sen. Ed Markey of Massachusetts asked FTC Chair Lina Khan to examine whether Tesla used “potentially deceptive and unfair practices” in its marketing of those technologies.</p><p><blockquote>在上周三的一封信中，康涅狄格参议员Richard Blumenthal和麻萨诸塞州参议员Ed Markey要求FTC主席Lina Khan调查特斯拉在营销这些技术时是否使用了“潜在的欺骗性和不公平的做法”。</blockquote></p><p> “We fear that Tesla’s Autopilot and FSD features are not as mature and reliable as the company pitches to the public,” they wrote, pointing to comments from Musk, as well as a 2019 YouTube video entitled “Full Self-Driving” and has a link to Tesla’s site.</p><p><blockquote>“我们担心特斯拉的Autopilot和FSD功能并不像该公司向公众宣传的那样成熟和可靠，”他们写道，并指出了马斯克的评论，以及2019年YouTube上一段题为“全自动驾驶”的视频，并有一个指向特斯拉网站的链接。</blockquote></p><p> Highlighting these risks and how they could affect Tesla’s current stock price, however, shouldn’t hide the fact that there are many analysts who continue to remain bullish on TSLA. Piper Sandler reiterated its overweight rating on the stock and its price target of $1,200 this month.</p><p><blockquote>然而，强调这些风险以及它们如何影响特斯拉当前的股价不应掩盖这样一个事实：许多分析师继续看好特斯拉。Piper Sandler重申了跑赢大盘对该股的评级以及本月1200美元的目标价。</blockquote></p><p> In a note, analysts Alexander Potter and Winnie Dong said:</p><p><blockquote>分析师Alexander Potter和Winnie Dong在一份报告中表示：</blockquote></p><p>   “Bottom line: We still really like this stock. Tesla is still the driving force behind higher [battery electric vehicle] penetration globally.”  <b>Bottom Line</b></p><p><blockquote>“底线：我们仍然非常喜欢这只股票。特斯拉仍然是全球[纯电动汽车]渗透率更高的驱动力。”<b>底线</b></blockquote></p><p> It’s difficult to predict the future course for Tesla stock given the huge amount of speculative interest in this name. But recent developments show that it will be quite hard for the EV automaker to exceed expectations in this tough manufacturing environment.</p><p><blockquote>鉴于人们对特斯拉股票的巨大投机兴趣，很难预测该股票的未来走势。但最近的事态发展表明，在这种严峻的制造环境下，这家电动汽车制造商很难超出预期。</blockquote></p><p> Investors should trade this name with caution.</p><p><blockquote>投资者应谨慎交易该名称。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investing.com/analysis/can-tesla-shares-hit-900-again-this-year-200599999\">investing.com</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.investing.com/analysis/can-tesla-shares-hit-900-again-this-year-200599999","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161561973","content_text":"Electric vehicle maker Tesla Motors' (NASDAQ:TSLA) stock is picking up momentum again. After falling from a record high $900.40, hit intraday on Jan. 25, TSLA shares have gained 17% during the past three months, outperforming the benchmark NASDAQ 100 Index.\nThe biggest question Tesla bulls now have is, whether, on top of the current gains, can the EV manufacturer's stock push through back to the all-time high of $900 this year?\nTesla Weekly Chart.\nGiven the highly volatile nature of the stock, it’s tough to predict whether the current Tesla rally has legs. But it’s important to note that the outlook for its car sales is becoming more uncertain than it was a year ago.\nFirst, the global chip shortage continues to cast doubt on Tesla’s ambitious sales targets for 2021. Chief Executive Officer Elon Musk highlighted challenges that come from the unpredictability of chip supplies and the hurdles he expects in ramping production at two new factories in Austin, Texas, and Berlin, later this year.\nTesla again delayed delivery of its semi-trailer truck—already two years late. The first trucks of this type are now slated for 2022. The company attributed the delay to supply-chain issues and limited battery-cell supply, as well as management trying to focus on getting new factories online. The company’s plans for its first pickup truck, once expected to go to customers as early as this year, are also being affected by parts issues.\nThis is what Musk told analysts last month:\n\n “While we’re making cars at full speed, the global chip-shortage situation remains quite serious. For the rest of this year, our growth rate will be determined by the slowest part in our supply chain.”\n\nRegulatory Probe\nBesides the risks to the market’s earnings consensus for this fiscal year, Tesla is facing a regulatory probe that could result in a massive recall.\nThe U.S.opened a formal investigation into Tesla’s Autopilot system last week after almost a dozen collisions involving first-responder vehicles. In the last seven years, Tesla has charged clients thousands of dollars for this feature.\nThe probe by the National Highway Traffic Safety Administration (NHTSA) covers an estimated 765,000 Tesla Model Y, X, S and 3 vehicles from the 2014 model year onward. The regulator—which has the power to deem cars defective and order recalls—said it launched the investigation after 11 crashes that resulted in 17 injuries and one fatality.\nBloomberg reported that Tesla has been criticized for years for labeling the system in a potentially misleading way. Since late 2016, it has marketed this higher-level functionality feature as Full Self-Driving Capability. In reality, Autopilot is a driver-assistance system that maintains vehicles’ speed and keeps them centered in lanes when engaged, though the driver is supposed to supervise at all times.\nTesla now sells that package of features—often referred to as FSD—for $10,000 or $199 a month.\nAfter the NHTSA launched of the probe, two Democratic senators asked the Federal Trade Commission to also investigate Tesla over the company’s advertising of its Autopilot and FSD technology.\nIn a letter last Wednesday, Sen. Richard Blumenthal of Connecticut and Sen. Ed Markey of Massachusetts asked FTC Chair Lina Khan to examine whether Tesla used “potentially deceptive and unfair practices” in its marketing of those technologies.\n“We fear that Tesla’s Autopilot and FSD features are not as mature and reliable as the company pitches to the public,” they wrote, pointing to comments from Musk, as well as a 2019 YouTube video entitled “Full Self-Driving” and has a link to Tesla’s site.\nHighlighting these risks and how they could affect Tesla’s current stock price, however, shouldn’t hide the fact that there are many analysts who continue to remain bullish on TSLA. Piper Sandler reiterated its overweight rating on the stock and its price target of $1,200 this month.\nIn a note, analysts Alexander Potter and Winnie Dong said:\n\n “Bottom line: We still really like this stock. Tesla is still the driving force behind higher [battery electric vehicle] penetration globally.”\n\nBottom Line\nIt’s difficult to predict the future course for Tesla stock given the huge amount of speculative interest in this name. But recent developments show that it will be quite hard for the EV automaker to exceed expectations in this tough manufacturing environment.\nInvestors should trade this name with caution.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810192870,"gmtCreate":1629950009190,"gmtModify":1631883959055,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Michael Burry vs Cathie Wood for win?&nbsp;","listText":"Michael Burry vs Cathie Wood for win?&nbsp;","text":"Michael Burry vs Cathie Wood for win?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/810192870","repostId":"1101434650","repostType":4,"isVote":1,"tweetType":1,"viewCount":2010,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154495218,"gmtCreate":1625537592434,"gmtModify":1631888415100,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a> shoot up so fast.. Not even have a chance to buy more at lower price..&nbsp;","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a> shoot up so fast.. Not even have a chance to buy more at lower price..&nbsp;","text":"$KEPPEL DC REIT(AJBU.SI)$ shoot up so fast.. Not even have a chance to buy more at lower price..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/154495218","isVote":1,"tweetType":1,"viewCount":1029,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178620662,"gmtCreate":1626818904156,"gmtModify":1631888076605,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"AMC&nbsp;Is time fly to the moon again?&nbsp;","listText":"AMC&nbsp;Is time fly to the moon again?&nbsp;","text":"AMC Is time fly to the moon again?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/178620662","repostId":"2152657163","repostType":4,"isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":155431842,"gmtCreate":1625448121186,"gmtModify":1633940625081,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Illegally collected users' personal data","listText":"Illegally collected users' personal data","text":"Illegally collected users' personal data","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155431842","repostId":"1169840279","repostType":4,"isVote":1,"tweetType":1,"viewCount":726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160738955,"gmtCreate":1623806126477,"gmtModify":1634027893984,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>是不是有不好消息呢？一晚跌16％","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>是不是有不好消息呢？一晚跌16％","text":"$Tiger Brokers(TIGR)$是不是有不好消息呢？一晚跌16％","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/160738955","isVote":1,"tweetType":1,"viewCount":2685,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3516165326153666","authorId":"3516165326153666","name":"海天飞鸟","avatar":"https://static.tigerbbs.com/11525d1cb6ee5144cf68f0f61953987a","crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3516165326153666","idStr":"3516165326153666"},"content":"奇怪呢，事出反常必有妖","text":"奇怪呢，事出反常必有妖","html":"奇怪呢，事出反常必有妖"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":184710129,"gmtCreate":1623724569461,"gmtModify":1631883987229,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"One more type vaccine can be used","listText":"One more type vaccine can be used","text":"One more type vaccine can be used","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/184710129","repostId":"2143736088","repostType":4,"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":844774304,"gmtCreate":1636465227237,"gmtModify":1636467782146,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.","listText":"With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.","text":"With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844774304","repostId":"1133150195","repostType":4,"repost":{"id":"1133150195","kind":"news","pubTimestamp":1636463600,"share":"https://www.laohu8.com/m/news/1133150195?lang=zh_CN&edition=full","pubTime":"2021-11-09 21:13","market":"us","language":"en","title":"U.S. government to buy $1 billion more worth of Merck's COVID-19 pill<blockquote>美国政府将再购买价值10亿美元的默克COVID-19药物</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1133150195","media":"Reuters","summary":"Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by","content":"<p>Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck &amp; Co Inc(MRK.N)and partner Ridgeback Biotherapeutics, the companies said on Tuesday.</p><p><blockquote>路透11月9日-美国政府将再购买价值10亿美元的默克公司(MRK.N)及其合作伙伴Ridgeback Biotherapeutics周二表示。</blockquote></p><p> The government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.</p><p><blockquote>政府在6月份同意以12亿美元购买170万个疗程的莫努匹拉韦，现在正在行使选择权再购买140万个疗程。</blockquote></p><p> That brings the total secured courses to 3.1 million and worth $2.2 billion. Merck said the government has the right to buy 2 million more courses as part of the contract.</p><p><blockquote>这使得安全课程总数达到310万门，价值22亿美元。默克表示，作为合同的一部分，政府有权再购买200万门课程。</blockquote></p><p> The drug has been closely watched since data last month showed that when given early in the illness it could halve the chances of dying or being hospitalized for those most at risk of developing severe COVID-19.</p><p><blockquote>自上个月的数据显示，如果在疾病早期服用，该药物可以将最有可能患严重COVID-19的人的死亡或住院几率减半以来，该药物一直受到密切关注。</blockquote></p><p> \"Molnupiravir, if authorized, will be among the vaccines and medicines available to fight COVID-19 as part of our collective efforts to bring this pandemic to an end,\" said Frank Clyburn, president of Merck's human health business.</p><p><blockquote>默克人类健康业务总裁弗兰克·克莱伯恩(Frank Clyburn)表示：“如果获得授权，莫努匹拉韦将成为可用于对抗COVID-19的疫苗和药物之一，作为我们结束这一流行病的集体努力的一部分。”</blockquote></p><p> With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.</p><p><blockquote>由于治疗COVID-19患者的选择有限，美国政府还获得了数百万剂辉瑞公司(PFE)的抗病毒药物。上周显示，该药物可将有严重疾病风险的成年人住院或死亡几率降低89%。</blockquote></p><p> Merck's application with the U.S. Food and Drug Administration will be taken up by a panel of independent experts on Nov. 30, following which the regulator is expected to make a decision.</p><p><blockquote>默克公司向美国提出的申请。美国食品和药物管理局将于11月30日由一个独立专家小组接管，随后监管机构预计将做出决定。</blockquote></p><p> Britain last week became the first country in the world to clear the use of molnupiravir.</p><p><blockquote>英国上周成为世界上第一个批准使用莫努匹拉韦的国家。</blockquote></p><p> Merck expects to produce 10 million courses of the treatment by the end of this year, with at least 20 million set to be manufactured in 2022.</p><p><blockquote>默克预计到今年年底将生产1000万个疗程的治疗，其中至少2000万个疗程将在2022年生产。</blockquote></p><p> The drugmaker's shares rose nearly 1% to $83.41 in premarket trading.</p><p><blockquote>该制药商股价在盘前交易中上涨近1%至83.41美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. government to buy $1 billion more worth of Merck's COVID-19 pill<blockquote>美国政府将再购买价值10亿美元的默克COVID-19药物</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. government to buy $1 billion more worth of Merck's COVID-19 pill<blockquote>美国政府将再购买价值10亿美元的默克COVID-19药物</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-09 21:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck &amp; Co Inc(MRK.N)and partner Ridgeback Biotherapeutics, the companies said on Tuesday.</p><p><blockquote>路透11月9日-美国政府将再购买价值10亿美元的默克公司(MRK.N)及其合作伙伴Ridgeback Biotherapeutics周二表示。</blockquote></p><p> The government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.</p><p><blockquote>政府在6月份同意以12亿美元购买170万个疗程的莫努匹拉韦，现在正在行使选择权再购买140万个疗程。</blockquote></p><p> That brings the total secured courses to 3.1 million and worth $2.2 billion. Merck said the government has the right to buy 2 million more courses as part of the contract.</p><p><blockquote>这使得安全课程总数达到310万门，价值22亿美元。默克表示，作为合同的一部分，政府有权再购买200万门课程。</blockquote></p><p> The drug has been closely watched since data last month showed that when given early in the illness it could halve the chances of dying or being hospitalized for those most at risk of developing severe COVID-19.</p><p><blockquote>自上个月的数据显示，如果在疾病早期服用，该药物可以将最有可能患严重COVID-19的人的死亡或住院几率减半以来，该药物一直受到密切关注。</blockquote></p><p> \"Molnupiravir, if authorized, will be among the vaccines and medicines available to fight COVID-19 as part of our collective efforts to bring this pandemic to an end,\" said Frank Clyburn, president of Merck's human health business.</p><p><blockquote>默克人类健康业务总裁弗兰克·克莱伯恩(Frank Clyburn)表示：“如果获得授权，莫努匹拉韦将成为可用于对抗COVID-19的疫苗和药物之一，作为我们结束这一流行病的集体努力的一部分。”</blockquote></p><p> With limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.</p><p><blockquote>由于治疗COVID-19患者的选择有限，美国政府还获得了数百万剂辉瑞公司(PFE)的抗病毒药物。上周显示，该药物可将有严重疾病风险的成年人住院或死亡几率降低89%。</blockquote></p><p> Merck's application with the U.S. Food and Drug Administration will be taken up by a panel of independent experts on Nov. 30, following which the regulator is expected to make a decision.</p><p><blockquote>默克公司向美国提出的申请。美国食品和药物管理局将于11月30日由一个独立专家小组接管，随后监管机构预计将做出决定。</blockquote></p><p> Britain last week became the first country in the world to clear the use of molnupiravir.</p><p><blockquote>英国上周成为世界上第一个批准使用莫努匹拉韦的国家。</blockquote></p><p> Merck expects to produce 10 million courses of the treatment by the end of this year, with at least 20 million set to be manufactured in 2022.</p><p><blockquote>默克预计到今年年底将生产1000万个疗程的治疗，其中至少2000万个疗程将在2022年生产。</blockquote></p><p> The drugmaker's shares rose nearly 1% to $83.41 in premarket trading.</p><p><blockquote>该制药商股价在盘前交易中上涨近1%至83.41美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/world/us/us-government-buy-14-mln-more-courses-mercks-covid-19-pill-2021-11-09/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.reuters.com/world/us/us-government-buy-14-mln-more-courses-mercks-covid-19-pill-2021-11-09/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133150195","content_text":"Nov 9 (Reuters) - The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck & Co Inc(MRK.N)and partner Ridgeback Biotherapeutics, the companies said on Tuesday.\nThe government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.\nThat brings the total secured courses to 3.1 million and worth $2.2 billion. Merck said the government has the right to buy 2 million more courses as part of the contract.\nThe drug has been closely watched since data last month showed that when given early in the illness it could halve the chances of dying or being hospitalized for those most at risk of developing severe COVID-19.\n\"Molnupiravir, if authorized, will be among the vaccines and medicines available to fight COVID-19 as part of our collective efforts to bring this pandemic to an end,\" said Frank Clyburn, president of Merck's human health business.\nWith limited options to treat people with COVID-19, the U.S government has also secured millions of doses of Pfizer Inc's(PFE.N)rival antiviral drug, which last week was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.\nMerck's application with the U.S. Food and Drug Administration will be taken up by a panel of independent experts on Nov. 30, following which the regulator is expected to make a decision.\nBritain last week became the first country in the world to clear the use of molnupiravir.\nMerck expects to produce 10 million courses of the treatment by the end of this year, with at least 20 million set to be manufactured in 2022.\nThe drugmaker's shares rose nearly 1% to $83.41 in premarket trading.","news_type":1,"symbols_score_info":{"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":1795,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":832181826,"gmtCreate":1629598305065,"gmtModify":1631888076539,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Agree penny stock is high risk...&nbsp;","listText":"Agree penny stock is high risk...&nbsp;","text":"Agree penny stock is high risk...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/832181826","repostId":"1172699620","repostType":4,"repost":{"id":"1172699620","kind":"news","pubTimestamp":1629450202,"share":"https://www.laohu8.com/m/news/1172699620?lang=zh_CN&edition=full","pubTime":"2021-08-20 17:03","market":"us","language":"en","title":"Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172699620","media":"Kiplinger","summary":"Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar","content":"<p>Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.</p><p><blockquote>细价股——那些低价交易的股票，通常每股股价不到一美元——是危险的。周期。事实上，除了少数例外，投资者应该避开这些超便宜的股票，这些股票通常在场外交易，而不是在主要交易所交易。</blockquote></p><p> Call them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"</p><p><blockquote>看涨期权他们细价股、微型股或场外交易股票；不管叫什么名字，都是坏消息。当前期投入如此之少的资金就可以进行投资时，快速轻松致富的承诺更容易上当。投资者可能会想，“风险有多大？”</blockquote></p><p> Plenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”</p><p><blockquote>大量。根据美国证券交易委员会的说法：“学术研究发现，场外交易股票往往流动性极差；经常成为涉嫌市场操纵的目标；平均产生负面且不稳定的投资回报；并且很少成长为大公司或过渡到在证券交易所上市。”</blockquote></p><p> We’ll break down what all that means below, but suffice to say, the SEC is not a fan.</p><p><blockquote>我们将在下面详细说明这一切的含义，但我只想说，SEC并不热衷于此。</blockquote></p><p> <h3><b>Why Penny Stocks Are So Dangerous</b></h3> To be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.</p><p><blockquote><h3><b>为什么细价股如此危险</b></h3>需要明确的是，这并不是说每个细价股或场外交易公司都是骗局。危险在于，场外市场是骗局股票的生存之地。把它想象成一个糟糕的社区。在那里会让你成为骗子的标志。</blockquote></p><p> For some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”</p><p><blockquote>在某些背景下，场外交易市场不同于纽约证券交易所或纳斯达克等交易集中的交易所。没有一个OTC交易所。相反，场外交易通过基于计算机和电话的系统将买家和卖家联系起来。任何不在纽约证券交易所、纳斯达克或其他美国成熟交易所交易的股票都可以进行场外交易。这些证券也被称为“非上市股票”。</blockquote></p><p> Typically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).</p><p><blockquote>通常，场外交易股票往往是高风险的微型股（市值低于3亿美元的小公司股票），其中包括纳米股（市值低于5000万美元的股票）。</blockquote></p><p> The SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.</p><p><blockquote>美国证券交易委员会长期以来一直警告投资者此类股票的高风险。该行业的自律机构金融业监管局（FINRA）同样对场外证券的购买和交易发出了危险信号。</blockquote></p><p> That’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.</p><p><blockquote>这是因为在场外交易市场上市的公司不需要像在纽约证券交易所或纳斯达克等主要交易所上市的公司那样提交定期或经审计的财务报告。换句话说，当他们声称有销售额和利润时，没有办法知道他们是否在说实话。各大交易所也有上市要求；场外交易股票则不然。例如，一家公司必须拥有至少400名股东且市值至少4000万美元才能在纽约证券交易所上市。OTC没有这样的要求。</blockquote></p><p> Put it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.</p><p><blockquote>综上所述，这使得无良的管理者更容易谎报业务前景或实施证券欺诈。</blockquote></p><p> But that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.</p><p><blockquote>但这还不是全部。在场外交易的股票往往“缺乏流动性”，这意味着它们的交易量通常很低，买家和卖家数量有限。这可能会使投资者很难或不可能以他们想要的价格买卖股票。</blockquote></p><p> That lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see&nbsp;<i>The Wolf of Wall Street</i>?</p><p><blockquote>流动性的缺乏也使许多场外交易股票成为“拉高抛售”计划的完美工具，即股票发起人引诱投资者购买股票，从而提高股价。然后，当价格足够高时，抽水者出售他的股票，导致股票下跌，给投资者留下糟糕的回报，甚至亏损。这里有人看到了吗<i>华尔街之狼</i>？</blockquote></p><p> To protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.</p><p><blockquote>为了保护投资者不上当受骗，SEC在2012年至2015年间暂停了800多只微型股（占场外交易市场的8%以上）的交易。股票一旦暂停交易，就不能重新上市，除非公司提供最新的财务信息来证明其实际运营。由于这种情况很少发生，交易暂停基本上使股票对诈骗艺术家毫无用处。</blockquote></p><p> <h3><b>Legitimate OTCs</b></h3> Be that as it may, there is one segment of the OTC market that investors need not fear.</p><p><blockquote><h3><b>合法OTC</b></h3>尽管如此，场外交易市场的一部分投资者不必担心。</blockquote></p><p> Amidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of&nbsp;<b>The <a href=\"https://laohu8.com/S/IDCBY\">Industrial and Commercial Bank of China Ltd.</a></b>&nbsp;(IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’s<b>Nestlé</b>(NSRGY), the largest food company in the world; China’s&nbsp;<b><a href=\"https://laohu8.com/S/TCEHY\">Tencent Holding Ltd.</a></b>&nbsp;(TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant&nbsp;<b><a href=\"https://laohu8.com/S/NTDOY\">Nintendo Co., Ltd.</a> </b>(NTDOY).</p><p><blockquote>在混混中，一些世界上最大、最受尊敬的外国公司将其美国股票在场外交易而不是在美国主要交易所上市。在这里，您可以找到<b>The<a href=\"https://laohu8.com/S/IDCBY\">中国工商银行。</a></b>（IDCBY），恰好是世界上最大的银行。您还可以购买瑞士的股票<b>雀巢</b>（NSRGY），全球最大的食品公司；中国的<b><a href=\"https://laohu8.com/S/TCEHY\">腾讯控股控股有限公司。</a></b>(TCEHY)，该国最大的互联网服务提供商之一；和日本游戏巨头<b><a href=\"https://laohu8.com/S/NTDOY\">任天堂有限公司。</a></b>（NTDOY）。</blockquote></p><p> Why would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?</p><p><blockquote>为什么大型国际上市公司会与发行高度投机性细价股的公司合作？</blockquote></p><p></p><p> The reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.</p><p><blockquote>原因与成本和便利性有关。例如，在纽约证券交易所或纳斯达克上市的外国公司必须为其所做的一切准备两套经审计的财务报表——一套符合国际会计准则，另一套符合公认会计原则(GAAP)在美国，这不是非处方药的要求。</blockquote></p><p> With an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.</p><p><blockquote>通过场外交易上市，外国公司可以以很低的成本和精力接触到庞大的美国股票投资者。</blockquote></p><p> The bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.</p><p><blockquote>最重要的是，除了大型老牌外国公司，场外交易股票风险太大。普通投资者不可能知道公司是否在上升。即使是合法的小公司也可能在一夜之间倒闭。场外交易股票的陷阱根本不值得。</blockquote></p><p> It’s easy enough to lose money investing in stocks. Why make it easier?</p><p><blockquote>投资股票很容易赔钱。为什么要让它更容易？</blockquote></p><p></p>","source":"lsy1629449927514","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Penny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPenny Stocks: Why You Should Always Stay Away<blockquote>细价股：为什么你应该永远远离</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Kiplinger</strong><span class=\"h-time small\">2021-08-20 17:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.</p><p><blockquote>细价股——那些低价交易的股票，通常每股股价不到一美元——是危险的。周期。事实上，除了少数例外，投资者应该避开这些超便宜的股票，这些股票通常在场外交易，而不是在主要交易所交易。</blockquote></p><p> Call them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"</p><p><blockquote>看涨期权他们细价股、微型股或场外交易股票；不管叫什么名字，都是坏消息。当前期投入如此之少的资金就可以进行投资时，快速轻松致富的承诺更容易上当。投资者可能会想，“风险有多大？”</blockquote></p><p> Plenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”</p><p><blockquote>大量。根据美国证券交易委员会的说法：“学术研究发现，场外交易股票往往流动性极差；经常成为涉嫌市场操纵的目标；平均产生负面且不稳定的投资回报；并且很少成长为大公司或过渡到在证券交易所上市。”</blockquote></p><p> We’ll break down what all that means below, but suffice to say, the SEC is not a fan.</p><p><blockquote>我们将在下面详细说明这一切的含义，但我只想说，SEC并不热衷于此。</blockquote></p><p> <h3><b>Why Penny Stocks Are So Dangerous</b></h3> To be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.</p><p><blockquote><h3><b>为什么细价股如此危险</b></h3>需要明确的是，这并不是说每个细价股或场外交易公司都是骗局。危险在于，场外市场是骗局股票的生存之地。把它想象成一个糟糕的社区。在那里会让你成为骗子的标志。</blockquote></p><p> For some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”</p><p><blockquote>在某些背景下，场外交易市场不同于纽约证券交易所或纳斯达克等交易集中的交易所。没有一个OTC交易所。相反，场外交易通过基于计算机和电话的系统将买家和卖家联系起来。任何不在纽约证券交易所、纳斯达克或其他美国成熟交易所交易的股票都可以进行场外交易。这些证券也被称为“非上市股票”。</blockquote></p><p> Typically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).</p><p><blockquote>通常，场外交易股票往往是高风险的微型股（市值低于3亿美元的小公司股票），其中包括纳米股（市值低于5000万美元的股票）。</blockquote></p><p> The SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.</p><p><blockquote>美国证券交易委员会长期以来一直警告投资者此类股票的高风险。该行业的自律机构金融业监管局（FINRA）同样对场外证券的购买和交易发出了危险信号。</blockquote></p><p> That’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.</p><p><blockquote>这是因为在场外交易市场上市的公司不需要像在纽约证券交易所或纳斯达克等主要交易所上市的公司那样提交定期或经审计的财务报告。换句话说，当他们声称有销售额和利润时，没有办法知道他们是否在说实话。各大交易所也有上市要求；场外交易股票则不然。例如，一家公司必须拥有至少400名股东且市值至少4000万美元才能在纽约证券交易所上市。OTC没有这样的要求。</blockquote></p><p> Put it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.</p><p><blockquote>综上所述，这使得无良的管理者更容易谎报业务前景或实施证券欺诈。</blockquote></p><p> But that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.</p><p><blockquote>但这还不是全部。在场外交易的股票往往“缺乏流动性”，这意味着它们的交易量通常很低，买家和卖家数量有限。这可能会使投资者很难或不可能以他们想要的价格买卖股票。</blockquote></p><p> That lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see&nbsp;<i>The Wolf of Wall Street</i>?</p><p><blockquote>流动性的缺乏也使许多场外交易股票成为“拉高抛售”计划的完美工具，即股票发起人引诱投资者购买股票，从而提高股价。然后，当价格足够高时，抽水者出售他的股票，导致股票下跌，给投资者留下糟糕的回报，甚至亏损。这里有人看到了吗<i>华尔街之狼</i>？</blockquote></p><p> To protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.</p><p><blockquote>为了保护投资者不上当受骗，SEC在2012年至2015年间暂停了800多只微型股（占场外交易市场的8%以上）的交易。股票一旦暂停交易，就不能重新上市，除非公司提供最新的财务信息来证明其实际运营。由于这种情况很少发生，交易暂停基本上使股票对诈骗艺术家毫无用处。</blockquote></p><p> <h3><b>Legitimate OTCs</b></h3> Be that as it may, there is one segment of the OTC market that investors need not fear.</p><p><blockquote><h3><b>合法OTC</b></h3>尽管如此，场外交易市场的一部分投资者不必担心。</blockquote></p><p> Amidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of&nbsp;<b>The <a href=\"https://laohu8.com/S/IDCBY\">Industrial and Commercial Bank of China Ltd.</a></b>&nbsp;(IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’s<b>Nestlé</b>(NSRGY), the largest food company in the world; China’s&nbsp;<b><a href=\"https://laohu8.com/S/TCEHY\">Tencent Holding Ltd.</a></b>&nbsp;(TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant&nbsp;<b><a href=\"https://laohu8.com/S/NTDOY\">Nintendo Co., Ltd.</a> </b>(NTDOY).</p><p><blockquote>在混混中，一些世界上最大、最受尊敬的外国公司将其美国股票在场外交易而不是在美国主要交易所上市。在这里，您可以找到<b>The<a href=\"https://laohu8.com/S/IDCBY\">中国工商银行。</a></b>（IDCBY），恰好是世界上最大的银行。您还可以购买瑞士的股票<b>雀巢</b>（NSRGY），全球最大的食品公司；中国的<b><a href=\"https://laohu8.com/S/TCEHY\">腾讯控股控股有限公司。</a></b>(TCEHY)，该国最大的互联网服务提供商之一；和日本游戏巨头<b><a href=\"https://laohu8.com/S/NTDOY\">任天堂有限公司。</a></b>（NTDOY）。</blockquote></p><p> Why would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?</p><p><blockquote>为什么大型国际上市公司会与发行高度投机性细价股的公司合作？</blockquote></p><p></p><p> The reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.</p><p><blockquote>原因与成本和便利性有关。例如，在纽约证券交易所或纳斯达克上市的外国公司必须为其所做的一切准备两套经审计的财务报表——一套符合国际会计准则，另一套符合公认会计原则(GAAP)在美国，这不是非处方药的要求。</blockquote></p><p> With an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.</p><p><blockquote>通过场外交易上市，外国公司可以以很低的成本和精力接触到庞大的美国股票投资者。</blockquote></p><p> The bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.</p><p><blockquote>最重要的是，除了大型老牌外国公司，场外交易股票风险太大。普通投资者不可能知道公司是否在上升。即使是合法的小公司也可能在一夜之间倒闭。场外交易股票的陷阱根本不值得。</blockquote></p><p> It’s easy enough to lose money investing in stocks. Why make it easier?</p><p><blockquote>投资股票很容易赔钱。为什么要让它更容易？</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.kiplinger.com/investing/603303/penny-stocks-always-stay-away\">Kiplinger</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TCEHY":"腾讯控股ADR","NTDOY":"任天堂","IDCBY":"工商银行ADR"},"source_url":"https://www.kiplinger.com/investing/603303/penny-stocks-always-stay-away","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172699620","content_text":"Penny stocks – those stocks that trade for low prices, often with share prices of less than a dollar per share – are dangerous. Period. Indeed, with a few exceptions, investors should steer clear of these uber-cheap stocks, which typically trade over-the-counter and not on a major exchange.\nCall them penny stocks, microcaps or OTC stocks; by any name, they’re bad news. Promises of quick and easy riches are easier to fall for when an investment can be made with so little money up front. An investor might think, \"How risky could it be?\"\nPlenty. Per the Securities and Exchange Commission: “Academic studies find that OTC stocks tend to be highly illiquid; are frequent targets of alleged market manipulation; generate negative and volatile investment returns on average; and rarely grow into a large company or transition to listing on a stock exchange.”\nWe’ll break down what all that means below, but suffice to say, the SEC is not a fan.\nWhy Penny Stocks Are So Dangerous\nTo be clear, this is not to say that every penny stock or OTC company is a scam. The danger is that the over-the-counter market is where the scam stocks live. Think of it as a bad neighborhood. Being there can make you a mark for a con.\nFor some background, the OTC market is different from exchanges like the New York Stock Exchange or Nasdaq, where trading is centralized. There is no one OTC exchange. Instead, the OTC connects buyers and sellers over a computer- and telephone-based system. Any stock that does not trade on the NYSE, Nasdaq or other established U.S. exchange can trade over-the-counter. These securities also are known as “unlisted stocks.”\nTypically, OTC stocks tend to be highly risky microcap stocks (the shares of small companies with market capitalizations of under $300 million), which include nanocap stocks (those with market values of under $50 million).\nThe SEC has long warned investors about the high risks associated with such stocks. The Financial Industry Regulatory Authority (FINRA), the industry’s self-regulatory agency, likewise waves a red flag over the buying and trading of OTC securities.\nThat’s because companies that list on the OTC aren’t required to file periodic or audited financial reports as they must do if they are listed on a major exchange, such as the NYSE or the Nasdaq. In other words, there’s no way to know if they’re telling the truth when they claim to have sales and profits. The major exchanges also have listing requirements; OTC stocks don’t. For example, a company must have at least 400 shareholders and a market value of at least $40 million to get a listing on the New York Stock Exchange. The OTC makes no such requirements.\nPut it all together, and it makes it easier for unscrupulous managers to lie about their business prospects or commit securities fraud.\nBut that’s not all. The shares that exchange hands on the OTC tend to be “illiquid,” meaning they often trade in low volumes and have a limited number of buyers and sellers. That can make it difficult or impossible for investors to buy or sell shares at the prices they want.\nThat lack of liquidity also makes many OTC stocks the perfect vehicle for “pump-and-dump” schemes where stock promoters lure investors to buy shares, increasing the stock price. Then, when the price gets high enough, the pumper sells his shares, causing the stock to fall and leaving investors with poor returns, or even losses. Anyone here see The Wolf of Wall Street?\nTo protect investors from falling for these schemes, the SEC suspended trading of more than 800 microcap stocks – more than 8% of the OTC market – between 2012 and 2015. Once a stock has been suspended from trading, it cannot be relisted unless the company provides updated financial information to prove it’s actually operational. Since that rarely happens, trading suspensions essentially render the shares useless to scam artists.\nLegitimate OTCs\nBe that as it may, there is one segment of the OTC market that investors need not fear.\nAmidst the riff-raff, some of the biggest, most respected foreign companies in the world list their U.S. shares over-the-counter instead of on the major U.S. exchanges. Here, you’ll find shares of The Industrial and Commercial Bank of China Ltd. (IDCBY), which happens to be the biggest bank in the world. You also can buy shares of Switzerland’sNestlé(NSRGY), the largest food company in the world; China’s Tencent Holding Ltd. (TCEHY), one of the country’s largest internet service providers; and Japanese gaming giant Nintendo Co., Ltd. (NTDOY).\nWhy would major, international publicly traded companies rub shoulders with firms that issue highly speculative penny stocks?\nThe reason has to do with cost and convenience. For example, a foreign firm listing on the NYSE or Nasdaq must prepare two sets of audited financial statements for everything it does – one to conform with international accounting standards, and another that adheres to the generally accepted accounting principles (GAAP) used in the U.S. That isn’t a requirement over-the-counter.\nWith an OTC listing, a foreign company gains access to the vast pool of U.S. equity investors at a fraction of the cost and effort.\nThe bottom line is that with the exception of large, established foreign firms, OTC stocks come with too many risks. It’s not possible for the average investor to know if the company is on the up and up. And even legitimate tiny companies can fail virtually overnight. The pitfalls of trading OTC stocks just aren’t worth it.\nIt’s easy enough to lose money investing in stocks. Why make it easier?","news_type":1,"symbols_score_info":{"IDCBY":0.9,"TCEHY":0.9,"NTDOY":0.9}},"isVote":1,"tweetType":1,"viewCount":2651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126293753,"gmtCreate":1624573312072,"gmtModify":1634004321073,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Buy both","listText":"Buy both","text":"Buy both","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/126293753","repostId":"1198422658","repostType":4,"isVote":1,"tweetType":1,"viewCount":478,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121407148,"gmtCreate":1624487270984,"gmtModify":1634005555174,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>每一天的波动都蛮大","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>每一天的波动都蛮大","text":"$Tiger Brokers(TIGR)$每一天的波动都蛮大","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121407148","isVote":1,"tweetType":1,"viewCount":848,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":166288231,"gmtCreate":1624012093523,"gmtModify":1631886432031,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/A17U.SI\">$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$</a> an hold for long term and get 5%dividend&nbsp;","listText":"<a href=\"https://laohu8.com/S/A17U.SI\">$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$</a> an hold for long term and get 5%dividend&nbsp;","text":"$ASCENDAS REAL ESTATE INV TRUST(A17U.SI)$ an hold for long term and get 5%dividend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/166288231","isVote":1,"tweetType":1,"viewCount":687,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":112633702,"gmtCreate":1622864774706,"gmtModify":1634097226642,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"It could give an extra impulse for Apple shares in the short- and mid-terms.","listText":"It could give an extra impulse for Apple shares in the short- and mid-terms.","text":"It could give an extra impulse for Apple shares in the short- and mid-terms.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/112633702","repostId":"1158897173","repostType":4,"isVote":1,"tweetType":1,"viewCount":301,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894215151,"gmtCreate":1628828691073,"gmtModify":1631888076569,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Take 3rd dose for those&nbsp;weak immune system&nbsp;","listText":"Take 3rd dose for those&nbsp;weak immune system&nbsp;","text":"Take 3rd dose for those weak immune system","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/894215151","repostId":"1127554137","repostType":4,"isVote":1,"tweetType":1,"viewCount":1816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143570117,"gmtCreate":1625805135339,"gmtModify":1631888076640,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Keep for long term, aim for high dividend","listText":"Keep for long term, aim for high dividend","text":"Keep for long term, aim for high dividend","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/143570117","repostId":"1119741032","repostType":4,"repost":{"id":"1119741032","kind":"news","pubTimestamp":1625803532,"share":"https://www.laohu8.com/m/news/1119741032?lang=zh_CN&edition=full","pubTime":"2021-07-09 12:05","market":"us","language":"en","title":"5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge<blockquote>随着利率暴跌，值得买入并获得巨额股息的5只蓝筹股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119741032","media":"24/7 wall street","summary":"Just last month, we were being warned that interest rates were ready to move meaningfully higher as ","content":"<p><a href=\"https://laohu8.com/S/JE\">Just</a> last month, we were being warned that interest rates were ready to move meaningfully higher as inflation and the Federal Reserve were teaming up to end the massive low interest rate paradigm we have been stuck in for years. Then, seemingly out of nowhere, rates have dived lower, with the 10-year Treasury trading at a 1.32% yield, down from near 1.70% at the end of May. The benchmark 30-year Treasury bond is back at the 1.94% level. These are the lowest interest rate levels since last winter.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>上个月，我们被警告说，随着通胀和美联储联手结束我们多年来陷入的大规模低利率模式，利率已准备好大幅走高。然后，利率似乎突然大幅走低，10年期国债收益率从5月底的近1.70%降至1.32%。基准30年期国债回到1.94%的水平。这是自去年冬天以来的最低利率水平。</blockquote></p><p> For income investors, this is another setback in what has become over a ten-year problem. While rates certainly could rise again, <a href=\"https://laohu8.com/S/AONE\">one</a> thing seems certain: the Federal Reserve will not raise rates until it is positive the economy is back at full strength. The only move the Fed looks poised to make in the near term is the beginning of the tapering of the $120 billion per month purchase of Treasury and mortgage debt.</p><p><blockquote>对于收益投资者来说，这是十多年来问题的又一次挫折。虽然利率肯定会再次上升，<a href=\"https://laohu8.com/S/AONE\">一</a>事情似乎是肯定的：在经济恢复全面强劲之前，美联储不会加息。美联储近期唯一准备采取的举措是开始缩减每月1200亿美元的国债和抵押贷款债务购买规模。</blockquote></p><p> We screened the BofA Securities research universe looking for blue chip stocks rated Buy that paid at least a 4% dividend. We found five that are very appealing now to growth and income investors. While all are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.</p><p><blockquote>我们筛选了美国银行证券研究领域，寻找支付至少4%股息的买入评级蓝筹股。我们发现了五种现在对成长型和收益型投资者非常有吸引力的股票。虽然所有报告都被评为买入，但重要的是要记住，任何分析师报告都不应用作任何买入或卖出决策的唯一依据。</blockquote></p><p> <a href=\"https://laohu8.com/S/MO\">Altria</a></p><p><blockquote><a href=\"https://laohu8.com/S/MO\">奥驰亚</a></blockquote></p><p> This maker of tobacco products offers value investors a great entry point now and was hit recently as cigarette sales have slowed. Altria Group Inc. (NYSE: MO) is the parent company of <a href=\"https://laohu8.com/S/PM\">Philip Morris</a> USA (cigarettes), UST (smokeless), John Middleton (cigars), Ste. Michelle Wine Estates and Philip Morris Capital. PMUSA enjoys a 51% share of the U.S. cigarette market, led by its top cigarette brand Marlboro.</p><p><blockquote>这家烟草产品制造商现在为价值投资者提供了一个很好的切入点，但最近由于卷烟销售放缓而受到打击。奥驰亚集团公司（纽约证券交易所股票代码：MO）是<a href=\"https://laohu8.com/S/PM\">菲利普·莫里斯</a>美国（香烟），UST（无烟），约翰米德尔顿（雪茄），Ste。米歇尔葡萄酒庄园和菲利普莫里斯资本。PMUSA在美国卷烟市场占据51%的份额，由其顶级卷烟品牌万宝路引领。</blockquote></p><p> Altria also owns over 10% of Anheuser-Busch InBev, the world’s largest brewer. In March 2008, it spun off its international cigarette business to shareholders. In December 2018, the company acquired 35% of Juul Labs, and it has purchased a 45% stake in cannabis company Cronus for $1.8 billion.</p><p><blockquote>奥驰亚还拥有全球最大啤酒制造商百威英博10%以上的股份。2008年3月，它将国际卷烟业务分拆给股东。2018年12月，该公司收购了Juul Labs 35%的股份，并以18亿美元收购了大麻公司Cronus 45%的股份。</blockquote></p><p> BofA Securities is very favorable toward the company’s plans for the future:</p><p><blockquote>美银证券非常看好该公司的未来计划：</blockquote></p><p>   Management presented at CAGNY (Consumer Analyst Group of <a href=\"https://laohu8.com/S/NWY\">New York</a>) where it discussed a new corporate focus on ESG, additional details on its IQOS plans and its “Moving beyond smoking” 10-yr plan. Smokeables (cigarettes/cigars) will remain an important part of its strategy, providing funding behind its long-term growth and shareholder returns. Over the last 5-yrs, smokeable and other comprehensive income grew at a 5.5% compounded annual growth rate despite volume declines.  Shareholders receive a 7.35% dividend. The analyst has a $58 target price on the shares, while the consensus target is lower at $53.89. Altria stock closed on Wednesday at $46.79 per share.</p><p><blockquote>管理层在CAGNY（消费者分析师小组<a href=\"https://laohu8.com/S/NWY\">纽约</a>）讨论了企业对ESG的新关注、IQOS计划及其“超越吸烟”10年计划的更多细节。Smokeables（香烟/雪茄）仍将是其战略的重要组成部分，为其长期增长和股东回报提供资金。在过去的5年里，尽管数量下降，吸烟和其他综合收入仍以5.5%的复合年增长率增长。股东获得7.35%的股息。分析师对该股的目标价为58美元，而共识目标价较低，为53.89美元。奥驰亚股价周三收于每股46.79美元。</blockquote></p><p> <a href=\"https://laohu8.com/S/CVX\">Chevron</a></p><p><blockquote><a href=\"https://laohu8.com/S/CVX\">雪佛龙</a></blockquote></p><p> This energy giant is a solid way for investors who are more conservative to be positioned in the sector. Chevron Corp. (NYSE: CVX) is a U.S.-based integrated oil and gas company, with worldwide operations in exploration and production, refining and marketing, transportation and petrochemicals. The company sports a sizable dividend and has a solid place in the sector when it comes to natural gas and liquefied natural gas.</p><p><blockquote>对于较为保守的投资者来说，这家能源巨头是在该行业定位的可靠途径。雪佛龙公司（纽约证券交易所股票代码：CVX）是一家总部位于美国的综合性石油和天然气公司，在勘探和生产、炼油和营销、运输和石化领域开展全球业务。该公司拥有可观的股息，并在天然气和液化天然气领域拥有稳固的地位。</blockquote></p><p> With the strongest financial base of the majors, coupled with an attractive relative asset base, many on Wall Street feel that Chevron offers the most straightforwardly positive risk/reward. Although current conditions do not warrant a large focus on production growth, Chevron possesses numerous medium-term drivers (<a href=\"https://laohu8.com/S/NBL\">Noble</a> integration, Permian, TCO/WPMP expansion, Gulf of Mexico exploration, Vaca Muerta, and so on) that should support production levels in the coming years.</p><p><blockquote>凭借各大巨头中最强大的财务基础，加上有吸引力的相对资产基础，华尔街的许多人认为雪佛龙提供了最直接的正风险/回报。尽管目前的情况不值得大力关注产量增长，但雪佛龙拥有众多中期驱动因素（<a href=\"https://laohu8.com/S/NBL\">高尚的</a>一体化、二叠纪、TCO/WPMP扩张、墨西哥湾勘探、Vaca Muerta等）应该会支持未来几年的生产水平。</blockquote></p><p> <a href=\"https://laohu8.com/S/IBM\">IBM</a></p><p><blockquote><a href=\"https://laohu8.com/S/IBM\">IBM</a></blockquote></p><p> This old-school tech giant still offers investors a very solid entry point. International Business Machines Corp. (NYSE: IBM) is a leading provider of enterprise solutions, offering a broad portfolio of information technology (IT) hardware, business and IT services, and a full suite of software solutions.</p><p><blockquote>这家老派科技巨头仍然为投资者提供了一个非常坚实的切入点。国际商业机器公司（纽约证券交易所代码：IBM）是一家领先的企业解决方案提供商，提供广泛的信息技术（IT）硬件、商业和IT服务以及全套软件解决方案。</blockquote></p><p> The company integrates its hardware products with its software and services offerings in order to provide high-value solutions. Analysts have cited the company’s potential in the public cloud as a reason for their positive outlook going forward.</p><p><blockquote>该公司将其硬件产品与其软件和服务产品相集成，以提供高价值的解决方案。分析师将该公司在公共云领域的潜力作为他们对未来前景持积极态度的原因。</blockquote></p><p> CEO Ginni Rommety, who had been in the position since 2012, stepped down in January, and the stock market greeted the news in a very positive manner. Arvind Krishna, who has led the company’s cloud computing business, became the new chief executive. Rometty will remain as executive board chair until the end of the year.</p><p><blockquote>自2012年以来一直担任该职位的首席执行官吉尼·罗梅蒂(Ginni Rommety)于1月份辞职，股市以非常积极的方式迎接这一消息。领导该公司云计算业务的Arvind Krishna成为新任首席执行官。罗睿兰将继续担任执行董事会主席直至今年年底。</blockquote></p><p></p><p> Holders of IBM stock receive a 4.69% dividend. The $175 BofA Securities price target is well above the $144.14 consensus figure. The shares closed at $139.82 on Wednesday.</p><p><blockquote>IBM股票持有人获得4.69%的股息。美国银行证券175美元的目标价远高于144.14美元的共识价。该股周三收于139.82美元。</blockquote></p><p> Shareholders receive a 5.21% dividend, which analysts feel comfortable will remain at current levels. The BofA Securities price target is $125, which compares to a $122.48 consensus target and the last Chevron stock trade on Wednesday at $102.93 a share.</p><p><blockquote>股东获得5.21%的股息，分析师认为股息将保持在当前水平。美国银行证券的目标价为125美元，而共识目标价为122.48美元，周三雪佛龙股票最后一次交易价格为每股102.93美元。</blockquote></p><p> LyondellBasell</p><p><blockquote>利安德巴塞尔</blockquote></p><p> This top chemical company with a sterling balance sheet is another solid play for conservative investors. LyondellBasell Industries N.V. (NYSE: LYB) manufactures chemicals and polymers, refines crude oil, produces gasoline blending components and develops and licenses technologies for production of polymers.</p><p><blockquote>这家拥有良好资产负债表的顶级化工公司是保守投资者的另一个可靠选择。利安德巴塞尔工业公司（纽约证券交易所股票代码：LYB）生产化学品和聚合物、精炼原油、生产汽油混合成分以及开发和许可聚合物生产技术。</blockquote></p><p> Over half of earnings are generated in the company’s Olefins and Polyolefins Americas segment, where costs are linked to the price of cheap natural gas in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States, while selling prices are correlated with the price of oil. The company has pursued a strategy of low-cost, high return on invested capital debottlenecks coupled with cash returns to shareholders.</p><p><blockquote>超过一半的收入来自该公司的烯烃和聚烯烃美洲部门，该部门的成本与该地区廉价天然气的价格相关。<a href=\"https://laohu8.com/S/UBNK\">团结的</a>国家，而销售价格与石油价格相关。该公司奉行低成本、高投资资本回报率的战略，消除瓶颈，并向股东提供现金回报。</blockquote></p><p> Note that debottlenecking is the process of identifying specific areas or equipment in oil and gas facilities that limit the flow of product (known as bottlenecks) and optimizing them so that overall capacity in the plant can be increased.</p><p><blockquote>请注意，去瓶颈是识别石油和天然气设施中限制产品流动的特定区域或设备（称为瓶颈）并对其进行优化的过程，以便提高工厂的整体产能。</blockquote></p><p> The company offers a 4.50% dividend. BofA Securities has set a $117 price target. The consensus target is $118.41, and LyondellBasell stock ended Wednesday at $100.40 a share.</p><p><blockquote>该公司提供4.50%的股息。美银证券将目标价定为117美元。共识目标为118.41美元，利安德巴塞尔股票周三收于每股100.40美元。</blockquote></p><p></p>","source":"lsy1620372341666","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge<blockquote>随着利率暴跌，值得买入并获得巨额股息的5只蓝筹股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Blue Chip Stocks to Buy With Huge Dividends as Interest Rates Plunge<blockquote>随着利率暴跌，值得买入并获得巨额股息的5只蓝筹股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">24/7 wall street</strong><span class=\"h-time small\">2021-07-09 12:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/JE\">Just</a> last month, we were being warned that interest rates were ready to move meaningfully higher as inflation and the Federal Reserve were teaming up to end the massive low interest rate paradigm we have been stuck in for years. Then, seemingly out of nowhere, rates have dived lower, with the 10-year Treasury trading at a 1.32% yield, down from near 1.70% at the end of May. The benchmark 30-year Treasury bond is back at the 1.94% level. These are the lowest interest rate levels since last winter.</p><p><blockquote><a href=\"https://laohu8.com/S/JE\">刚刚</a>上个月，我们被警告说，随着通胀和美联储联手结束我们多年来陷入的大规模低利率模式，利率已准备好大幅走高。然后，利率似乎突然大幅走低，10年期国债收益率从5月底的近1.70%降至1.32%。基准30年期国债回到1.94%的水平。这是自去年冬天以来的最低利率水平。</blockquote></p><p> For income investors, this is another setback in what has become over a ten-year problem. While rates certainly could rise again, <a href=\"https://laohu8.com/S/AONE\">one</a> thing seems certain: the Federal Reserve will not raise rates until it is positive the economy is back at full strength. The only move the Fed looks poised to make in the near term is the beginning of the tapering of the $120 billion per month purchase of Treasury and mortgage debt.</p><p><blockquote>对于收益投资者来说，这是十多年来问题的又一次挫折。虽然利率肯定会再次上升，<a href=\"https://laohu8.com/S/AONE\">一</a>事情似乎是肯定的：在经济恢复全面强劲之前，美联储不会加息。美联储近期唯一准备采取的举措是开始缩减每月1200亿美元的国债和抵押贷款债务购买规模。</blockquote></p><p> We screened the BofA Securities research universe looking for blue chip stocks rated Buy that paid at least a 4% dividend. We found five that are very appealing now to growth and income investors. While all are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.</p><p><blockquote>我们筛选了美国银行证券研究领域，寻找支付至少4%股息的买入评级蓝筹股。我们发现了五种现在对成长型和收益型投资者非常有吸引力的股票。虽然所有报告都被评为买入，但重要的是要记住，任何分析师报告都不应用作任何买入或卖出决策的唯一依据。</blockquote></p><p> <a href=\"https://laohu8.com/S/MO\">Altria</a></p><p><blockquote><a href=\"https://laohu8.com/S/MO\">奥驰亚</a></blockquote></p><p> This maker of tobacco products offers value investors a great entry point now and was hit recently as cigarette sales have slowed. Altria Group Inc. (NYSE: MO) is the parent company of <a href=\"https://laohu8.com/S/PM\">Philip Morris</a> USA (cigarettes), UST (smokeless), John Middleton (cigars), Ste. Michelle Wine Estates and Philip Morris Capital. PMUSA enjoys a 51% share of the U.S. cigarette market, led by its top cigarette brand Marlboro.</p><p><blockquote>这家烟草产品制造商现在为价值投资者提供了一个很好的切入点，但最近由于卷烟销售放缓而受到打击。奥驰亚集团公司（纽约证券交易所股票代码：MO）是<a href=\"https://laohu8.com/S/PM\">菲利普·莫里斯</a>美国（香烟），UST（无烟），约翰米德尔顿（雪茄），Ste。米歇尔葡萄酒庄园和菲利普莫里斯资本。PMUSA在美国卷烟市场占据51%的份额，由其顶级卷烟品牌万宝路引领。</blockquote></p><p> Altria also owns over 10% of Anheuser-Busch InBev, the world’s largest brewer. In March 2008, it spun off its international cigarette business to shareholders. In December 2018, the company acquired 35% of Juul Labs, and it has purchased a 45% stake in cannabis company Cronus for $1.8 billion.</p><p><blockquote>奥驰亚还拥有全球最大啤酒制造商百威英博10%以上的股份。2008年3月，它将国际卷烟业务分拆给股东。2018年12月，该公司收购了Juul Labs 35%的股份，并以18亿美元收购了大麻公司Cronus 45%的股份。</blockquote></p><p> BofA Securities is very favorable toward the company’s plans for the future:</p><p><blockquote>美银证券非常看好该公司的未来计划：</blockquote></p><p>   Management presented at CAGNY (Consumer Analyst Group of <a href=\"https://laohu8.com/S/NWY\">New York</a>) where it discussed a new corporate focus on ESG, additional details on its IQOS plans and its “Moving beyond smoking” 10-yr plan. Smokeables (cigarettes/cigars) will remain an important part of its strategy, providing funding behind its long-term growth and shareholder returns. Over the last 5-yrs, smokeable and other comprehensive income grew at a 5.5% compounded annual growth rate despite volume declines.  Shareholders receive a 7.35% dividend. The analyst has a $58 target price on the shares, while the consensus target is lower at $53.89. Altria stock closed on Wednesday at $46.79 per share.</p><p><blockquote>管理层在CAGNY（消费者分析师小组<a href=\"https://laohu8.com/S/NWY\">纽约</a>）讨论了企业对ESG的新关注、IQOS计划及其“超越吸烟”10年计划的更多细节。Smokeables（香烟/雪茄）仍将是其战略的重要组成部分，为其长期增长和股东回报提供资金。在过去的5年里，尽管数量下降，吸烟和其他综合收入仍以5.5%的复合年增长率增长。股东获得7.35%的股息。分析师对该股的目标价为58美元，而共识目标价较低，为53.89美元。奥驰亚股价周三收于每股46.79美元。</blockquote></p><p> <a href=\"https://laohu8.com/S/CVX\">Chevron</a></p><p><blockquote><a href=\"https://laohu8.com/S/CVX\">雪佛龙</a></blockquote></p><p> This energy giant is a solid way for investors who are more conservative to be positioned in the sector. Chevron Corp. (NYSE: CVX) is a U.S.-based integrated oil and gas company, with worldwide operations in exploration and production, refining and marketing, transportation and petrochemicals. The company sports a sizable dividend and has a solid place in the sector when it comes to natural gas and liquefied natural gas.</p><p><blockquote>对于较为保守的投资者来说，这家能源巨头是在该行业定位的可靠途径。雪佛龙公司（纽约证券交易所股票代码：CVX）是一家总部位于美国的综合性石油和天然气公司，在勘探和生产、炼油和营销、运输和石化领域开展全球业务。该公司拥有可观的股息，并在天然气和液化天然气领域拥有稳固的地位。</blockquote></p><p> With the strongest financial base of the majors, coupled with an attractive relative asset base, many on Wall Street feel that Chevron offers the most straightforwardly positive risk/reward. Although current conditions do not warrant a large focus on production growth, Chevron possesses numerous medium-term drivers (<a href=\"https://laohu8.com/S/NBL\">Noble</a> integration, Permian, TCO/WPMP expansion, Gulf of Mexico exploration, Vaca Muerta, and so on) that should support production levels in the coming years.</p><p><blockquote>凭借各大巨头中最强大的财务基础，加上有吸引力的相对资产基础，华尔街的许多人认为雪佛龙提供了最直接的正风险/回报。尽管目前的情况不值得大力关注产量增长，但雪佛龙拥有众多中期驱动因素（<a href=\"https://laohu8.com/S/NBL\">高尚的</a>一体化、二叠纪、TCO/WPMP扩张、墨西哥湾勘探、Vaca Muerta等）应该会支持未来几年的生产水平。</blockquote></p><p> <a href=\"https://laohu8.com/S/IBM\">IBM</a></p><p><blockquote><a href=\"https://laohu8.com/S/IBM\">IBM</a></blockquote></p><p> This old-school tech giant still offers investors a very solid entry point. International Business Machines Corp. (NYSE: IBM) is a leading provider of enterprise solutions, offering a broad portfolio of information technology (IT) hardware, business and IT services, and a full suite of software solutions.</p><p><blockquote>这家老派科技巨头仍然为投资者提供了一个非常坚实的切入点。国际商业机器公司（纽约证券交易所代码：IBM）是一家领先的企业解决方案提供商，提供广泛的信息技术（IT）硬件、商业和IT服务以及全套软件解决方案。</blockquote></p><p> The company integrates its hardware products with its software and services offerings in order to provide high-value solutions. Analysts have cited the company’s potential in the public cloud as a reason for their positive outlook going forward.</p><p><blockquote>该公司将其硬件产品与其软件和服务产品相集成，以提供高价值的解决方案。分析师将该公司在公共云领域的潜力作为他们对未来前景持积极态度的原因。</blockquote></p><p> CEO Ginni Rommety, who had been in the position since 2012, stepped down in January, and the stock market greeted the news in a very positive manner. Arvind Krishna, who has led the company’s cloud computing business, became the new chief executive. Rometty will remain as executive board chair until the end of the year.</p><p><blockquote>自2012年以来一直担任该职位的首席执行官吉尼·罗梅蒂(Ginni Rommety)于1月份辞职，股市以非常积极的方式迎接这一消息。领导该公司云计算业务的Arvind Krishna成为新任首席执行官。罗睿兰将继续担任执行董事会主席直至今年年底。</blockquote></p><p></p><p> Holders of IBM stock receive a 4.69% dividend. The $175 BofA Securities price target is well above the $144.14 consensus figure. The shares closed at $139.82 on Wednesday.</p><p><blockquote>IBM股票持有人获得4.69%的股息。美国银行证券175美元的目标价远高于144.14美元的共识价。该股周三收于139.82美元。</blockquote></p><p> Shareholders receive a 5.21% dividend, which analysts feel comfortable will remain at current levels. The BofA Securities price target is $125, which compares to a $122.48 consensus target and the last Chevron stock trade on Wednesday at $102.93 a share.</p><p><blockquote>股东获得5.21%的股息，分析师认为股息将保持在当前水平。美国银行证券的目标价为125美元，而共识目标价为122.48美元，周三雪佛龙股票最后一次交易价格为每股102.93美元。</blockquote></p><p> LyondellBasell</p><p><blockquote>利安德巴塞尔</blockquote></p><p> This top chemical company with a sterling balance sheet is another solid play for conservative investors. LyondellBasell Industries N.V. (NYSE: LYB) manufactures chemicals and polymers, refines crude oil, produces gasoline blending components and develops and licenses technologies for production of polymers.</p><p><blockquote>这家拥有良好资产负债表的顶级化工公司是保守投资者的另一个可靠选择。利安德巴塞尔工业公司（纽约证券交易所股票代码：LYB）生产化学品和聚合物、精炼原油、生产汽油混合成分以及开发和许可聚合物生产技术。</blockquote></p><p> Over half of earnings are generated in the company’s Olefins and Polyolefins Americas segment, where costs are linked to the price of cheap natural gas in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States, while selling prices are correlated with the price of oil. The company has pursued a strategy of low-cost, high return on invested capital debottlenecks coupled with cash returns to shareholders.</p><p><blockquote>超过一半的收入来自该公司的烯烃和聚烯烃美洲部门，该部门的成本与该地区廉价天然气的价格相关。<a href=\"https://laohu8.com/S/UBNK\">团结的</a>国家，而销售价格与石油价格相关。该公司奉行低成本、高投资资本回报率的战略，消除瓶颈，并向股东提供现金回报。</blockquote></p><p> Note that debottlenecking is the process of identifying specific areas or equipment in oil and gas facilities that limit the flow of product (known as bottlenecks) and optimizing them so that overall capacity in the plant can be increased.</p><p><blockquote>请注意，去瓶颈是识别石油和天然气设施中限制产品流动的特定区域或设备（称为瓶颈）并对其进行优化的过程，以便提高工厂的整体产能。</blockquote></p><p> The company offers a 4.50% dividend. BofA Securities has set a $117 price target. The consensus target is $118.41, and LyondellBasell stock ended Wednesday at $100.40 a share.</p><p><blockquote>该公司提供4.50%的股息。美银证券将目标价定为117美元。共识目标为118.41美元，利安德巴塞尔股票周三收于每股100.40美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://247wallst.com/investing/2021/07/08/5-blue-chip-stocks-to-buy-with-huge-dividends-as-interest-rates-plunge/\">24/7 wall street</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://247wallst.com/investing/2021/07/08/5-blue-chip-stocks-to-buy-with-huge-dividends-as-interest-rates-plunge/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119741032","content_text":"Just last month, we were being warned that interest rates were ready to move meaningfully higher as inflation and the Federal Reserve were teaming up to end the massive low interest rate paradigm we have been stuck in for years. Then, seemingly out of nowhere, rates have dived lower, with the 10-year Treasury trading at a 1.32% yield, down from near 1.70% at the end of May. The benchmark 30-year Treasury bond is back at the 1.94% level. These are the lowest interest rate levels since last winter.\nFor income investors, this is another setback in what has become over a ten-year problem. While rates certainly could rise again, one thing seems certain: the Federal Reserve will not raise rates until it is positive the economy is back at full strength. The only move the Fed looks poised to make in the near term is the beginning of the tapering of the $120 billion per month purchase of Treasury and mortgage debt.\nWe screened the BofA Securities research universe looking for blue chip stocks rated Buy that paid at least a 4% dividend. We found five that are very appealing now to growth and income investors. While all are rated Buy, it is important to remember that no single analyst report should be used as a sole basis for any buying or selling decision.\nAltria\nThis maker of tobacco products offers value investors a great entry point now and was hit recently as cigarette sales have slowed. Altria Group Inc. (NYSE: MO) is the parent company of Philip Morris USA (cigarettes), UST (smokeless), John Middleton (cigars), Ste. Michelle Wine Estates and Philip Morris Capital. PMUSA enjoys a 51% share of the U.S. cigarette market, led by its top cigarette brand Marlboro.\nAltria also owns over 10% of Anheuser-Busch InBev, the world’s largest brewer. In March 2008, it spun off its international cigarette business to shareholders. In December 2018, the company acquired 35% of Juul Labs, and it has purchased a 45% stake in cannabis company Cronus for $1.8 billion.\nBofA Securities is very favorable toward the company’s plans for the future:\n\n Management presented at CAGNY (Consumer Analyst Group of New York) where it discussed a new corporate focus on ESG, additional details on its IQOS plans and its “Moving beyond smoking” 10-yr plan. Smokeables (cigarettes/cigars) will remain an important part of its strategy, providing funding behind its long-term growth and shareholder returns. Over the last 5-yrs, smokeable and other comprehensive income grew at a 5.5% compounded annual growth rate despite volume declines.\n\nShareholders receive a 7.35% dividend. The analyst has a $58 target price on the shares, while the consensus target is lower at $53.89. Altria stock closed on Wednesday at $46.79 per share.\nChevron\nThis energy giant is a solid way for investors who are more conservative to be positioned in the sector. Chevron Corp. (NYSE: CVX) is a U.S.-based integrated oil and gas company, with worldwide operations in exploration and production, refining and marketing, transportation and petrochemicals. The company sports a sizable dividend and has a solid place in the sector when it comes to natural gas and liquefied natural gas.\nWith the strongest financial base of the majors, coupled with an attractive relative asset base, many on Wall Street feel that Chevron offers the most straightforwardly positive risk/reward. Although current conditions do not warrant a large focus on production growth, Chevron possesses numerous medium-term drivers (Noble integration, Permian, TCO/WPMP expansion, Gulf of Mexico exploration, Vaca Muerta, and so on) that should support production levels in the coming years.\nIBM\nThis old-school tech giant still offers investors a very solid entry point. International Business Machines Corp. (NYSE: IBM) is a leading provider of enterprise solutions, offering a broad portfolio of information technology (IT) hardware, business and IT services, and a full suite of software solutions.\nThe company integrates its hardware products with its software and services offerings in order to provide high-value solutions. Analysts have cited the company’s potential in the public cloud as a reason for their positive outlook going forward.\nCEO Ginni Rommety, who had been in the position since 2012, stepped down in January, and the stock market greeted the news in a very positive manner. Arvind Krishna, who has led the company’s cloud computing business, became the new chief executive. Rometty will remain as executive board chair until the end of the year.\nHolders of IBM stock receive a 4.69% dividend. The $175 BofA Securities price target is well above the $144.14 consensus figure. The shares closed at $139.82 on Wednesday.\nShareholders receive a 5.21% dividend, which analysts feel comfortable will remain at current levels. The BofA Securities price target is $125, which compares to a $122.48 consensus target and the last Chevron stock trade on Wednesday at $102.93 a share.\nLyondellBasell\nThis top chemical company with a sterling balance sheet is another solid play for conservative investors. LyondellBasell Industries N.V. (NYSE: LYB) manufactures chemicals and polymers, refines crude oil, produces gasoline blending components and develops and licenses technologies for production of polymers.\nOver half of earnings are generated in the company’s Olefins and Polyolefins Americas segment, where costs are linked to the price of cheap natural gas in the United States, while selling prices are correlated with the price of oil. The company has pursued a strategy of low-cost, high return on invested capital debottlenecks coupled with cash returns to shareholders.\nNote that debottlenecking is the process of identifying specific areas or equipment in oil and gas facilities that limit the flow of product (known as bottlenecks) and optimizing them so that overall capacity in the plant can be increased.\nThe company offers a 4.50% dividend. BofA Securities has set a $117 price target. The consensus target is $118.41, and LyondellBasell stock ended Wednesday at $100.40 a share.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":492,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121402363,"gmtCreate":1624487036452,"gmtModify":1634005558059,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Crypto&nbsp;bubble going to burst","listText":"Crypto&nbsp;bubble going to burst","text":"Crypto bubble going to burst","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121402363","repostId":"2145531099","repostType":4,"isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":119786848,"gmtCreate":1622565116184,"gmtModify":1634100401935,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"AMC is a big jump up","listText":"AMC is a big jump up","text":"AMC is a big jump up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/119786848","repostId":"2140626460","repostType":4,"isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":870828808,"gmtCreate":1636602784935,"gmtModify":1636602785083,"author":{"id":"3580168616843436","authorId":"3580168616843436","name":"林欣霓","avatar":"https://static.tigerbbs.com/a28a5c6d65cfcd6a5024f3b15f4975e8","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580168616843436","idStr":"3580168616843436"},"themes":[],"htmlText":"Wood saids The next big 'Aha moment' for the market is when we see some success on [Tesla's] full self-driving autonomous front[微笑]&nbsp;","listText":"Wood saids The next big 'Aha moment' for the market is when we see some success on [Tesla's] full self-driving autonomous front[微笑]&nbsp;","text":"Wood saids The next big 'Aha moment' for the market is when we see some success on [Tesla's] full self-driving autonomous front[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870828808","repostId":"2182005821","repostType":4,"isVote":1,"tweetType":1,"viewCount":2226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}